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CHAPTER ONE 
INTRODUCTION 
A. Termino1..2.g:£ 
1. Types Qf Biological Rhythms 
Halberg (1959) differentiates the terms "rhythm" 
and "biorhythm" by defining a rhythm as a "statistically 
validated physiologic change recurring with a reproduc-
ible waveform" and by defining "biorhythm" as a rhythm 
"which persists under a variety of test conditions, such 
as blinding, constancy (as far as possible) with respect 
• to light (or darkness), and environmental temperature, as 
well as ad libitum feeding or other conditions and sched-
ules". The frequency or period of a rhythm may be in-
dicated by the adjective preceding it (~infra). 
The word "circadian" is derived from the Latin 
1 
circa~. which means "about one day". This term refers 
to rhythms having a period of 20-28 hours and a frequency 
of about one cycle per day (Halberg, 1959). Subsequently, 
this term was used by some workers only in reference to 
those rhythms which are endogenous and have a character-
istic free-running pattern (Aschoff, 1960; Pittendrigh, 
1960). The term "diurnal" was then used to indicate 
rhythms which had only been measured on a 24-hour basis, 
t 
but it is ambiguous due to its secondary meaning of 
"daily" as opposed to nocturnal, or nightly. Halberg 
(1963a) and Mills (1966) consider the use of the term 
"diurnal" inappropriate because of this lack of clarity. 
wurtman (1967) criticized the ambiguous use of the term 
"circadian" and suggested that it be restricted only to 
those studies which qualify as free-running as determined 
by continuous monitoring. He suggested that the use of 
the term "daily rhythm" or "24-hour rhythm" be utilized 
to refer to those systems which are sampled on a single 
24-hour cycle. 
Halberg has also coined other terms to refer to 
• 
those rhythms which are non-circadian. The roots of 
these terms are based on the common prefixes used in 
physics with reference to light spectra. Ultradian 
rhythms are those which have a frequency greater than one 
cycle per day, or a period of between one and 19.9 hours 
(Halberg, Engeli, Hamburger, and Hillman, 1965). The 
term "infradian" refers to a rhythm with a frequency of 
less than one cycle per day, or a period of greater than 
28.5 hours (Halberg and Reinberg, 1967). 
In addition to these common types of rhythms, 
Halberg and Reinberg (1967) have subdivided physiological 
rhythms as follows: "1) a high frequency domain of 
rhythms with periods sho~ter than 0.5 hours; 2) a medial 
frequency domain of rhythms with periods ranging in length 
from 0.5 hours to 2.5 days, including the regions of ul-
tradian (periods of 0.5 - 19.9 hours), circadian (periods 
2 
from 20~28 hours), and infradian (28.5 hours - 2.5 days) 
rhythms; 3) a low frequency domain of rhythms with periods 
longer than 2.5 days: inter alia, circasepten (with a 
period of approximately 7 days), circavigintan (with a 
period of approximately 20 days), circatrigintan (a per-
iod of approximately 30 days), and circannual (a period of 
approximately one year) rhythms". 
2. Other Terminology ~ 1.!! Reference 
to Biological .,:Ehythms 
The term "cycle" refers to the smallest part of a 
rhythm which repeats itself. A period is the time in-
terval occupied by a single cycle. The frequency of a 
rhythm refers to the number of cycles produced in a given 
time period. Exogenous rhythms are those rhythms which 
may be altered by alteration of environmental parameters, 
whereas endogenous rhythms are those which persist under 
conditions of constant environmental factors, such as 
constant light or darkness. These latter rhythms are 
also referred to as "free-running" (Mills, 1966). Phase-
shifting is a term used to describe manipulations of the 
synchronization routine, which may lead to a shifting of 
the rhythms along the time axis. A sudden shift of twelve 
hours in a controlled environmental parameter is generally 
described as inversion. Zeitgeber (sometimes used in the 
German form as a tribute to Aschoff), or entraining agents 
(Pittendrigh, 1960) are terms referring to those environ-
mental factors which are important in setting the phase 
of a biological rhythm, such as light, temperature, noise 
cues, feeding schedules, etc. 
3. Circadian Versus Local ~ 
The time axis of any study of rhythms can be ex-
pressed by either circadian time or local clock time. 
Circadian ~ is based on a time scale utilizing dawn, 
or first light ex,osure as time zero. This method of 
temporal expression is often used by authors in the study 
of biological rhythms in lower animal forms. Local clock 
~ (eg. Central Standard Time, CST, in this area) will 
be used throughout this thesis for two reasons: 1) the 
4 
animals used for these studies were purchased from com-
mercial breeders, and their first exposure to light is 
therefore unknown, and 2) this type of data is more readily 
appreciated when expressed on a clock time basis. 
B. Historical Aspects 
The first known publication in the area of the 
physiological effects of light was a book written by J. c. 
~ 
Ebermaier, the court-bookseller of Osnabruck, Germany, 
entitled "Versuch einer Geschichte des Lichtes in Ruck-
sicht seines Einflusses auf die gesamte Natur, und auf 
5 
den menschlichen Korper, auber dem Gesicht, besonders."* 
(Ebermaier, 1799). This book dealt with the effects of 
light on human subjects as well as with the concepts of 
circadian and seasonal rhythms in humans. M. Deyeux (1815) 
published a doctoral thesis dealing with body temperature 
variations on a 24-hour basis in human subjects. Many 
studies on body temperature fluctuation followed this 
initial work of Deyeux's, and by 1925 investigators had 
examined variability in such phenomena as urinary ex-
• 
cretion, excretory rhythms, gonadal weights, and the in-
fluence of day-length on migrational habits of birds 
(Lahr, 1889; Campbell and Webster, 1921, 1922; Simpson, 
1924; Rowan, 1925). Cannon's concept of homeostasis was 
eventually modified to envisage a constantly changing 
milieu rather than a static condition, and this milieu 
was believed ~o have a predominently circadian rhythm, 
which included some components of shorter or longer dur-
ation. In August 1937, the Society for Biological Rhythms 
held its first meeting at Ronneby, Sweden (Mills, 1966). 
The more recent studies in this field will be con-
sidered in the Review of Literature. 
*"An essay on the history of light, concerned with its 
influence on man, with or without the sense of sight." 
6 
C. Practical Considerations 
Environmental alterations will often reflect them-
selves in the life patterns of the organism. In the case 
of man, there are variable environmental exposures such as 
the equivalent periods of light or darkness found at the 
equator as opposed to the long midsummer and midwinter 
periods of light or darkness at the poles. Thus, dif-
ferent populations are out of phase with one another 
(Mills, 1966). TAese differences presented very little 
problem to man until he improved travel to speeds which 
were faster than his capability to adapt to a new environ-
ment. When man flies at supersonic speeds, he may cross 
several time zones, and he subsequently must adapt his in-
ternal milieu to a new pattern. In long distance flights, 
70% of the travelers experience some physiological dis-
comfort. Stru.ghold (1962) has termed this condition 
"asynchronosis", and it is exhibited by most higher mam-
mals traversing four or more time zones in succession. He 
suggests three possible prophylactic measures for this prob-
1 em: "1) arrive at one's destination several days in ad-
vance and allow the biological system to adjust rhythmi-
cally to the environment: 2) pre-adaptation or pre-flight 
synchronization by initiating a sleep/wake schedule iden-
tical to that at the point of destination several days 
before travel, or 3) the use of mild drugs to accelerate 
the physiological adjustment". However, "asynchronosis" 
may also be used by some companies to accelerate the re-
tirement of executives. This is accomplished by extended 
7 
global travel for the executive, without allowing proper 
time for adjustment to the local rhythms (Parkinson, 1957). 
These environmental problems also affect pilot 
efficiency. Crane (1963) has described a higher inci-
dence of flight accidents at night than during the day. 
0 
The increased accident rate coincides with the trough of 
mental and psychomotor efficiency in man (Browne, 1961). 
Klein et.!!:!• (1970) have noted that pilots exhibit a cir-
cadian pattern when tested on a supersonic simulator. The 
peak and trough of this pattern occur at 2-3 pm and 4-5 am 
respectively. Eastward, but not westward, flight patterns 
also caused decreased efficiency due to the increased 
sleep loss manifested by pilots traveling eastward. 
During space travel, man encounters a day of 1.5 
hours duration. This has led to work/sleep cycle prob-
lems in the Apollo space program. On Apollo 7, cycles 
were quite irregular and the crew was poorly adapted. The 
commander fell asleep d~ing his watch, while another crew 
member was taking d-amphetamine to stay alert during his 
work period. On Apollo 8, sleep period scheduling was 
8 
left at the option of the crew. Secobarbital was included 
in the medical kit to aid in sedation for the sleep per-
iods. Sleep cycles still varied markedly from the orig-
inal patterns of the crew, and crew fatigue led to pro-
cedural errors and forced "time-changes" in the flight 
plan. Apollo missions 9 and 10 allowed the crew to sleep 
simultaneously. This improvement was a factor in the 
ability of these crews to maintain their original sleep 
patterns. On the Apollo 11 mission, the crew slept well 
• 
except for the period of time spent by two of the crew-
members in the lunar module (LM). The environment was 
too noisy and the space suits were too cold to allow ad-
equate sleep. The LM commander had little, if any, sleep; 
the LM pilot estimated his sleeping time at two hours 
(Berry, 1970). 
Such studies indicate the need to develop tech-
niques that minimize the undesirable physiological dis-
tress associated with man's biological clock, when it is 
forced to run out of phase with its "normal" environment. 
CHAPTER TWO 
REVIEW OF LITERATURE 
L 
10 
A. Parameters AffectiQg Biological Rhythms 
The synchronization of circadian rhythms has been 
explained by various mechanisms. One theory (Bunning, 
1964) proposed that rhythms are acquired by evolutionary 
selection, while another (Went, 1960) deals with the pos-
sibility of rate-limiting feedback steps, which are self-
limiting within a given oscillatory range. A third (Brown, 
1960) has been proposed which suggests that circadian 
rhythms are contrelled from the surrounding environment 
by both strong synchronizers (Zeitgeber), eg. light, and 
weak synchronizers, eg. barometric pressure (cf. Soll-
berger, 1969). Some of these parameters and their influ-
ence on biological rhythms will be considered. 
1. Temperature 
The effects of ambient temperature on circadian 
oscillations appear to be minimal within a 5-10° F. 
range from the normal environmental temperature. Harker 
(1958) showed that changes of 5-10° F. in ambient tempera-
ture cause no alteration in circadian patterns; however, 
Brown and Webb (1948) have shown that a large tempera-
ture change (to an envirpnmental temperature of o° C.) can 
result in delay of the diurnal color changes in Uca pugnax, 
a species of crab. It appears that temperature changes 
might become a strong synchronizing factor if they are 
sufficiently altered, but small fluctuations in tempera-
ture appear to have no effect on biological rhythms 
(Sollberger, 1969). 
A body temperature rhythm is exhibited by many 
mammalian species, and one might question whether this 
rhythm is a cause or an effect of the various circadian 
oscillations. 
Body temperature results from the balance between 
heat production and heat loss. Heat production varies in 
0 
a circadian fashion and is directly proportional to the 
body temperature rhythm (Bornstein and Volker, 1926). 
Kleitman and Ramsaroop (1948) noted similarities in the 
rhythm of body temperature and heart rate. They admin-
istered thyroid hormone over a two week period, and 
noted a definite association between the pulse rate and 
the body temperature, Kleitman (1949) demonstrated that 
the body temperature rhythm of the rabbit is associated 
with the feeding pattern. The rhythm in mouse rectal 
temperature has been associated with the motor activity 
rhythm (Halberg, 1959). This investigation has shown 
that artificial alterations of body temperature have no 
effect on the activity nhythm. Brahmachary (1967) sug-
gested that the motor activity rhythm is a primary rhythm, 
and that the body temperature follows the metabolic ac-
tivity associated with this primary rhythm. 
It is interesting to digress and consider the 
Feldberg hypothesis concerning temperature regulation. 
Feldberg and Myers (1964) noted that application of 5-HT 
close to the hypothalamus increases body temperature, 
whereas that of norepinephrine (NE) decreases body tem-
perature. They suggested that the biogenic amines might 
12 
be directly concerned with the control of body temperature. 
To summarize, the body temperature rhythm is an 
effect rather than a cause of the various circadian os-
• 
cillations; it is also possible that alterations of bio-
genie amine levels in the vicinity of the "temperature 
control center" of the hypothalamus are responsible for 
this rhythm. 
2. Illumination 
The influence of illumination on biological rhythms 
should be considered with regard to photoperiod, intensity, 
and spectrum of the light. source. 
The importance of photoperiod as a primary ~­
geber is discussed extensively by Aschoff (1960). The 
connection between the illumination period and the many 
light-related circadian variables has been developed in 
recent years. The effects of light are believed to be 
mediated via the pineal gland in mammals (Wurtman et al., 
1968a). Continual light or increased timing of 
photoperiods results in decreased pineal weight, decreased 
size of the pineal parenchymal cells, decreased pineal 
lipids, and a loss of the gonadal inhibitory effects of 
the pineal (cf. Reiter and Fraschini, 1969). The in-
fluence of the pineal gland on body growth, pituitary, 
adrenal, thyroidal, and gonadal function has been pointed 
out by these investigators. The pathway for the light-
mediated effects on the pineal appears to be mediated via 
the retina, inferior accessory optic tract, and post-
o 
ganglionic sympathetic fibers from the superior cervical 
ganglion to the pineal gland (Kappers, 1960; Moore et al., 
1968). Taylor and Wilson (1970) recently demonstrated 
the inhibitory actions of light on the electrophysiologi-
cally-recorded impulses from the pineal gland. They have 
also confirmed the pathway proposed by Moore et al. (1968) 
by the use of photic alteration and ganglion-blocking 
drugs. Light entering the eyes is the important factor 
in this pathway, although light, which directly penetrates 
the skull, cannot be discounted (Lisk and Kannwischer, 
1964). 
The effects of light intensity on circadian peri-
odicity has not been examined as extensively as those of 
' 
the photoperiod. The intensity of light in most arti-
ficially-lit animal rooms ranges from 10-150 foot-candles. 
Reiter (1969) demonstrated that these levels of l~ght are 
1 3 
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inhibitory to the pineal gland. 
Marshall and Bowden (1936) described the effects 
of various wavelengths of liBht on the timing of the 
ferret sexual cycle. They found that estrus began ear-
lier in the season in animals exposed to ultraviolet 
0 light (3650 A.), while heat rays and infrared illumination 
have no effect on this cycle. A similar study by Luce-
Clausen and Brown (1939) indicated delayed onset of estrus 
in rats bred in darkness; normal onset of estrus oc-
• 
curred in rats exposed to visible or infrared illumina-
tion. Ott (1964) described some effects of spectral al-
terations on cells in tissue culture, and on reproduc-
tive characteristics and sexual ratio of offspring in 
both fish and mice. Spalding et al. (1969) described 
the spectral effects of light on motor activity in albino 
mice. They noted that the lowest activity occurred in 
mice exposed to blue or green light, or daylight; in-
termediate activity occurred under yellow, and the highest 
activity was noted in either red light or darkness. The 
retinal receptors of this nocturnal species are mainly 
composed of rods, which contain a red substance, rhodop-
sin. This substance ab~orbs in all of the spectral 
regio~s except red. Thus, the red light spectrun is 
practically equivalent to darkness in this species, (cf. 
Spalding~~., 1969). Wurtman and Weisel (1969) noted 
that rats reared under Vita-Lite (93% of daylight spec-
trum) have larger gonads and smaller spleens than those 
1 5 
reared under a conventional cool-white fluorescent source. 
3. Barometric Pressure 
Harker (1958) described barometric pressure as a 
weak synchronizer, suggesting that although it is incapa-
ble of controlling a circadian rhythm, it might have an 
influence on an existing rhythm. Brown (1954) proposed 
that an increase ~n the respiratory rates of various 
species of crabs and salamanders is caused by an increase 
in the rate of barometric pressure change. Brown et al. 
(1956a) also noted a direct relationship between the 
activity of oysters and rate of environmental pressure 
changes. Hayden and Lindberg (1969) demonstrated that a 
body temperature circadian rhythm can be entrained in 
pocket mice (Perognathus longimembria) by fluctuations 
in ambient barometric pressure in the face of constant 
ambient temperature and darkness. However, positive en-
trainment was obtained in only 50% of the mice tested, 
and the investigators have concluded that the "normal 
daily cycle of barometric pressure is probably seldom, 
( 
if ever, an adequate synchronizing agent for circadian 
rhythms". 
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4. Sound 
Halberg~ al. (1954) hold that the sound due to the 
activity of normal mice has an effect on the activity of 
blind mice. However, the influence of sound on biological 
rhythms has rarely been studied. In 1966, "the first clear 
demonstration that a biological clock can be influenced by 
sound" was presented by Menaker and Eskin. They used re-
corded bird songs to entrain activity rhythms in sparrows. 
It is apparent that sound might be a weak synchronizer • 
• 
5. Feeding Habits 
Alterations in feeding patterns have been suggested 
to cause circadian fluctuations. Calhoun (1945) demon-
strated that altered motor activity in rodents can occur 
by changes in feeding schedules.. Stein ( 1951) noted that 
feeding rhythms in birds will persist in constant light or 
darkness, even though the sleep pattern has been altered. 
Harker (1958) proposed that feeding schedules might change 
biological rhythms associated with motor activity and metab-
olism in mammals. Honova and co-workers (1968) suggested 
that the rhythm in the activity of tyrosine transaminase 
might be controlled by the feeding pattern in both rats 
~ 
and humans. Rohles and Osbaldiston (1969) noted that the 
feeding patterns in monkeys are independent of light and 
temperature, but appear to be related to social entrain-
ment. Thus, feeding habits appear to be a weak 
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synchronizer in biological oscillations. However, more 
extensive studies involving mammals maintained in the ab-
sence of temperature and light fluctuations are not a-
vailable. 
6. Popula.1:!:..2n 
The size of the group of animals used in a circadi-
an study might have a weak effect on synchronization of the 
biological rhythm. 
Studies in°insects such as the beetle (Park and 
Sejba, 1935) and the fruitfly (Harker, 1958) indicated 
that insect activity might be related to the size of the 
population. Isolation produces aggressive behavior in 
mice, which is accompanied by changes in serotonin metab-
olism (Valzelli and Garattini, 1967). These changes in 
5-HT metabolism could alter the sleep/wakefulness cycle. 
The possible role of 5-HT in sleep will be considered 
elsewhere (~infra). Harker (1958) noted a reversal 
of motor activity in those rats, which are low in the 
social order of their colony. Rohles and Osbaldiston 
(1969) noted that the individual feeding rhythms of two 
isolated monkeys coincided when the animals were placed 
( 
together. They attribute this alteration to the social 
entrainment of the feeding rhythm, and they intimate that 
social entrainment might be as important as light or tem-
perature for rhythm entrainment. Quay and co-workers 
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(1969) examined the effects that population factors of the 
environment had on the CNS. They found that isolated rats 
have greater body pineal gland weights, and a higher 
ratio of pineal to brain weight than do grouped animals. 
Grouped animals exhibited a greater mean cerebral cortical 
weight than the isolated animals. No difference was noted 
in the concentration of pineal 5-HT or in the pineal ac-
tivity of acetylserotonin methyltransferase (HIOMT) be-
tween grouped and isolated rats, but differences in brain 
• 
acetycholinesterase were noted. The ratio of cortical 
AChE/ChE decreased in grouped rats; the critical mass for 
this change appears to be 3-4 rats/cage regardless of 
cage dimension. 
7. Species 
The species of an organism appears to have some 
bearing on the nature of its biological rhythm, eg. man 
exhibits a diurnal pattern, whereas rodent species ex-
hibit a nocturnal one (Harker, 1958). The ability of 
various animal species to adapt to altered photoperiods 
is also reflected by the species involved. Phase-
shifting leads to a resynchronization of the biological 
~ 
rhythms in two days in spiders (Aschoff, 1963), while 
about three weeks are required for this process in mice 
and rats (Massarelli et~., 1970). However, 
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resynchronization time is not constant for all rat species 
(Kleitman, 1949). 
8. ~ 
Sex hormones can affect circadian oscillations. 
Slonaker (1912) demonstrated that motor activity in the 
rat increased during the estrus cycle and was maximal at 
the peak of estrus. Colvin and co-workers (1968) noted 
circadian alterations in sleep/wakefulness cycles super-
imposed on the e~rus cycle. By means of chronically im-
planted electrodes, they monitored females and found that 
the pre-estrus rat exhibits paradoxical sleep in the after-
noon followed by an alert pattern in the evening. The 
day of vaginal cornification is marked by a high per-
centage of paradoxical sleep after a night in which ther.e 
is no paradoxical sleep and the animal is alert. The in-
vestigators state that "hormonal changes during the day 
of proestrus appear to increase alertness that night, com-
pensated by an increase in sleep, especially paradoxical 
sleep, the following day'1 • It is apparent that monthly 
rhythms influence circadian ones. 
9. Other Influences .QQtBiological Rhythms 
Kleitman (1949) described many periodic phenomena 
related to lunar variations, eg. 1) the severity of scar-
let fever is related to the blood pH, which exhibits a 
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rhythm that correlates with the lunar phase, 2) epileptic 
attacks are more frequent during the full moon, 3) more 
male and fewer female deaths occur during the period of 
the full moon. Brown and co-workers (1956b) reported 
that male rats in a continuous dim light environment ex-
hibited greater motor activity when the moon was below the 
horizon.· 
Brown's group have proposed the presence of an "in-
ternal clock", bY. which biological rhythms are controlled 
0 
independently from environmental time-signals. Various 
atmospheric rhythms have been proposed to control this 
"internal clock". The color change rhythm of the crab, 
~. exhibits a tidal rhythm as does its daily oxygen 
consumption rate. Oysters from New Haven, Conn. were ship-
ped to Evanston, Ill. for such an experiment. The open-
ing of their valves was timed to the lunar cycle of New 
Haven for two weeks until they phase-shifted to the Evan-
ston lunar cycle (cf. Harker, 1958)0 Some correlation 
has also been noted between cosmic ray cycles and meta-
bolic cycles (Brown et al., 1958). Terrestrial magnetism 
has also been shown to fluctuate rhythmically with solar 
and lunar periods. Thetdirectional movement of the mud 
snail Nassarius has been shown to be related to this mag-
netic-lunar cycle (Brown et al., 1960). 
Olfaction has been included because of a report in 
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the literature concerning the relationship between pineal 
gland activity and olfactory stimulation. Miline et al. 
(1963) exposed rats to the pungent odor of isonitrile for 
six hours, and noted atrophic alterations of the pineal 
parenchymal cells. 
The aforementioned factors might function as un-
derlying rhythms which are responsible for some of the bio-
logical variations associated with circadian oscillations. 
B. •Cyclic Patterns in Mammals 
1. Rhythms in Physiological Activity 
Circadian rhythms in motor activity have been 
studied extensively in the mouse (Davis, 1933; Johnson, 
1939; Park and Woods, 1940; Saelens et al., 1968) and the 
rat (Slonaker, 1912; Shirley, 1928; Browman, 1937; Quay, 
1970). These investigators established that rodents are 
nocturnal animals with motor activity peaks during the dark 
phase of an illumination cycle. Holmquest and co-workers 
(1966) defined the relationship in rats between motor ac-
tivity and body weight as well as adrenal function. After 
forty days of random illumination, activity rhythms were 
lost with no effect on ~he steady rise of body weight and 
no effect on the weights of the endocrine organs. Quay 
(1970) described the effects of pinealectomy on the motor 
activity rhythms in the rat. He noted that both normal and 
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pinealectomized rats will reverse their activity rhythms in 
response to photoperiod reversal, but there was a difference 
between the two groups with regard to the characteristics 
of the phase-shifting response. 
Curtis (1937) reported motor activity rhythms for 
both the sheep and the pig; these marnraals exhibit peak 
activity during the day. Lindsley et al. (1964) initiated 
a diurnal motor activity rhythm in infant monkeys that had 
lived in darkness for three years. This rhythm took from 
0 
3-5 weeks for stabilization following the initiation of a 
standard light period. Winget et al. ( 1 969) described the 
correlation between the diurnal motor activity rhythm of 
the monkey and its deep body temperature rhythm. These 
workers view the two rhythms as coupled oscillators ("os-
cillators which are normally synchronized, but may oscil-
late independently of each.other"), which is the same situ-
ation that exists in man between human body temperature and 
activity (Aschoff~ al., 1967). In summary, man, sheep, 
pig, and monkey are all diurnal species, while the rat and 
the mouse are among the nocturnal species. 
Hoshizaki ~ !!1.· (1969) demonstrated circadian as-
pects of electroencephalographic patterns, cardiovascular 
~ 
responses, respiration, and food and water intake in the 
monkey. They noted that the EEG generally shows a waking 
pattern during the light phase and a sleeping pattern in 
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the dark phase. They noted peaks of the ECG and blood 
pressure curves during the light hours. Respiration ap-
peared to peak during the dark phase. Food and water con-
sumption were greater during the light phase. 
Rats exhibit a circadian rhythm with regard to self-
induced hypothalamic and septal reinforcing brain stimula-
tion (Terman and Terman, 1970). This study was conducted 
in constant light, sound, temperature, and humidity. The 
rhythms were similar to those normally seen for mo.tor ac-
• 
tivity in rodents. Sofia and Salama (1970) demonstrated a 
circadian rhythm for shock-induced aggressive behavior in 
mice. This rhythm coincides with the locomotor activity 
rhythm in mice, and it appeared to be exogenous in nature 
because it is lost under continuous illumination. 
One can generalize that in a given species, most of 
the physiological parameters appear to peak concomitantly 
with the peak of motor activity. 
2. Rhythms Involving Hormone Levels of Blood ~ Urine 
Circadian variations .in the levels of plasma 17-
hydroxycorticosteroids (17-0HCS) have been well documented 
in the human and many species (cf. Krieger, 1970). This 
( 
biological fluctuation in 17-0HCS levels mimics the rhythm 
noted for plasma adrenocorticotrophic hormone (ACTH) levels. 
Since the rhythm of ACTH levels is noted in the absence of 
~-
~ 
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adrenal tissue, it is assumed that the circadian periodici-
ty of plasma 17-0HCS is secondary to that of the ACTH 
levels (cf. Krieger, 1970). 
In man, the rhythm in 17-0HCS levels peaks in the 
early morning hours, while in nocturnal animals, eg. rat, 
the rhythm peaks in the early evening hours. The rhythm 
can be reversed within eight days in either species by a 
reversal of the photoperiod (cf. Krieger, 1970). The 
human infant, who exhibits an inconsistent sleep pattern, 
• 
does not exhibit a circadian cycle in the levels of 17-
0HCS. This cycle is developed between 3 and 13 years of 
age, and its development lags behind the development of a 
circadian sleep/wakefulness cycle, which occurs at 5-8 
months of age (Franks, 1967). However, the infant monkey 
exhibits a circadian pattern for 17-0HCS levels in the 
first week of life (Bowman~ al., 1970). 
The rhythm in plasma 17-0HCS levels is absent in 
Cushing's disease (Doe et al., 1960), in which pituitary 
ACTH production increases. The response of humans to ACTH 
administration is lowered at night, suggesting _that a 
rhythm might also occur in adrenal sensitivity (Perkoff 
ltl al., 1959). However, the main factor in the control of 
17-0HCS rhythm might actually be a circadian rhythm in the 
levels of the peptide which releases ACTH, viz., cortico-
trophin releasing factor (CRF). The sensitivity of the 
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neurosecretory cells of the anterior pituitary to the ef-
f ects of CRF might also account for the circadian rhythm 
(Clayton et al., 1963). The neurohumoral agents which 
affect the neurosecretion process have been examined. 
Krieger et al. (1968) noted that atropine and sodium 
thiamylal both lead to a loss of the peak in 17-0HCS levels. 
They proposed that cholinergic mechanisms are involved in 
the release of ACTH and that these might be responsible 
for the rise of P.lasma corticosteroids. Krieger and Rizzo 
• 
(1969) demonstrated that any alteration of 5-HT levels 
will block the circadian rise in 17-0HCS levels; however, 
alteration of central NE content had no effect on this 
rhythm. It appears that both cholinergic and serotonergic 
mechanisms might be involved in ACTH release. 
Zimmerman and Critchlow (1967) studied the effects 
of stress on the rise of plasma corticosterone levels at 
different times of the light/dark cycle. They found that, 
although a circadian rhythm in plasma 17-0HCS levels was 
present, the stress-induced increases in steriod levels 
did not differ significantly between peak and trough times 
of the rhythm. 
Bartter and co-wQrkers (1962) showed that the daily 
rhythms in the urinary excretion of aldosterone, 17-keto-
steroids, and 17-0HCS lag two to three hours behind the 
plasma rhythm of 17-0HCS levels. They noted correlations 
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between the ACTH rhythm and the rhythms in sodium, potas-
sium and hydrogen ion excretion, the circulatory levels of 
white blood cells, and the secretion of glucocorticoids 
and mineralocorticoids. Boyd and McLeod (1964) noted 
correlations between the circadian rhythm of plasma 17-0HCS 
and intraocular pressure, with the latter rhythm lagging 
about four hours behind the former. 
The release of human growth hormone (HGH) has also 
been shown to var/ on a circadian basis. Sassin et al. 
(1969) related the release of HGH to the period of slow-
wave sleep. If the sleep pattern is reversed, the rhythm 
of HGH release is also reversed. 
Groot (1967) demonstrated that the ovaries of pro-
lactin-treated (pseudopregnant) rats contain less ascorbic 
acid and more progesterone at 1600 hours, than at 1000, 
1200, or 1400 hours. Endogenous release of lutenizing 
hormone (LH) is believed to be the cause of this rhythm. 
The rate of release of anti-diuretic hormone (ADH) 
has also been considered as a circadian variable. Zsoter 
and Sebok (1955) demonstrated a circadian pattern for serum 
ADH levels in man, with a peak at night. This alteration 
in ADH levels helps to ~xplain the decreased urinary out-
put associated with the sleeping phase. 
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3. Rhythms in the ~els of ~trolytes 
Mills (1966) described the circadian fluctuations 
in the levels of urinary phosphate excretion, which exhibit 
low values during sleep and rise upon waking. This rhythm 
appears to be related to.the behavioral and activity pat-
terns of the subject. Norn (1929) demonstrated that the 
circadian patterns of urinary sodium, potassium, and chlor-
ide exhibited a trough during the sleeping phase with a 
peak in the waki~g phase in man. These rhythms are altered 
by alteration of environmental parameters, and they appear 
to be exogenous (Mills, 1966). The effects of glomerular 
filtration rate on these urinary rhythms are uncertain, 
according to Mills (1966). 
Ammonia and acid excretion in man is high at night 
and decreases in the morning; these rhythms are unaffected 
by alteration in food intake. The urinary excretions of 
urea, uric acid, and creatinine are decreased at night. 
Calcium and magnesium excretion rises during the early 
daylight hours, and exhibits a nadir at night. The levels 
of these ions vary markedly with food intake (cf. Mills, 
1 966). 
Min and co-worke4s (1966) described renal rhythms 
in the excretion of various ions; these rhythms were mon-
itored in human subjects who were inactive and fed at 
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constant intervals. Magnesium and calcium excretions were 
highest in the early morning hours, while peak excretion 
of either sodium or potassium occurred in the late morning 
hours. The rhythm of phosphorous excretion exhibited a 
·peak late in the day with a trough in the early morning 
hours. Fasting resulted in a loss of the excretory rhythms 
of potassium and phosphorous. Bahorsky and Bernardis 
(1967) observed that fed rats exhibited rhythms in the 
serum levels of sodium and potassium with peaks in the 
• 
early dark phase; however, they found no rhythm in the ser-
um levels of phosphorous or urea nitrogen. Fasted rats 
exhibited a significant peak in serum sodium in the early 
dark phase, but the rhythm in serum potassium was lost. 
It appears that most of the human circadian rhythms of 
urinary metabolites are also present in nocturnal animals, 
although they are 180° out of phase with each other as one 
might anticipate. 
4. Rhythms in Constituents of Carbohydrate, Lipid and 
Protein Metabolism 
Blood glucose levels vary in a circadian fashion in 
the rat (Pauly and Scheving, 1967; Friedman and Walker, 
1969a), mouse (Dziekanowska and Andrzej, 1961), chicken 
(Twiest and Smith, 1970), and cow (Allcroft, 1933). The 
nocturnal rodent species exhibit maximal levels of serum 
glucose during the dark, while the latter two diurnal 
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species exhibit maximal levels during the light. Bahorsky 
and Bernardis (1967) noted that the circadian pattern of 
serum glucose levels is abolished in fasted rats, although 
a definite pattern was found in fed rats similar to that 
found by other investigators. Jarrett and Keen (1969) 
noted that normal individuals exhibited diurnal variations 
in the glucose tolerance test, but hyperglycemic patients 
did not. 
A circadia~ pattern has been demonstrated for the 
liver glycogen levels of the rat and the rabbit (Agren 
et al., 1931). These rhythms were abolished by adrenal-
ectomy. Sollberger (1964) demonstrated circadian varia-
tions in hepatic glycogen levels in several species; the 
rhythm generally peaks during the light phase in the di-
urnal, and during the dark in the nocturnal species. He 
contends that the two primary synchronizers for the glyco-
gen rhythm are food intake and light. Fuller and Diller 
(1970) found that the hepatic glycogen rhythm, in rats 
fed ad libitum, peaks at 0500-0800 hours, late in the dark 
phase. In rats fed a single meal from 0800-1200 hours, 
hepatic glycogen levels exhibited a prolonged peak from 
1200-2000 hours, suggesting the importance of food intake 
in this rhythm. 
Fuller and Diller (1970) also noted that plasma 
free fatty acid (PFFA) levels exhibit a circadian pattern, 
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inversely related to glycogen levels. They propose that 
the control of both the hepatic glycogen and PFFA rhythms 
might be due to food intake, hormonal factors, or neural 
control via the autonomic nervous system. 
Feigin and co-workers (1968) demonstrated that 
total whole blood amino acid levels in man exhibit a peak 
at 1200-2000 hours and a trough at 0400-0800 hours. Tewks-
bury and Lohrenz (1970) demonstrated that urinary amino 
acid levels exhibit a similar rhythm to those of whole 
blood, and they propose that a basic rhythm in amino acid 
levels is normally present, and that the levels are aug-
mented by food intake. 
Forsgren (1935) established the presence of cir-
cadian variations in albumin content in rodents and man. 
Nir and co-workers (1969) have shown that pineal RNA levels 
as well as protein synthesis are depressed by continuous 
light exposure, but not by an altered illumination sched-
ule; no change in pineal DNA levels was noted. The RNA 
and DNA content and the level of protein synthesis of 
animals in continuous darkness and those on an alternating 
illumination schedule were similar. It appears from these 
results that continuous ~ight exposure leads to a decreased 
cellular metabolism in the pineal gland. 
l ~ 
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5. Periodicity in Enzyme Sistems 
The activities of various enzymes have been examined 
on a circadian basis. 
Most of the studies of circadian enzyme rhythms in 
the CNS have been done on the pineal gland. Hydroxyindole-
O-methyl transferase (HIOMT), the enzyme which forms mela-
tonin in the pineal, exhibits a circadian pattern in rats. 
This pattern of HIOMT activity appears to be inhibited by 
light, since it is abolished in blinded animals or in the 
• 
presence of continuous light (Axelrod et al., 1963). 
This exogenous rhythm is also lost by lesion of the ac-
cessory optic tract, but not by lesions in the primary op-
tic tract (Chase et al., 1969). The increased activity of 
HIOMT in the darkness appears to be related to a choliner-
gic mechanism since atropine methylbromide inhibited the 
rise in HIOMT activity normally seen during darkness. Ac-
tivity was restored by the administration of oxotremorine 
oxalate, a cholinomimetic (Wartman et al., 1969). A dif-
ferent type of biorhythm was noted in the activity of 
pineal 5-hydroxytryptophan decarboxylase (5-HTPD). Ac-
tivity of this enzyme is highest at midday and lowest at 
midnight in nocturnal mammals (Quay, 1963a), in sharp con-
trast to the rhythm of HIOMT activity. Snyder et al. 
(1965a) demonstrated that blinding or sympathetic denerva-
tion pr€vent the increased enzymatic activity of 5-HTPD 
normally produced by light. The adenyl cyclase activity 
of the pineal also appears to be sensitive to alterations 
in illumination since Weiss (1969) demonstrated that rats 
exposed to continuous light exhibit a potentiation in the 
norepinephrine-induced activation of this enzyme. Quay 
(1963b) showed that continuous light decreased activity of 
succinate dehydrogenase in the rat pineal, which indicates 
that illumination can affect the metabolism of the Krebs 
cycle. McGeer ana_McGeer (1966) noted that the activity 
of tyrosine hydroxylase, which limits the synthesis of 
catecholamines, also exhibits a circadian rhythm in the 
rat pineal. Tyrosine hydroxylase activity is also maximal 
during the dark phase in this nocturnal species. 
Several hepatic enzymes exhibit circadian patterns. 
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Hepatic tyrosine transaminase (TAT) fluctuates on a cir-
cadian basis, which appears to be determined by the pattern 
of food intake (Fuller, 1970). This rhythm persists in the 
absence of the pituitary gland, adrenal glands, thyroid 
glands, or the pancreas. The activity of TAT in the brain 
does not fluctuate, which suggests that the control mechan-
isms of hepatic TAT activity are not effective centrally 
(cf. Fuller, 1970). The(presence of 24-hour rhythms in the 
activities of hepatic steriod hydroxylase (Colas et~., 
1969) and tryptophan pyrrolase (Rapoport et al., 1966) have 
also been demonstrated. Radzialowski and Bousquet (1968) 
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noted that a circadian pattern exists in the activities of 
the drug-metabolizing enzymes in the rat liver. Maximal ac-
tivity was noted at 1400 hours. Phillips and Berry (1970) 
demonstrated a similar circadian pattern in the activity of 
mouse lever phosphoenolpyruvate carboxykinase, which cata-
lyzes the synthesis of phosphoenolpyruvate from pyruvate. 
Van Pilsum and Halberg (1964) noted a circadian pat-
tern in the activity of transamidase in the mouse kidney; 
highest activity was noted in the light period • 
• 
A circadian rhythm in the activity of cholesterol-
7-alphahydroxylase, which is controlled by the adrenocor-
tical system and involved in the biosynthesis of bile acids, 
has been demonstrated (Gielen et al., 1970). 
Circadian variation of enzyme activity might be in-
fluenced by fluctuations in the levels of available cofac-
tors. The concentration of brain S-adenosylmethionine 
(SAM), which plays an important role as a methyl donor in 
several reactions, has been shown to vary on a 24-hour 
basis. Peak levels were noted in rat brain during the dark 
phase, and trough levels during the light phase (Wurtman 
~ .§:1., 1970). 
6. Periodicity in~ Levels of Putative Transmitter 
Substances and Their Metabolites 
The levels of putative CNS transmitters in various 
areas of the CNS as well as in the whole brain have been 
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shown to exhibit 24-hour fluctuations by many investigators. 
Wurtman and co-workers (1968b) noted a circadian 
pattern in the plasma levels ·of the precursor amino acids 
of monoamine biosynthesis. In man levels of phenylalanine, 
tyrosine and tryptophan are generally lowest at 0200 hours 
and maximal at 1050 hours. Methionine, cysteine, and iso-
leucine levels also exhibit 24-hour fluctuations, while 
alanine, glycine, and glutamate levels vary slightly. Co-
burn~~· (1968J demonstrated that the rhythm in plasma 
tyrosine levels appears to be regulated by dietary protein 
intake and by the activity of TAT. 
Scheving and co-workers (1968a) demonstrated an ul-
tradian pattern for DM levels of whole rat brain. 
Norepinephrine levels in the CNS have been shown to 
vary on a 24-hour basis in most brain regions. However, 
Scheving and co-workers (1968a) have found an ultradian 
pattern for NE levels in the whole brain of the rat. The 
norepinephrine rhythm of the caudate nucleus of the rat is 
circadian with maximal levels occurring during the dark 
phase (Friedman and Walker, 1968; 1969a). Manshardt and 
Wurtman (1968) examined the circadian rhythms of the NE 
levels in the hypothalamus, midbrain, thalamus, and stri-
atum of the rat. Peaks occurred during the dark phase 
except in the striatum and midbrain, in which no rhythm 
was noted. Reis and Wurtman (1968) demonstrated a 
~ 
. . 
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circadian alteration in the NE content of the cat hypothal-
amus and cervical cord. They did not find 24-hour fluctu-
ations in any other area of the cat brain, but they util-
ized only two sacrifice points on the 24-hour time base, 
one at the onset of the light phase, the other at the on-
set of the dark phase; thus, they might have missed peak 
values during the middle of either phase. This appears 
to have been the case, since in a study in the cat brain 
extended to four J>Oints, Reis et al. (1968) noted cir-
cadian fluctuations in the NE content of the cat cervical 
_cord, pons, substantia nigra-lateral tegmentum, anterior 
hypothalamus, tuber cinereum, and pineal gland. Ultradian 
patterns were described for the superior colliculi and the 
lateral thalamus. Reis and Gutnick (1970) noted that the 
NE levels of the cervical and sacral-coccygeal areas of the 
cat spinal cord varied in a circadian pattern peaking at 
1900 hours while those of the thoracic cord exhibited a 
biphasic pattern. Wurtman et al. (1967) examined the fac-
tors controlling the circadian fluctuations of the NE con-
tent of the rat pineal gland. Norepinephrine levels of 
this tissue at the end of the dark period were three times 
greater than those of t~e light period. They found that 
the rhythm is abolished by continuous light, continuous 
darkness or blinding. Rat adrenal epinephrine varies on a 
24-hour basis with maximal levels during the light phase 
l 
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(Scheving et al., 1968b). Pohorecky et al. (1969) noted 
that continuous illumination or darkness, as compared to 
cyclic illumination, leads to a decreased activity of 
phenylethanolamine-N-methyl transferase (PN1'-1T) in the rat 
adrenal, and to a decreased epinephrine content. The ac-
tivity of PNMT in the olfactory bulb and tubercle of the 
rat brain is increased during darkness, suggesting that 
epinephrine production increases in these areas during 
darkness. 
Circadian rhythms in brain 5-HT levels have been 
found in the mouse (Albrecht~ al., 1956) and rat (Dixit 
and Buckley, 1967; Scheving et al., 1968a; Friedman and 
Walker, 1 968, 1969a). Maximal levels occur in the light, 
minimal levels in the dark, in these nocturnal species: 
Pineal 5-HT levels also vary in a circadian fashion with 
the peak in the daytime (Quay, 1963a). Snyder~ al. 
(1965b) discovered that this 5-HT rhythm bears an inverse 
relationship to the pineal melatonin rhythm and that it is 
abolished by superior cervical ganglionectomy. However, 
the pineal 5-HT rhythm in immature rats is unaffected by 
sympathectomy (Machado et~., 1969). Quay (1968) in-
vestigated the 5-HT rhy~hms in various regions of the rat 
brain and noted that levels are maximal during the light 
phase in the frontal cortex, hypothalamus, and lateral 
lower brainstem. He further noted very little rhythmic 
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alteration in the 5-HT levels of the cerebral cortex. Reis 
et al. (1969a) observed that the 5-HT content of the cat 
--
upper brainstem and telencephalon varied on a circadian 
basis. Ultradian rhythms were demonstrated in the sub-
stantia nigra-lateral tegmentum and in the anterior hypo-
thalamus. In general, 5-HT levels are inversely related to 
those of the catecholamines in the CNS, suggesting the pos-
sibility of different control mechanisms or that the en-
zymatic systems involved alternately used one or the other 
• 
amines (Valzelli and Garattini, 1967). 
Acetylcholine levels of the rat brain describe 
similar circadian patterns whether measured by bioassay 
(Friedman and Walker, 1969b) or by gas chromatography 
(Massarelli et al., 1970). This rhythm is marked by a 
peak during the dark, with a nadir in the light. 
Wilson (1965) demonstrated a circadian pattern in 
the primary excretion of histamine in the rat. Maximal 
levels were noted in the urine during the dark phase. 
Friedman and Walker (1968) showed that the histamine con-
tent of the rat caudate nucleus varied on a circadian pat-
tern with maximal levels during the dark phase. They 
(1969a) further noted that serum histamine levels exhib-
ited a circadian pattern with maximal levels prior to the 
onset of the dark phase. 
Rhythms Inv.Qlying the Formed Elements of the Blood 
In the first hour of wakefulness, the eosinophil 
. 
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and lymphocyte counts decrease, while that of neutrophils 
increases (Sharp, 1960; Bartter et al., 1962). These 
changes might be related to the rhythm of 17-0HCS; how-
ever, light and social habits appeared to be primary syn-
chronizers for the rhythm in eosinophil count (cf. Mills, 
1966). 
C. C i:r'badian Rhythms in Drug Response 
Several studies have been conducted which indicate 
the importance of information regarding circadian effects 
in drug dosage regimens. Holmgren (1933) noted that the 
effect of insulin and E on rabbit blood sugar depended on 
the time of their administration. Mollerstrom (1937) rec-
ognized the presence of this insulin rhythm in his treat-
ment of diabetic patients. Some drug firms have begun 
manufacture of "day" and "night" pills to compensate for the 
diurnal fluctuations in drug metabolism (Sollberger, 1969). 
1. Drugs Affecting the Cholinergic System 
Pauly and Scheving (1964) demonstrated in rats that 
t 
the peak toxicity of tremorine occurred between 2200-0400 
hours. A trough was obtained in the mid-afternoon. Sub-
lethal doses of tremorine produced tremors after a shorter 
latency during the dark phase. Walker (1969) noted in mice 
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that peak toxicity of acetylcholine, pilocarpine, and oxo-
tremorine was greatest during the dark. He also noted that 
the circadian toxicity curve for atropine sulphate exhib-
ited a pattern inverse to that of ACh with peak toxicity 
occurring during the light. Spoor and Jackson (1966) dem-
onstrated that the response to the isolated right atrium 
of the rat to ACh varied with the time of day. A greater 
bradycardia was noted at 1100 hours than at 2300 hours. 
Merritt and Sulk~wski (1969) reported that the injection 
of JB-336, an anticholinergic psychotogenic compound, dis-
rupted the circadian pattern of 5-HT levels in the rat 
pineal gland. 
2. Drugs Affecting the ~nergic System 
Wurtman et al. (1970) demonstrated the presence of 
a circadian rhythm in s-adenosylmethionine, in rat brain, 
which was markedly affected by the administration of 
1-DOPA; they suggested that this phenomenon may be impor-
tant with regard to the therapeutic effects of this com-
pound in Parkinsonism. 
Wahlstrom (1964) noted in the canary that MAO inhib-
ition by pheniprazine, pargyline, or nialamide decreased 
the duration of the motor activity rhythm for a few days and 
then increased it. A circadian variation in drug response 
was demonstrated. Greater effects were obtained when drugs 
, 
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were administered in the late evening than in the early 
morning. 
Saelens !U .§:!• (1968) have noted the effects of par-
gyline and alpha-methyl-m-tyrosine on motor activity in 
mice. Pargyline was found to cause an increase in the mo-
tor activity of the dark phase, while alpha-methyl-m-
tyrosine had an opposite effect during the dark phase. 
The investigators concluded that "adrenergic systems in 
the brain have a _,ariable influence on locomotor activity". 
Black and co-workers (1969) demonstrated a daily 
rhythm in the effects of reserpine in the rat. The per-
cent of NE depletion by reserpine was greater at night than 
during the day. They also noted a non-significant decrease 
in brain NE half-life at night. The effects of reserpine 
on the sleep patterns of rabbits have been demonstrated by 
Tabushi and Himwich (1969). They found that reserpine 
dosage caused a marked suppression of paradoxical sleep. 
The pattern following reserpine administration is char-
acterized by an alert pattern for 1.5-2 hours followed by 
slow-wave sleep. 
3. Qli§. Stimulants and Convuls~ 
Wahlstrom (1968) demonstrated that the activity of 
amphetamine sulphate in the canary was greater at night 
than early in the morning. 
~ Webb and Russell (1966) studied the influence of 
24-hour rhythms on the convulsant effects of hexafluoro-
diethyl ether in the rat. Seizure component times were 
shorter at 2200 hours (dark phase) than at 1000 hours 
(light phase). The time interval for the occurrence of 
tonic convulsions and the onset of post-ictal depression 
was greater in the dark than in the light phase. A cir-
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cadian fluctuation was also noted in the percentage of 
animals exhibiting two clonic seizures following a single 
exposure to the d;ug. Fifty percent responded at 1000 
hours, while only ten percent responded at 2200 hours. 
Lutsch and Morris (1967) demonstrated that peak convulsant 
activity of lidocaine hydrochloride in mice occurred at 
2100 hours; minimal activity was noted at 1500 hours. 
4. QN§. Depressants 
Davis (1962) observed that both isolated and grouped 
mice exhibited a similar trough response in pentobarbital 
sodium sleeping times, but the grouped mice exhibited a 
longer sleeping time during the day than did the isolated 
mice. Pauly and Scheving (1964) noted in the rat that the 
peak circadian toxicity of pentobarbital sodium occurred 
at 2200-0400 hours, and the nadir in the mid-afternoon. 
Friedman and Walker (1969a) showed that the longest sleep 
onset time and the shortest sleep duration following pen-
tobarbi tal sodium administration in the rat occurred during 
'l~ ...•. ' ' 
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the dark phase of an alternating light/dark cycle. An in-
verse relationship occurred during the light phase. It was 
further noted that pentobarbital sodium reversed the cir-
cadian pattern in body temperature. 
Marte and Halberg (1961) described a peak suscepti-
bility to chlordiazepoxide-induced lethal depression in the 
mouse at 2400 hours. Haus and Halberg (1959) noted that 
the crest and trough responses in the mouse to lethal de-
pression from ethanol are at 2000 and 0800 hours, respec-
• 
tively. 
Morris and Lutsch (1967) demonstrated a 24-hour pat-
tern in the analgesic potency of a standard dose of mor-
phine in the mouse. They found that peak analgesia oc-
curred at 2100 hours with a trough at .1500 hours. Reis 
~al. (1969b) correlated the daily rhythm in NE levels in 
a given brain region of the cat and the susceptibility of 
that region to the norepinephrine-induced action of mor- · 
phine. 
5. Antihistamines 
A circadian pattern in the effects of antihista-
minic drugs in humans has been demonstrated by Reinberg 
t 
and Sidi (1965). They adapted six male subjects to a rou-
tine circadian cycle for one week and tested the antihis-
taminic drug, cyproheptadine. The skin reaction to his-
tamine gave a peak response at 2300 hours, but differences 
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in its time course of action were noted between 0700 hours 
and 1900 hours. 
6. Antipyretics 
Reinberg et al. (1967) showed that the duration of 
urinary salicylate excretion exhibits circadian fluctua-
tions. They tested the rhythm in six human subjects, pre-
viously adapted to a programmed illumination cycle. The 
time course of salicylate excretion was longest when the 
drug was given at°1900 hours. Radzialowski and Bousquet 
(1968) noted in the rat that metabolism of aminopyrine is 
maximal at 0200 hours and minimal at 1400 hours. Adrenal-
ectomy abolished the rhythm, suggesting the possibility 
that the rhythm of 17-0HCS might have a function in this 
rhythmic effect. 
7. Antibiotics 
Wilson (1965) showed that chloramphenicol influenced 
the pattern of rat histamine excretion in the urine. Chlor-
amphenicol shifted the peak response in this rhythm from 
the early dark phase to the center of that phase. Krauer 
and Dettli (1969) noted a 24-hour rhythm in children un-
der one year old for th~.rate of excretion of sulfisom-
idine. The rate is twenty percent lower during the night. 
Halberg et.§:!. (1955) described a 24-hour periodicity in 
the resistance of mice to an E. coli endotoxin; this type 
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of altered systemic resistance to bacterial strains might 
be a partial cause of the circadian effects of antibacter-
ials. 
8. Miscellaneous Rhythms in Drug Response 
Ertel et al. (1964) demonstrated a circadian effect 
in lethality following the administration of methopyrapone, 
an adrenal corticosteroid inhibitor (SU-4885), in mice. 
Szeberenyi and co-workers (1969) noted that the plasma 
half-life of SU-4~85 in rats was much longer at 2200 hours 
than at 1000 hours. 
In summary, only a small number of drugs from the 
myriad of therapeutic compounds now in use have actually 
been examined for their efficacy over a 24-hour period. 
Many of those examined exhibited a periodicity in response, 
suggesting the possibility that dosage should be evaluated 
with reference to the time of administration as well as to 
the other factors, which are now generally considered in 
the administration of therapy. 
D. Putative Transmitter Substances and Their 
Relationsh.!.E to ~bral Excitabilit~ 
1. Dopamine 
Blaschko (1957) first proposed that 3,4-dihydroxy-
phenylethylamine, or dopamine (DM), a biochemical precur-
sor of NE, might have a physiological role of its own. 
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Dopamine has subsequently been shown to be present in the 
brain of all mammalian species (cf. Hornykiewicz, 1966) 
and differentially distributed in the CNS. High levels 
are found in the corpus striatum, substantia nigra, and 
globus pallidus, whereas low levels are found in NE-rich 
areas as the hypothalamus (Hornykiewicz, 1966). The turn-
over of DM is also very high in the striatum, with a half-
life of 2-4 hours depending on the technique used (Iver-
sen and Glowinsk~, 1966). 
The DM-rich corpus striatum might have a role in 
the control of cortical excitability as Umbach (1959) has 
demonstrated that stimulation of the cat caudate nucleus 
decreases seizure activity in various brain areas. This 
restraining effect was confirmed by Jung and Hassler 
( 1 960) 0 
The inhibitory activity of DM has been documented 
in a number of physiological preparationso McGeer and co-
workers (1961) found the inhibitory effect of DM to be 
sixty times that of GABA on the crayfish stretch receptor 
neuron. It was also found to be ten times as potent as 
1-NE or 1-E in this regard. Iontophoretic application 
of DM has been used to Terify this inhibitory action in 
various areas of the cat brain, viz. the lateral genicu-
late nucleus (Curtis and Davis, 1962), cerebral cortex 
(Krnj evic and Phillis, 1963a), hippocampus (Bloem et &·, 
r 
~ ,, 
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1965), caudate nucleus (York, 1967), and nucleus cuneatus 
and gracilis of the dorsal spinal column (Steiner and 
Meyer, 1966). York (1967) also demonstrated that the in-
hibitory action of DM was blocked by phenoxybenzamine, an 
alpha-adrenergic blocking agent. 
Relationships between central DM levels and motor 
activity have also been proposed. Everett and Wiegand 
(1962) found a correlation between the level of brain DM 
and the degree of motor hyperactivity in mice. Dominic 
• 
and Moore (1969) have shown that motor activity and brain 
DM levels fall progressively as the dose of alpha-methyl-
tyrosine is increased. Dopamine has also been implicated 
as an important compound in dextroamphetamine-induced hy-
peractivity (Laverty and Sharman, 1965). The extensive 
literature on the role of DM in the formation of Parkin-
sonian tremor has been reviewed by Hornykiewicz (1966). 
The level of striatal DM appears to be critical for pro-
per function in the extrapyramidal system, and decreased 
DM levels can be found consistently in the corpus striatum 
of Parkinsonian patients (Bernheimer .£1 .§!.., 1963). Homo-
vanillic acid, the major metabolite of DM in the stria,-
tum, also exhibits decr~ased levels in Parkinsonism, in-
dicating a disruption of DM synthesis in these patients 
(Bernheimer and Hornykiewicz, 1965). 
The role of DM in the alteration of seizure 
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phenomena has not been extensively studied, although some 
reports are available. Engel and co-workers (1968) evalu-
ated the effects of electroshock convulsions on the cereb-
ral metabolism of DM. They found that DM levels of the 
cerebrum are not significantly altered by electroshock, 
when they are measured ten minutes after the seizure epi-
sode. However, homovanillic acid levels are increased 54% 
over those of control animals, suggesting that the syn-
thesis and metabolism of DM is increased following the 
• 
seizure. Hanigan (1971) has noted that DM levels are di-
rectly proportional to the seizure latency time; thus, it 
is possible that this post-seizure increase in DM levels 
may play a role in the refractoriness following the sei-
zure. 
Spencer and Turner (1969), on the other hand, have 
shown that the effects of pentylenetetrazol-induced convul-
sions are potentiated by the prior administration of dex-
amphetamine. An intact DM synthesis is necessary for this 
potentiation, but altered synthesis of either NE or 5-HT 
had no effect on the seizures. Thus, DM appears to have a 
facilitatory action in seizures induced by pentylenetet-
razol, although its action in electroconvulsive shock ap-
pears to be inhibitory to the seizure due to its action in 
increasing latency time (Hanigan, 1971). 
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2. NorepineEhrine and Epinephrine 
The physiological significance of NE was elucidated 
by Barger and Dale in 1910 when they noted that it mimicked 
some of the actions of sympathetic stimulation. Von Euler 
(1946) first described the presence of "sympathin" in mam-
malian brain and spinal cord. He also described a high 
concentration of NE in the CNS compared with that of E. 
The highest levels of NE are found in the hypothalamus, 
1-3 mcg. per gral\ in man (Bertler, 1961), rat (Glowinski 
and Iversen, 1966), and cat (Bertler and Rosengren, 1959). 
The midbrain and pons also contain relatively high levels 
of NE, while low levels are found in the striatum, cereb-
ral hemispheres, hippocampus, and cerebellum (Carlsson, 
1959). Fifty percent of the total CNS content of NE is 
found in the "aminergic" nerve endings (DeRobertis, 1966). 
The importance of E in the mammalian nervous system 
is questionable. Extremely low levels of E are found in 
the rat CNS, although conversion of NE to E has been dem-
onstrated via the enzyme, phenylethanolamine-N-methyltrans-
ferase, or PNMT (Pohorecky et al., 1968). Barchas and co-
workers (1969) have noted the presence of a heat-labile 
substance that inhibits tthe activity of adrenal PNMT, which 
they have isolated from the rat brainstem. They suggest 
that "the low ratio of epinephrine formation in rat brain 
may be associated with this substance". 
" 
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Electrophysiological studies on the central actions 
of NE have often been contradictory. Some investigators 
indicate that the predominant action of catecholamines on 
the cerebral cortex is inhibitory (Krnjevic, 1967; Malcolm 
et al., 1967). On the other hand, recent studies have 
--
shown that NE may be excitatory to cortical cells (Roberts 
and Straughan, 1968; Johnson et al., 1968). These inves-
tigators demonstrated that the pharmacological state of the 
preparation may bG crucial in demonstration of the actions 
of NE. 
,, 
On encephale isole preparations, twice as many 
cells were excited by NE as were inhibited. In prepara-
tions anesthetized with nitrous oxide-halothane mixtures, 
4t times as many cells were excited by NE as were depressed. 
However, under barbiturate anesthesia, which is commonly 
used, eight times as many cells were depressed by NE as 
were excited. 
Bradley and Wolstencroft (1965) found that 48% of 
pontine and medullar neurons responded to NE with differing 
responses: 29% were excited and 19% were inhibited. These 
investigators (cf. Bradley, 1969) reported that 80% of 
brainstem neurons responded to NE: 20% were excited and 
60% were inhibited in this study. Boakes et al. (1968) 
have shown that the excitatory responses of the brainstem 
are stereospecific for NE as they only occur with 1-NE, 
whereas the inhibitory responses were found to occur with 
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either the 1- or d- form. 
Norepinephrine has also been shown to be depressant 
in various brain areas, viz. the medial geniculate nucleus 
of cats (Tebecis, 1967), the hypothalamus (Bloom et al., 
1963), hippocampus, caudate nucleus, and mitral cells of 
the olfactory bulb (cf. Bradley, 1969). 
Studies of intact animals have also led to some 
conflicting reports. Many investigators view NE as an ex-
citatory factor :iJ1 behavioral studies, while others refer 
to it as a behavioral depressant. Systemic administration 
of NE sometimes leads to an arousal response. Administra-
tion of 1-DOPA and amphetamine result in behavioral stimu-
lation. In spite of these seemingly excitatory phenomena, 
the direct actions of NE appear to be inhibitory. A re-
view by Himwich and Alpers (1970) provides a thorough dis-
cussion of the role of catecholamines in various behavioral 
disorders. Dewhurst (1968) has proposed a theory which at-
tempts to explain some of the conflicts that have evolved 
in catecholamine research. He classifies amines as "type 
A" (fat-soluble), excitant; "type B", with biphasic action; 
and "type C" (water soluble), depressant.. Salmoiraghi 
(1966) has proposed two~types of adrenergic receptors that 
are responsible for the dual actions of catecholamines in 
the CNS. 
The effects of these catecholamines on various 
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types of convulsive behavior have been investigated by sev-
eral researchers. Swinyard and co-workers noted that the 
intravenous administration of either NE or E in mice raises 
the threshold for pentylenetetrazol-induced seizures, 
while only E increased the threshold for MES-induced sei-
zures (Swinyard et al., 1964). 
The role of these amines during the course of the 
seizure is difficult to assess, but in several studies 
the levels of am\nes following a seizure have been exam-
ined. Breitner and co-workers (1964) reported that NE lev-
els in the rat brain are decreased after multiple shocks 
delivered over a short period of time. This fact is not 
surprising since Kopin and Baldessarini (cf. Glowinski and 
Baldessarini, 1966) have shown release of labelled NE from 
brain slices into a perfusing medium after low voltage 
electrical stimulation. Hinesley and co-workers (1968) ex-
amined the effects of both electroshock and pseudoshock (a 
sham shock procedure) in order to assess the actual role of 
neurotransmitter substances in convulsive seizures. They 
found that NE levels are significantly decreased in the 
cerebral hemispheres of shocked animals, but no alteration 
was noted in the other brain areas examined. These re-
duced NE levels may reflect an increased turnover rate 
during the seizure state as has been noted in rats ex-
posed to electroconvulsive shock twice daily for one week 
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(Kety et .§1., 1967), or to seizures induced by hyperbaric 
oxygen (OHP; Neff and Costa, 1967). Partial confirmation 
of this supposition can be found in the work of Ladisich 
and co-workers, who have shown that chronic ECS treatment 
decreased levels of NE, and simultaneously increased the 
levels of the acid metabolites of NE in all brain parts 
examined (Ladisich et al., 1969). They also demonstrated 
that brain homogenates from shocked animals have a lower 
capacity for NE uptake • 
• 
Most of the pharmacological manipulations involving 
the catecholamines also involve 5-HT, so several studies 
will be considered under the heading of "biogenic amines", 
(cf. Section II-D-4). A few studies have been done util-
izing specific inhibition of the rate-limiting step in 
catecholamine biosynthesis. Blenkarn .and co-workers (1969) 
demonstrated that neither alpha-methyl tyrosine or dl-DOPA 
has any effect on OHP-induced seizures. Musacchio and co-
workers (1969) have shown that the activity of tyrosine 
hydroxylase, the rate-limiting step in catecholamine bio-
synthesis, was increased by 15% in the whole brain of rats 
exposed to ECS treatment twice daily for one week; activity 
was increased by 10% int the cortex and by 24% in the brain-
stem. The aforementioned studies suggest that convulsions 
lead to an increased NE synthesis and may alter its uptake 
as well. This process is accompanied by increased 
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degradation since turnover is augmented in the post-seizure 
period(~ supra). 
3. Serotonin 
Serotonin, or 5-hydroxytryptamine, was initially 
isolated from blood platelets and the intestinal mucosa 
by Page and Erspamer in 1948. They also noted its vaso-
constrictor properties, and Rapport (1949) identified the 
compound chemically in 1949. Amin and co-workers (1954) 
reported the pre~ence of 5-HT in the CNS of the dog. Since 
that time, 5-HT has been found in several plant species, 
and in all invertebrate and vertebrate species that have 
been examined (cf. Erspamer, 1966). 
The differential distribution of 5-HT in the CNS has 
been recognized for several years (Gaddum and Giarman, 
1965). The pineal gland contains an exceptionally high con-
centration of 5-HT, 56.9-72.6 micrograms/grams of tissue in 
the rat (Owman, 1963). Other brain areas rich in 5-HT in-
elude the midbrain, hypothalamus, and the septal area. 
Low concentrations are found in the cerebral cortex, cer-
ebellum, and the.CNS white matter (Bogdanski~ al., 1957). 
The neurophysiological actions of 5-HT on the CNS 
have been extensively examined. Marrazzi and Hart (1956) 
suggested that 5-HT might be an inhibitory substance as 
they found that it depressed evoked transcallosal responses. 
r 
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Krnjevic and Phillis (1963a) found that 5-HT depressed 
cortical activity induced by both glutamate and peripheral 
stimulation. Roberts and Straughan (1967) demonstrated 
that 5-HT has both excitatory and inhibitory actions on the 
/ 
cat encephale isole. Hoffer et al. (1968) found that the 
application of 5-HT leads to activation of cerebellar 
Purkinje cells. The actions of 5-HT on the brainstem are 
also seemingly paradoxical. Bradley and Wolstencroft 
(1965) found tha• 5-HT application to single neurons of 
the pons and medulla led to variable effects: 40% of the 
neurons tested were excited by 5-HT, while 49% were in-
hibited. The effects of 5-HT on the lateral geniculate 
nucleus are depressant when stimulation is induced by the 
optic tract, but no effect is noted with antidromic stim-
ulation or application of excitant amino acids (Curtis 
and Davis, 1962; 1963). Serotonin is also depressant to 
the hypothalamus (Bloom~ al., 1963), olfactory bulb 
(Bloom et al., 1964), hippocampus (Biscoe and Straughan, 
1965), and spinal cord (Phillis et al., 1968). 
Although most of the studies of 5-HT previously 
mentioned describe the substance as an inhibitory factor, 
several studies on 5-HTtlevels in convulsive states have 
minimized its impbrtance in the production of the seizure 
pattern. Bonnycastle and co-workers (1957) reported no 
change in 5-HT levels following ECS seizure activity, but 
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an increase after diphenylhydantoin administration. Ly-
sergic acid diethylamide, a potent blocker of the action of 
5-HT in the CNS, does not affect seizure susceptibility 
(Lessin and Parkes, 1959). Garattini and co-workers (1960) 
reported an increase of 5-HT in the CNS following ECS ac-
tivity, but they are cautious in interpreting these re-
sults due to contradictory data presented by other workers 
(cf. Garattini and Valzelli, 1965, p. 213). Hinesley and 
co-workers (1968~ have clarified this paradox somewhat in 
demonstrating that CNS levels of 5-HT are elevated sig-
nificantly by both ECS and pseudoshock procedures. This 
increase was not seen in animals that were handled only. 
Thus, stress and handling contribute to these increases in 
5-HT levels which were assumed to be due to the convu.lsion 
process. 
A diet with excess tryptophan, a precursor of 5-HT 
in the CNS, lowered the hexafluorodiethyl ether seizure 
threshold in immature rats (Gallagher, 1969). Brain levels 
of 5-HT are unchanged one hour after exposure to OHP. 
Neither p-chlorophenylalanine, which decreases central 
5-HT levels, nor 5-HTP, which increases them, has any ef-
fect on ORF-induced seieures (Blenkarn et al., 1969). 
Neff and Costa (1967) reported that the turnover rate of 
5-HT in the brain is increased in QI-IP-treated animals. 
The exact role of 5-HT in these seizure induction methods 
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deserves further study. 
Para-chloroamphetamine, which appears to increase 
the level of free 5-HT, has anti-convulsant actions, but 
these require cautious interpretation due to the ampheta-
mine-like actions of this drug on catecholamine receptorso 
Schlesinger and co-workers have reported that p-chloro-
phenylalanine increases the susceptibility to audiogenic 
seizures in mice (Schlesinger et al., 1969). The adminis-
tration of 5-HTP.has been reported to decrease seizure 
susceptibility (cf. Maynert, 1969; Prockop et al., 1959). 
The data above indicates that 5-HT might play an inhibitory 
role in central convulsive mechanisms, but more study is 
necessary to confirm this hypothesis. 
4. The~ of Biogenic Amines iQ Seizure Susceptibility 
The purpose of this section is to review some of the 
studies which have dealt with simultaneous alterations in 
the levels of two or more biogenic amines. 
Extensive research has been undertaken to examine 
the relationship of decreased biogenic amine levels to sei-
zure susceptibility. Toman and Everett (1958) found that 
drug-induced depletion of biogenic amines shortens the 
electroshock latency time, and that increased amine levels 
F- produced an opposite effect. Reserpine, which lowers 
levels of both catecholamines and serotonin, also lowers 
r 
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the threshold to both electroshock and chemoshock seizures 
(Chen et al., 1954). DeSchaepdryver and co-workers (1962) 
demonstrated a threefold increase in electroshock thres-
hold in reserpinized rabbits, in which catecholamine levels 
had been restored by administration of DOPA and an MAO 
inhibitor. When the catecholamine levels are reduced by 
the administration of alpha-methyl tyrosine, an increase in 
seizure susceptibility occurs (Rudzik and Mennear, 1966). 
It appears that &ecreases in the levels of biogenic amines 
are directly proportional to decreases in the resistance to 
electroshock or chemoshock seizure induction. 
Similar studies have been performed which demon-
strate that increased levels of biogenic amines increase 
resistance to seizure. Kobinger and co-workers (1958) 
noted that administration of DOPA with an MAO inhibitor 
elevated the threshold for pentylenetetrazol-induced sei-
zures. However,_ DOPA alone had no effect on the seizure 
threshold in mice pretreated with either iproniazid or re-
serpine (Prockop et al., 1959). Oliver and co-workers 
(1970) found that tranylcypromine counteracted reserpine-
induced increases in the incidence of OHP seizures and the 
decrease in average onset times. Increased levels of free 
catecholamines could be a critical factor in seizure re-
duction. The anticonvulsant action of amphetamine might 
be due to an action of this type. Administration of other 
blockers of catecholamine reuptake, such as imipramine, 
amitriptyline, and cocaine, have also been shown to de-
crease the seizure susceptibility (cf. Maynert, 1969). 
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MAO inhibition by either pargyline or iproniazid increases 
latency time and survival, and decreases the frequency of 
OHP-induced convulsions. This effect appears to be dis-
sociated from the metabolism of either 5-HT or NE (Blenkarn 
et al., 1969). This suggests that DM might be the substance 
responsible for ~his action. Pfeifer and Galambos (1967) 
have implicated DM as the substance involved in the actions 
of reserpine and of MAO inhibitors on seizure susceptibil-
ity. 
The inverse relationship between catecholamine lev-
els and seizure susceptibility is well illustrated by the 
actions of metaraminol on seizure susceptibility. This 
drug, which displaces NE from its intracellular storage 
sites, first reduces and then increases seizure suscepti-
bility. Thus, NE levels are increased (in the free state) 
initially, and then depleted as the free NE is broken 
down and not replaced (Mennear and Rudzik, 1966). 
Although many of the studies on the relationship be-
tween catecholamine levels and decreased seizure suscepti-
bility have involved MAO inhibition, Lehmann (1967) has 
also shown that pyrogallol, an inhibitor of COMT, increases 
the threshold for audiogenic seizures. Furthermore, this 
l 
59 
effect is markedly enhanced by the use of imipramine or an 
MAO inhibitor. 
Six genera of mice were evaluated on the basis of 
their electroshock threshold and their brain biogenic amine 
levels (Scudder et al., 1966). Those strains of mice that 
exhibited the longest latency to minimal electroshock sei-
zures also had the highest central levels of biogenic amines, 
and vice versa. 
Thus, it appears that most of the available litera-
• 
ture is in agreement on the relationship between the bio-
genie amines and seizure susceptibility; the levels of these 
amines appear to be directly proportional to seizure re-
sistance. 
5. Glutamate and 4-aminobutyric Acid (GABA) 
The actions of both glutamate and GABA will be con-
sidered under the same heading since their physiological 
actions are interrelated. 1-Glutamic acid is the main pre-
cursor of GABA; this conversion is catalyzed by the enzyme, 
glutamic acid decarboxylase (GAD), and it is essentially 
irreversible (cf. Roberts, 1960). The relationship between 
these two compounds has been amplified further by Roberts 
t (1968), who has proposed that "the variation of chloride 
ion content at nerve endings may regulate the GAD activity 
and thus determine the proportions of glutamic acid and 
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GABA which might be released on stimulation". 
GABA was first identified in 1910 by Ackerman and 
Kutscher. In 1950, two independent research groups local-
ized large quantities of GABA in the mammalian CNS (Awapara 
et al., 1950). Kuffler and Eyzaguirre (1955) proposed that 
--
GABA might play a role in inhibitory transraission in the 
CNS; this supposition was partially confirmed when GABA 
was found to be a major component of an inhibitory brain ex-
tract called Factor I (Bazemore, Elliot, and Florey, 1957) • 
• 
Until recently, GABA was believed to be present 
only in the mammalian CNS, but Scriver and Whelen ( 1969) 
found it in rat kidney. Most of the data on GABA levels 
pertains to the CNS. Fahn and Cote (1968), in a study of 
GABA distribution in the monkey brain, found the highest 
levels in the substantia nigra, globus pallidus, and hypo-
thalamus. Certain areas of the thalamus and cerebral cor-
tex contained lower amounts, while white matter contained 
the lowest concentrations of GABA. In keeping with the 
proposed inhibitory action of GABA, cerebellar levels are 
highest in the axons of cells with proposed inhibitory 
function, viz., Purkinje, basket, stellate, and Golgi 
Type II cells (Kuriyamatet al., 1966a). On the other hand, 
glutamic acid, a fairly ubiquitous substance, is the most 
abundant amino acid in brain tissue (Tallan, 1962). High-
est levels are found in the cerebral hemispheres, and 
61 
lowest levels are noted in the spinal cord (Shaw and Heine, 
1 965) • 
Physiological actions of these amino acids have been 
investigated and these studies tend to strengthen theories 
concerning their functional roles (vide supra). Glutamic 
acid leads to a reversible depolarization of spinal moto-
neurons (Curtis et al., 1960) and cortical neurons (Krnjevic, 
1964) when applied extracellularly. Intracellular appli-
cation has little.effect (Coombs, Eccles, and Fatt, 1955). 
Eccles (1964) proposed that glutamate acts extracellularly 
by increasing membrane permeability to sodium and potassium 
ions. The role of glutamic acid as a putative excitatory 
transmitter has been discussed (Curtis, 1969). On the 
other hand, the extracellular administration of GABA leads 
to hyperpolarization and an increased membrane conductance 
in cortical neurons (Krnjevic and Schwartz, 1967), Deiter's 
cells (Obata et al., 1967), and spinal motoneurons (Curtis 
et al., 1968a&b). Krnjevic and Schwartz (1967) demon-
strated that the equilibrium potential for GABA is close to 
that evoked by direct cortical stimulation. GABA inhibits 
cortical activity at low dose levels with rapid onset and 
a transient time course uf action; it is capable of block-
ing most types of cortical activity (Bradley, 1969). 
Rogozea and co-workers (1969) proposed that GABA depresses 
-hippocampal neurons, and is responsible for supression of 
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the orienting reflex. Electrophoretic application of GABA 
to the retinal ganglion inhibits both spontaneous and light 
driven activity (Straschill and Perwein, 1969). 
Some recent studies have attempted to relate the 
central levels of these amino acids with the functional 
state of the animal. Jasper and co-workers (1965) measured 
levels of these substances following their extraction from 
the pia-arachnoid space. They found that arousal is as-
sociated with bot~ a high rate of glutamate release and 
a low rate of GABA release; the opposite was noted in ani-
mals with an EEG pattern of sleep. Stimulation of either 
the lateral geniculate body or of the cortex, which lead to 
a powerful inhibition of cortical discharge, caused an in-
creased efflux of GABA (Mitchell and Srinivasan, 1969). 
Jasper and Koyama (1969) demonstrated that reticular stimu-
lation increases glutamate levels in the superfusate from 
cat cerebral cortex.· They also noted GABA release during 
sleep periods, confirming the previous studies of Jasper 
and co-workers (1965). Obata and Takeda (1969) demon-
strated the release of GABA into the perfusate of the 
fourth ventricle following stimulation of the cat cerebel-
lar cortex. 
Intracerebral, intracarotid, or intraventricular 
injection of glutamate produces convulsions, which can be 
antagonized by GABA administration (Hayashi, 1952, 1958; 
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Ta.ni, 1954). The intracarotid and intraventricular admin-
istration of GABA as well as its topical application to 
the cortex, increased the threshold for both electroshock 
and chemoshock seizures (Guleti and Stanton, 1960; !Iayashi, 
1958; Rech and Domino, 1960). The balance between gluta-
mate and GABA might actually be the key factor with regard 
to the effects of this amino acid system (vide supra) on 
cerebral excitability (Roberts and Kuriyama, 1968; :May-
nert, 1969). 
• 
The effects of many convulsion-producing substances 
and procedures are associated with a decrease in the cen-
tral levels of GABA. Relationships have been established 
between lowered GABA levels and OHP (Wood and Watson, 1963; 
Wood et al., 1969), pyridoxine deficiency (Tower, 1960; 
cf. Ann. N.Y. Acad. Sci., 166, 1-364, 1969), hydrazide 
convulsants such as thiosemicarbazide (Killam and Bain, 
1957), picrotoxin (Sytinsky and Thinh, 1964; Saito and 
Tokunaga, 1967; Galindo, 1969), methionine sulfoximine 
(DeRobertis et al., 1967), pentylenetetrazol (Whistler 
et al., 1968), bemegride (Whistler et al., 1968), and 
allylglycine (Alberici et al., 1969). Reserpine, which 
decreased seizure resistance (vide supra), lead to de-
creases in GABA levels (Tada, 1963). Conversely, cer-
tain substances that increase the central GABA levels have 
been shown to possess anti-convulsant actions. Substances 
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of this type include hydroxylamine (Eidelberg et al., 1960), 
and aminoxyacetic acid (Kuriyama et al., 1966b). Maynert 
and Kaji (1962) disputed the action of GABA by noting that 
animals with increased GABA levels were indistinguishable 
from controls in response to either electroshock or chemo-
shock. Diphenylhydantoin, a commonly used anti-convulsant 
drug, increases GABA levels; however, this drug exerts ac-
tions on a number of other metabolic processes (Woodbury, 
1969). The incre~se in GABA levels might be the result, 
rather than the cause of the action of diphenylhydantoin in 
the control of seizures. 
The current status of GABA can be summed up in the 
following comment by Eugene Roberts (1968): "much more re-
fined systems must be sought in which to measure accurately 
the total quantity of GABA released in response to an ex-
actly known amount of stimulation. Until such experiments 
are performed, GABA must remain only a promising candidate 
for the role of inhibitory transmitter in vertebrates" o 
4. Glycine 
Glycine, the first amino acid to be isolated, was 
• 
identified in 1820 by Braconnot. He termed the substance 
sugar of gelatin, and Berzelius (1848) later termed it 
"glycine". The substance has recently been proposed as an 
inhibitory transmitter in the mammalian spinal cord. In 
1960, Curtis and Watkins described a non-specific inhibitory 
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action of glycine on spinal nerves. However, subsequent in-
vestigation has indicated that glycine may have a role as 
an inhibitory transmitter in the lumbosacral spinal cord 
of the cat (Aprison and Werman, 1965; Davidoff et al., 1967; 
Graham et al., 1967; Werman et al., 1967; 1968). Evidence 
for this role is presented in recent reviews by Aprison and 
co-workers (1969a) and Werman and Aprison (1968). 
Glycine, the simplest of amino acids, is found ubi-
quitously in mammals. Its distribution in the CNS of mam-
• 
mals exhibits a rostral-caudal gradient with the.highest 
levels being noted in the medulla oblongata and the spinal 
cord (Aprison et al., 1968; Aprison et al., 1969b). In 
general it was found that "glycine concentration was a) 
two to five times higher in the medulla oblongata, cervical 
enlargement, and lumbar enlargement than in four brain areas 
rostral to the medulla oblongata, b) lower in the mid-
thoracic cord than in the cervical and lumbar enlargements, 
and c) generally invariant in the brain areas other than in 
the medulla oblongata" (Aprison et al., 1969b). The in-
vestigators correlated these high levels of glycine with 
the amount of musculature supplied by the various spinal 
areas investigated. Thew found that a positive correlation 
existed between the number of interneurons and the glycine 
concentration (Davidoff et al., 1967; Graham et al., 1967). 
Glycine has been shown to hyperpolarize both 
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cortical (Curtis et al., 1968b) and spinal motoneurons 
(Curtis et ~1.·, 1 968a; Werman et al., 1 968) • The reversal 
potential of glycine hyperpolarization is similar to that 
of the actual inhibitory processes of spinal motoneurons 
(Curtis et al., 1968a; Werman et al., 1968). Glycine is 
a more potent depressant of spinal motoneurons and inter-
neurons than is GABA, and the reverse is true for cortical 
neurons. Glycine and GABA are equipotent on the Renshaw 
cell and cuneate neurons of the spinal cord (Curtis et al., 
• 
1968b). Glycine also possess potent inhibitory actions on 
the cuneate nucleus of the medulla (Galindo et al., 1967). 
The inhibitory actions of glycine in the spinal cord 
are prevented by the iontophoretic application of two po-
tent convulsant agents, strychnine (Curtis, 1963; 1969) and 
picrotoxin (Davidoff and Aprison, 1969). Wood and co-
workers demonstrated that glycine can protect rats from 
the effects of OI1P-induced seizures (Wood et~., 1966). 
Immature rats fed a diet with excess glycine exhibited no 
change from controls in response to hexafluorodiethyl ether 
(Gallagher, 1969). Glycine has been shown to protect rats 
from convulsions induced by homocysteine; however, homo-
serine, serine, betaine,tand glucose all share this action 
(Sprince et al., 1969). Although some studies indicate 
that glycine may play a part in convulsive phenomena, much 
study is needed for the confirmation of this role. 
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Acet~lcholine 
The intracarotid, intraventricular, or intracisternal 
administration of acetylcholine (ACh), as well as local ap-
plication to exposed brain areas, results in precipitation 
of grand mal seizures, or EEG symptoms similar to those of 
grand mal epilepsy (cf. Maynert, 1969). Similar results 
occur when cholinesterase is inhibited in the CNS, allow-
ing an increased central level of ACh (Feldberg and Sher-
wood, 1954). 
• 
Richter and Crossland (1949) have reported that ACh 
content in the CNS is decreased during the initial shock 
stimulus, returns to normal levels, and is then decreased 
again during the convulsive episode. Acetylcholine levels 
of the brain are also decreased during chemoshock seizures 
elicited by pentylenetetrazol or picrotoxin (Stone, 1957). 
Longo (1966) has shown that atropine has no effect on the 
convulsant response to pentylenetetrazol. Stone has also 
demonstrated the convulsive effects of tetraethyl pyro-
phosphate (TEPP), a potent anticholinesterase; he found that 
these seizures c.ould be antagonized by the administration 
of atropine. It appears that the ACh content of the brain 
is decreased following various types of seizure patterns 
induced by different convulsant procedures. This decreased 
ACh content is believed to be associated with an increased 
release and degradation of this neurotransmitter agent; 
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such a decrease is not unexpected in light of the increased 
transmission associated with the convulsive episode (Stone, 
1 969) • 
Maynert (1969) has evaluated some of the older 
studies on the role of ACh in seizure susceptibility, and 
he has noted that many of these studies were performed in 
anesthetized animals, which show an altered metabolism of 
ACh. Sobotka (1969) demonstrated that brain levels of ACh 
in the mouse are ~ncreased following administration of 
MSO, a convulsant substance with a 60-90 minute latent per-
iod prior to convulsion. Thus, it appears that ACh levels 
might be normal or increased prior to the actual convulsive 
episode, and they are decreased due to the release of the 
stored ACh during the convulsion. The role of ACh in con-
vulsive episodes has been thoroughly reviewed by Curtis 
(1969) and Maynert (1969). 
8. Generalizations 
In general an increased level of any of these puta-
tive inhibitory transmitters leads to a decrease in seizure 
susceptibility; conversely, seizure susceptibility appears 
to be increased by the administration of putative excita-
tory substances. 
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E. Objectives 
It is difficult to ascertain accurately the nature 
of drug efficacy without adequate information regarding the 
background upon which a drug acts. Inhibitory systems are 
involved in convulsive disorders and their amelioration, 
and a number of chemical substances have been considered as 
inhibitory transmitter candidates in the CNS. It is the 
purpose of this study: 
1) 
2) 
3) 
• to acquire background information by determin-
ing the levels of putative inhibitory trans-
mitters of the CNS as a function of the time 
of day using a "normalu light cycle, and to 
examine the effect of a "reversed" light 
cycle on some of these amine levels. 
to determine the role of these circadian vari-
ations in transmitter levels on the. response 
to maximal electric shock ~eizures. 
to determine the diurnal and nocturnal fluc-
tuations in the response of rodents to selected 
convulsant drugs and to common anti-convul-
sants in antagonizing maximal electroshock 
seizures. 
• 
CHAPTER III 
MATERIALS AfID METHODS 
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A. Basic ~xperimental Conditions and Procedures 
1. Animals 
Male albino rats of Sprague-Dawley strair~ (Holtzman 
Breeders, Madison, Wisconsin), weighing 275-315 grams, 
were used for all rat experiments. ':::hey were housed in 
pairs in stainless steel wire mesh cages, 11x9x9 inches. 
Pel-E-Cel bedding (Paxton Products, Paxton, N. J.) was used 
as an absorbent material beneath the mesh bottoms of the 
cages, so that an!'mals had no direct contact with the bed-
ding. 
Male albino mice of Ha/ICR strain (A. R. Schmidt 
Breeders, Madison, Wisconsin), weighing 32-37 grams, were 
used. These animals were caged in groups of twenty ani-
mals each in stainless steel wire mesh cages, 16x6x9 
incheso Softwood sawdust was used for bedding material, 
but animals had no contact with this material, which can 
influence drug responsiveness (Vesell, 1968). 
2. Environmental Conditions 
Both mice and rats were given food (Purina Rat Chow) 
and tap water ad 1.i!2J:tum. The composition of Rat Chow con-
sisted of 24% crude protein, not less than 4% fat, 5% crude 
fiber and 9~~ ash, with vitamins and minerals added. Feed-
ing, watering, and cage cleaning were performed at various 
times of the day to prevent these procedures from becoming 
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entrainment stimuli. Cage racks were kept in a quiet, well 
ventilated, windowless room, which measured 9x12x13.5 feet. 
Temperature was stable at 23 + 1° c. Ambient humidity was 
fairly constant at 25 ± 5%, as was the barometric pressure 
at 732-762 mm. of mercury. These three parameters were re-
corded on a 24-hour basis by a Lambrecht KG recorder 
(Gottingen Type 235). 
3. Lighting Conditions and Photoperiods 
Animals us~d for the initial studies of dopamine 
and GABA levels (in corpus striatum, thalamus-hypothalamus, 
and corpora quadrigemina) were exposed to 85 foot-candles 
of incandescant light as measured by a Gossen Luna-Pro CdS 
light meter. Light was provided by General Electric 150 
watt light bulbs at a distance of four feet from the cage 
front. These bulbs had no appreciable effect on the tem-
perature of the room as monitored by the Lambrecht recorder. 
Animals for all subsequent studies were adapted un-
der conditions of Vita-Lite (Duro-Test Corp., North Bergen, 
N. J.) lighting, a fluorescent light source with a spectrum 
approximating that of daylight. This similarity can be 
noted in spectra A and C of Figure 1. The lights were 
placed at a distance of 5-6 feet from the front of the 
cages, and their output was measured at 100 foot-candles 
l by the Gossen light meter. 
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All animals were adapted for a minimum of three weeks 
prior to experimentation. Two types of light cycles were 
used: 1) a ~al cycle in which the photoperiod lasted 
from 0800-2000 hours CST., and 2) a reverse cycle in which 
the photoperiod lasted from 2000-0800 hours CST. These 
photoperiods were automatically timed by a Sears Kenmore 
timer (All purpose 24-hour timer, 15 amps output). 
4. Dissection of Tissues 
a. Brain Areas 
Groups of six rats were killed by decapitation 
(Harvard Decapitator, Model No. 130 RM) at 3-6 hour inter-
vals around the clock. The skull was opened by an incision 
with surgical scissors following the midline suture. The 
dura was incised, and the brain was removed following sep-
aration from the cranial nerves. The brain was immediately 
placed on a cold aluminum block or on a cold glass plate, 
and rinsed with cold 0.9% saline solution to remove vis-
ible blood. It was blotted on filter paper and dissected 
into the following regions (depending upon the experiment): 
cerebellum, frontal cortex, corpus striatum, thalamus-
hypothalamus, corpora quadrigemina, pons, medulla; upper 
brainstem consisting of thalamus, hypothalamus, and mid-
brain; and lower brainstem consisting of pons and medulla 
(cf. Figure 9 in Zeman and Innes, 1963). Excised tissues 
were weighed on a Holler-Smith tissue balance (Model G, 
500 mg. counter-weight), and frozen in liquid nitrogen 
within three minutes after decapitation. Tissues were 
stored at -~5° c. for periods up to three weeks prior to 
amine quantification. 
b. Spinal Cord Dissection 
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Groups of six animals were killed by decapitation, 
and the spinal cord was exposed by laminectomy with a fine-
pointed surgical scissors. Any excess tissue was trimmed 
• 
away from the rostral area of the cord. The cord was 
lifted from the canal by a probe, which had been used to 
break the dorsal and ventral roots in order that the cord 
could be removed ~ bloc. The cord was rinsed with O. ~~ 
saline solution, and was placed on a cold glass plate~ The 
cord was then divided into the cervical enlargement, lum-
bar enlargement, and the thoracic spinal cord (cf. Figure 
20, Zeman and Innes, 196)). These areas were weighed and 
frozen in liquid nitrogen within 4-5 minutes following de-
capitation. They were stored at -~5° c. for 1-2 weeks 
prior to glycine assay. 
5. Methods of Amine Analysis 
a. Dopamine 
Tissues were analyzed for dopamine (DM) by the 
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method of Sourkes and Murphey (1961). The tissues were 
homogenized in 5 ml. of 10% trichloracetic acid (TCA) in a 
glass Potter-Elevjehm homogenizer. The pestle was rinsed 
with 1.0 ml. of 10% TCA, which was allowed to run off into 
the homogenizing tube. The tubes were centrifuged at 1000g 
for 10 minutes in a IEC Model V centrifuge (radius head, 
7.5 inch). The supernatant fluid, which contained the cat-
echolamines, was placed in a 50 ml. glass-stoppered cen-
trifuge tube cont•ining 1 ml. of a freshly prepared 0.2% 
ascorbic acid solution, which prevented the oxidation of 
DM. The tissue pellet was washed twice with 2 ml. portions 
of 10% TCA, and the washes added to the centrifuge tube. 
Standard tubes containing O, 0.25, 0.50, or 1.00 micrograms 
of DM were. carried siII).ul taneously through the entire method 
in order to establish the standard curve for DM in this pro-
cedure. 2.5 ml. of 10% EDTA solution, one drop of 1% phen-
olphthalein solution, and 0.5 grams of Woelm alumina (Alu-
pharm Chemicals, New Orleans, La.) were added to each tubeo 
EDTA, disodium form, aided in the chelation of divalent 
cations, and its presence facilitated consistent recoveries 
of DM. Woelm non-alkaline alumina was specified because of 
its low percentage of "fines", which prevent rapid settling, 
as well as for its neutrality, which allows more rapid pH 
adjustment. Phenolphthalein was used as an indicator for 
the following titration. The solutions were titrated to 
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a pale pink (pH 8.2-8.4) with 5N, and then 1N, sodium hy-
droxide. This pH range has been shm·m to be optimal for 
catecholamine adsorption onto the alumina (Anton and Sayre, 
1962). The tubes were then stoppered and shaken at high 
speed for 15 minutes on an Eberbach shaker. After the 
alumina had settled, the supernatant fluid was removed by 
suction with a small-bore glass tube connected to a faucet 
aspirator. The alumina was washed twice with 5 ml. por-
tions of distille~ water, pH 7.0. After removal of the 
second wash, 5 ml. of 0.5 N acetic acid were added to each 
tube. The tubes were shaken on high speed for 15 minutes, 
and were centrifuged 15 minutes at 1000g. This step re-
moved the catecholamines from the alumina and separated the 
alumina, so that 2.0 ml. of the acid solution containing 
dopamine could be removed from each vessel sans alumina. 
Recovery of catecholamines was in the range of 60 ± 4%. 
Two sets of test tubes (18 x 150 mm.) were designated 
set A and set B. Each tube received 2.0 ml. of 1M sodium 
acetate buffer, pH 6.0. 1.0 ml. of acid eluate from each 
centrifuge vessel was added to each tube of sets A and B. 
Set B tubes were developed for the fluorimetric analysis of 
DM by the addition of O.~ ml. of Oo01 N iodine (in absolute 
ethanol), 0.5 ml. of alkaline sulfite solution exactly 
three minutes later, and 1.0 ml. of 5N hydrochloric acid, 
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containing 2 mg./ml. of ascorbic acid, exactly three minutes 
after the alkali addition. Set A tubes were used as blanks 
and treated similarly except that the added alkaline sul-
fite contained 2 mg./ml. of ascorbic acid, and the 5N hydro-
chloric acid was added just prior to reading the fluori-
meter. The tubes were allowed to stand in diffuse daylight, 
or under an ultra-violet source, for at least forty-five 
minutes before reading. The fluorophore formed was stable 
for up to one week. The solution was transferred to a 
• 
quartz cuvette with a 10 mm. light path. DM fluorescence 
was read at an excitation wavelength of 330 millimicrons 
(uncorrected) and an emission wavelength of 375 millimicrons 
(uncorrected). An Aminco-Bowman Spectrophotofluorimeter 
(SPF model) was used for all fluorimetric analyseso A num-
ber 2 slit scheme was used for DM analysis and the emitted 
fluorescence was amplified on a RCA 1P21 photomultplier 
tube. 
Treatment of catechols with iodine at weak acid pH 
leads to formation of products which isomerize in alkaline 
media to dihydroxyindoles in the case of dopamine-like sub-
stances (trihydroxyindoles in the case of epinephrine or 
norepinephrine). Figure 2 depicts this conversiono In 
alkali, however, the DM fluorophore will emit light in the 
same region of the spectrum as will the fluorophores of 
epinephrine or norepinephrine; therefore, the solution is 
HO 
HO 
DOPAMINE 
HO 
HO 
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Figure 2. The conversion of dopamine to a fluorophore 
(A) via dihydroxyindole condensation . 
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acidified with 5 N hydrochloric acid. The DM fluorophore 
then fluoresces at a lower wavelength allowing a quantific-
ation free from extraneous catechol fluorescence. 
Calculation of DM. content in the tissues was per-
formed by construction of a standard curve based on the 
standard solutions treated concomitantly with the samples 
(minus their respective blanks). Then, the dopamine con-
tent of any tissue was calculated as follows: 
B -A = the relative fluorescence of tube "B" x x • 
Bx = the reading for tube "x" in set B 
Ax = the reading for tube 11 x" in set A 
The amount (mcg.) of DM in the tissue sample "x" 
could then be ascertained from the standard curve. This 
amount was then multiplied by the tissue factor (the re-
ciprocal of the tissue weight in grams)" to give the con-
centration of DM in the tissue in micrograms/gram of wet 
tissue weighto 
b. Dopamine, Serotonin, and Norepinephrine 
Determination in a Single Tissue Sample 
The technique of Ansell and Beeson (1968) was used 
for simultaneous determinations of NE, 5-HT, and DM in the 
same brain sample (Figure 3). A tissue sample, weighing 
from 100-500 mg. was homogenized in 5 ml. of acid butanol 
using a glass Potter-Elvejhem homogenizing tube with a 
Teflon pestle (Kontes). One liter of acid butanol consists 
... 
Homogenate of tissue 
in acid butanol 
iso-octane/ H20 
Monoamines in water 
layer 
5-HT 
iso-octane 
phosphate buffer, pH 7.0 
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buffer 
ninhydrin, 
heat 
Condensation of fluorescent 
product with 5-HT 
2 M Sodium acetate 
( pH= 7.2) 
Pre-washed alumina 
0.25 M 
acetic acid 
catecholamines 
in acid 
neutralize 
( 10 N NaOH) 
con ensa ion 
via THI procedure 
Figure 3. The Ansell and Beeson procedure (flow sheet). 
The supernatant is indicated by supn. 
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~· of 0. 999 1 • of washed bu tanol mixed with 0. 85 ml. of con-
,_ 
,, 
centrated hydrochloric acid, 1.0 gram of potassium metabi-
sulfite as an anti-oxidant, and 0.1 cram of EDTA, disodium 
salt, used as a chelating agent for divalent cations. 
Homogenization was carried out with the base of the tube 
cooled in a beaker of ice to prevent monoamine degradation. 
All tissues were homogenized in 5 ml. of acid butanol with 
the exception of the cortex blank, which contained 400-500 
mg. of cortical t~sue homogenized in 10 ml. of acid bu-
tanol. This homogenate was split, and one portion was 
shaken with a 50 lambda portion of mixed standard solution 
containing 250 nanograms each of DM, NE, and 5-HT. All 
homogenates were centrifuged at 1000g for five minutes. 
4.0 ml. of the supernatant butanol layer was then 
shaken in a 50 ml. glass-stoppered centrifuge tube with 
10 ml. of 2,2,4-trimethylpentane (iso-octane) and 5.0 ml. 
of double distilled water. This melange was shaken at 
high speed on an Eberbach shaker for two minutes. This step 
transfers the monoamines from the butanol layer into the 
aqueous layer by solvent saturation. These vessels were 
centrifuged for two minutes at 1000g to separate the liquid 
layers. The upper (organic) phase was aspirated off with 
a Pasteur paper tip attached to a Tygon tube-faucet aspir-
ator combination. 4.5 ml. of the aqueous phase was added 
to 1.0 ml. of 2M sodium acetate solution and 200 mg. of 
pre-washed Woelm alumina in a 12. ml. glass-stoppered cen-
trifuge tube (Kontes). Woelm alumina was pre washed with 
1N hydrochloric acid followed by 35-40 rinses of distilled 
water to raise the pH to above 4.0, and then heated to 
200° C. for two hours prior to storage in a dessicator. 
The pH of each sample tube was checked with a Beckman pH 
meter, and was adjusted to a range of 7.2.-7.4 with 0.5N 
sodium hydroxide, when necessary. 
8) 
This mixtu~e was shaken for ten minutes, and then 
centrifuged for five minutes at 1500g. This step involves 
the adsorption of catecholamines onto the alumina, while 
the 5-HT remains in solution. Since catecholamines are un-
stable in alkaline media, the adsorption of catecholamines 
at pH 7.2 represents an improvement in methodology, which 
is possible because of the use of pre-washed alumina nd 
the absence of phosphate ions. The aqueous solution, con-
taining 5-HT, was transferred to a 50 ml. glass-stoppered 
centrifuge tube containing 11.0 ml. of purified butanol. 
1.0 ml. of 0.35 M borate buffer, pH 10, and 3.0 grams of 
sodium chloride. This melange was shaken for ten minutes 
on high speed and centrifuged for two minutes at 1000g. 
This step transfers the t5-HT from the salt-saturated, al-
kaline aqueous media into the organic phase. Then ten ml. 
of the organic phase were added to a 50 ml tube containing 
15 ml. of iso-octane and 1.0 ml. of freshly prepared 0.05 M 
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phosphate buffer, pH 7.0o This mixture was shaken for two 
minutes at 1000g. This solvent saturation drove the 5-HT 
back into the aqueous media, and the upper organic layer 
was removed by aspiration. 
A portion (1.2 ml.) of the aqueous phase from each 
tube was added to 0.1 ml. of fresh 0.1 M ninhydrin solution, 
and heated at 75° C. for thirty minutes. An unextracted 
standard ( 50 ng.), a blank, and a tissue blank were also 
treated similarly. After heating, the tubes were allowed 
• 
to cool for a minimum of one hour. The fluorophore that 
is developed remains stable for several days. These 
samples were read in the Aminco-Bowman SPF at an excitation 
wavelength of 385 millimicrons (uncorrected) and at an 
emission wavelength of 495 millimicrons (uncorrected). 
Slit scheme number 5 is used for the quantification of the 
serotonin-ninhydrin cendensation product, which is linear 
in absorbance from 5-HT concentrations of 0.5-5000ng. 
Meanwhile, the alumina was washed with 2 ml. of 
double distilled water, pH 7.0, by shaking for two minutes 
at high speed. The tubes were then eluted with 1.0 ml. of 
0.25 M acetic acid. The tubes were shaken for fifteen min-
utes at high speed, and(spun at 1500g for five minutes. The 
supernatant ac~d was transferred to an 18 x 150 mm. test 
tube with a Pasteur pipet. These samples were adjusted to 
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pH 6.50 by the addition of 10 N sodium hydroxide from a 
micrometer syringe. The pH was continuously monitored with 
a probe electrode and Beckman pH meter, while the tube was 
shaken on a table-top vortex mixer. 
A 0.5 ml. portion of the adjusted supernatant was 
mixed with 50 microliters of Oo1 M EDTA in 1.0 M sodium 
acetate buffer, pH 6.50. EDTA is added to stabilize the 
catecholamine fluorophores, and it increases fluorescence 
in this procedure 0 by 50-75%. Fifty microliters of 0.1 M 
iodine (in absolute ethanol) was added to begin the oxida-
tion step of the hydroxyindole formation (Figure 2). This 
was followed exactly two minutes later by the addition of 
freshly prepared alkaline sulfite (0.1 ml.). Then, after 
two additional minutes, 0.1 ml. of 6 M acetic acid was ad-
ded to each tube. The tubes were heated at 100° c. for two 
minutes and cooled rapidly to room temperature. One ml. of 
double distilled water was then added to each tube, and 
these samples were read immediately for NE fluorescence. 
This fluorescence was read at an excitation wavelength of 
385 millimicrons (uncorrected) and at an emission wavelength 
of 485 millimicrons (uncorrected). These samples, as well 
as those of DM, were read at slit scheme number 2 in the 
Aminco-Bowman SPF. The samples were then transferred from 
the cuvette back into their respective tubes, and they were 
re-heated for four minutes at 100° c., to destroy the NE 
r !It 
~· 
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··. ~: fl uorophore. To assure the absence of NE interference, the 
samples were assayed for DM on the following day. DM 
fluorescence is excited at a wavelength of 330 millimicrons 
and read at emission wavelength of 385 millimicrons (both 
uncorrected). 
Amine content is calculated by comparison with the 
internal standard as described below: 
4 
x 4-"";5 x 250 x 2. 4 x 1 y = 
ng./gram 
of amine 
R = fluormetric reading of tube "x" 
x 
Bx = fluormetric reading of tissue blank 
Rstd = fluormetric reading of cortex standard 
Bstd = fluormetric reading of cortex blank 
4/4.5 (250)= actual amount of amine extracted 
5/4 = correction factor for the volume of 
butanol homogenate used 
1/y = the tissue factor, where y is the wet 
tissue weight 
This method has sensitivity for each of the amines as fol-
lows: 20 ng. for NE, 30 ng. for 5-HT, and 100 ng. for DM; 
where sensitivity is defined as that quantity of each amine 
which must be present i~ order to give a reading which is 
equal to twice that of its blank value. The recoveries 
with this method are in the range of 51 ± 8%. 
l 
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c. 4-aminobutyric Acid (GABA) 
GABA was extracted from tissues in ethanol (Baxter, 
1961) and was assayed by the method of Jakoby ,1962). The 
tissues were homogenized in a Potter-Elvejhem homogenizer 
with a Teflon pestle. The frozen sample was placed direct-
ly into the homogenizing vessel containing six ml. of ice-
cold ethanol (80%). After homogenization, the pestle was 
rinsed into the tube with 2 ml. of 75% ethanol. The samples 
were then centrif~ged at 1500g for ten minutes. The super-
natant fluid was decanted into a twenty ml. beaker follow-
ing centrifugation. The contents were evaporated to dry-
ness under an infra-red lamp (Infra-dry cabinet, Precision 
Scientific Co.). Beakers were removed just at the point 
of complete evaporation to avoid the formation of a brown 
denaturation product, which increased blank values. One 
w~. of distilled water per 100 mg. of wet tissue was added 
to each beaker, and the resuspended extract was transferred 
to a 3 ml. polycarbonate centrifuge tube (11 x 77 mm.). 
These tubes were centrifuged at 20,000 x g@ 4° c. for 
thirty minutes on an IEC B-20 high speed refrigerated cen-
trifuge. A 0.2 ml. aliquot of each supernatant was pipet-
ted into a 1 ml. Pyrex beaker, and the fluid was evaporated 
at 50° c. in vacuo (20-25 psi.). The tubes were stored in 
a vacuum desicator until the enzymatic determinations were 
performed. 
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Determinations were made by adding 0.5 ml. of double 
distilled water to the dried contents in the 1 ml. beaker. 
The resuspended solution was quantitatively transferred to 
a microcuvette of 10 mm. light path, 1.25 ml. total volume 
(Sargent Chemical Co.). 0.4 ml. of a reagent mixture was 
then added to the microcuvette. This reagent mixture con-
tained 0.05 mls. of 1.0 M Tris buffer, pH 7.9, 0.15 ml. 
of 1.0 M sodium sulfate solution, 0.05 ml. of 0.7% mer-
captoethanol in Tris buffer, pH 7.9, 0.05 ml. of nicotine 
• 
adenine dinucleotide phosphate (NADP), solution, 20 mgo/ml., 
and 0.1 ml. of a solution of GABASE-CF, 50 mg./ml. (con-
centration was increased onl~ when aging of the enzyme 
necessitated a greater amount of enzyme so that the reaction 
could be completed in ten minutes). At this point, a con-
trol absorbancy reading was recorded at 340 millimicrons on 
a Beckman DU spectrophotometer. 0.1 ml. of a 0.02 M alpha-
ketoglutarate solution, pH 7.9, is added to initiate the 
reaction indicated in Figure 4. Absorbance readings were 
then taken every thirty seconds until maximum absorption 
was attained. 
The Tris buff er stabilizes the system against any 
pH change due to the release of hydrogen ions. Sodium 
sulfate is used to prevent protein precipitation during 
the reaction. N.ADP and alpha-ketoglutarate initiate the 
reaction per ~· GABASE-CF is a cell-free preparation of 
II" .\-1 ·11., -1 ·11., -1 ·11" -1 ·oo II 
- - - - + 
·l-11mi11ohutyri<· <H·id 
succinic acid 
0 
I 
HOOC-C-CH2-CH2-COOH 
o<_-ketoglutaric acid 
HOOC-CH2-cH2-yH-COOH 
NH2 
glutamic acid 
Figure 4. Reaction of GABA wi t h GABASE-CFo 
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an enzyme, purified following extraction from Pseudomonas 
fluorescens (Worthington Biochemical Co.). This prepara-
tion is free from TPNH oxidase activity, and glutamate does 
not interfere in the reactions of this enzyme. 
A standard curve of 4, 6, 8, and 10 microgr&ms stan-
dards was run with each group of samples, and these read-
ings were used to plot a curve, which was linear in this 
range. The method was sensitive to 30 ng. of GABA in the 
tissue extract. 1*)1.e control reading for each sample was 
subtracted from the maximum absorbance change, and the ac-
tual value of GABA in the tissue was calculated as follows: 
micrograms GABA x 10 ~~ 1 = micromoles of GABA/gram WTW 
50 = a constant based on resuspension of the tissue 
with 10 ml. water/gm. of tissue, and the sub-
sequent use of 0.2 ml. of extract for the final 
reading 
103.1 = the molecular weight of one micromole of GABA 
50/103.1 is reduced to a constant, 0.48496, 
which is used when the calculations are made 
d. Determination of Glycine 
Glycine was quantified by modification of the 
co::..orimetric method of Aprison and Werman (1965). The 
tissues were homogenized in 5~~ TCA (in a volume equal to 
a 10% w/v homogenate) in a Potter-Elvejhem homogenizing 
tube (Kontes). ( ~he homogenate was transferred to a poly-
carbonate centrifuge tube (11 x 77 mm.), and samples were 
centrifuged at 23,000g at a temperature of 4° C. for twenty 
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minutes (IEC :S-20 High Speed Refrigerated Centrifuge, no. 
870 Head). 100 microliters of the supernatant from each 
sample were placed in 6 x 50 mm. Pyrex tubes. A similar 
quantity of 8 mcg./ml., 16 mcg./ml., and 32 mcg./ml. s-can-
dard solutions was treated in the same manner. Forty 
microli ters of a freshly prepared 7~~ sodium nitrite solu-
tion were added to each tube with the exception of a "gly-
cine" blank (32 mcg./ml. glycine) and the tissue blanks. 
The blanks receiv~d distilled water in place of the sodium 
nitrite solution. . The tubes were "buzzed" on a Beckman 
micromixer. Forty microliters of 1N sulfuric acid were ad-
ded to each tube, and the tubes were "buzzed" again. Each 
tube was capped with a parafilm cover. A small pinhole 
was placed in each cover to allow for the escape of gaseous 
products, and the tubes were placed in a covered water bath 
at 100° C. for forty-five minutes. This step results in the 
diazotization of glycine to glycollic acid in the presence 
of nitrous acid and heat (the glycine content of the blank 
tubes is not converted, but remains as glycine throughout 
the procedure). 
The tubes were cooled and centrifuged at 1500 rpm 
for five minutes to remove the condensation from the walls 
of the tube and concentrate it in the bottom of the tube. 
Forty lambdas from each tube were removed and placed in a 
Pyrex 10 x 75 mm. test tube. Five lambdas of a freshly 
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prepared 200% stannous chloride solution were added to each 
tube, and the tubes were "buzzed". This addition of stan-
nous chloride results in the elimination of excess nitrite, 
which will otherwise interfere with the next reaction. 1o0 
:nl. of concentrated sulfuric acid, reagent grade, was added 
to each tube in order to convert the glycollic acid to 
formaldehyde. Then 20 microliters of a fresh 5% chromo-
tropic acid solution were added to each tube in subdued 
light, and the t~es were "buzzed". Each tube was "buzzed" 
and placed in darkness immediately following this addition 
because chromotropic acid is extremely sensitive to light, 
and any extended exposure will disrupt the colorimetric re-
action. All tubes were allowed to cool for forty-five 
minutes in the dark. Samples were then measured for their 
absorbance in a Coleman 6/10 spectrophotometer by using 
10 x 75 mm. glass cuvettes. The chromophore is measured 
at 580 millimicrons (Figure 5). 
Glycine concentration, in mcg./ml., for the original 
solution was calculated from the standard curve. Blanks 
were subtracted from their respective samples. Then, the 
concentration of glycine in mcg./ml. was multiplied by 
10/75.1, and the result (of this manipulation was equal to 
the concentration of glycine in the tissue in micromoles 
per gram of wet tissue weight. The number "10" is used as 
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THANSFOIMATION OF GLYCINE TO A CHROMOPHOHE 
Glycine in 
NaN02 / lN H2so4 ) HO-CH2 -COOH 5 % TCA HEAT 
glycollic acid 
I 
SnC1
2 / cone. H2
so
4 ~ 
Purple color < HCHO @ 580 mu. formaldehyde 
Chromotropic 
Acid 
Figure 5. Transformation of glycine to a chromophore. 
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a multi plication factor because of the 1 o~~ dilution during 
homogenization. The figure "75 .1" is the molecular weight 
of glycine. This method is highly specific, and does not 
suffer from the recovery losses associated with chromate-
graphic techniques. It has been found to be sensitive to 
-8 2 x 10 moles of glycine. 
B. Determination of Rectal Temnerature Rhythm 
Rectal temperature was monitored in a group of sixty 
• male rats at three hour intervals over a 24 hour period. A 
Yellow Springs Telethermometer (Model no. 44 TA) equipped 
with a flexible thermister probe (YSI Model no. 42 SC) was 
used for these measurements. The probe was cleaned with 
water at 320 C. and dried after each temperature determin-
ation. This procedure allowed rapid equilibration to the 
actual animal temperature because the temperature of the 
probe approached that of the animal. The probe was lub-
ricated with Mazola Corn Oil (Corn Products Co., New York) 
and inserted approximately five centimeters into the colon. 
The thermister probe was maintained in ~ until the tem-
perature reading remained constant for a period of 40-50 
seconds. The probe was then removed, and the temperature 
~ 
recorded. Animals were handled in a gentle manner in order 
to avoid any excitement which could interfere with the tern-
perature measurement. 
r 
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C. Motor Ac ti vi ty Rhyt:f'F::s in Mice 
Animals were adapted for four weeks to either a 
normal or reverse cycle. Six mice were then placed into 
individual photoactometer chambers with food and water 
available ad libitum. They were allowed to acclimate to 
this condition for at least twelve hours prior to activity 
monitoring. The photometer unit is shown in the photograph 
in Figure 6A and 6B. This cage has six photocells placed 
equidistantly aro~nd the perimeter of the cage. An infra-
red light, located in the center of the unit, emits a con-
tinuous beam to the photocell; whenever that beam is broken, 
and activity count is recorded on a separate counting unit. 
The counters were placed outside of the animal quarters to 
prevent the clicking sound of the counters from affecting 
the activity of the mice. Animal activity was monitored for 
a sixty minute period, which was checked with a stop-watch 
to assure accurate timing of the counters. At the end of 
the 24-hour observation period, the availability of food 
and water was confirmed in each unit. 
D. l\1easurement of Response to Maximal Electroshock (MES) 
and the Evaluation of the Effects of Various 
Convulsant ~ Anti-convulsant Drugs 
1. MES Methodology 
MES seizures were evoked in mice using a shock 
Figure 6A. Front view of photoactome ter cag e. The scale 
n ot ed on the c h e ckered ~uler in t he for egr ound of the pic-
ture is equal to one inch per division. A complete de-
scription of the apparatus is g iven in the text . 
96 
97 
Figure 6B. Top vie1v of photoactome t er c a g eo The scale 
noted on the c he ckered ruler in the foreground of the pic-
ture is equal to one ineh per division . A complete de-
scription of the apparatus is given in the text. 
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apparatus as described by Woodbury and Davenport (1952, cf. 
Figure 7). The shock was administered via corneal elec-
trodes, which had been moistened with 0.9% saline solution. 
The stimulus parameters were current intensity of 50 ma. 
with a duration of 0.2 second as described by Swinyard et 
alo, 1952. Three Cramer timers were arranged to start 
simultaneoulsy with each stimulus, and these timers were 
stopped following the various phases of the seizure (Figure 
8). • 
A similar study was performed in rats that were 
adapted and shocked at the University of Nebraska College 
of Pharmacy. The adaptation lighting at the latter in-
stitution consisted of sunlight (through window glass) ra-
ther than Vita-lite. The MES technique was also similar 
to that previously described for mice except that the stim-
ulus parameters were 150 ma. at 0.2 seconds. 
Animals to be shocked were picked up and held by the 
scruff of the neck; their eyes placed in contact with the 
premoistened corneal electrodes, and the shock was delivered 
by the depression of a foot-switch. The components of MES 
seizure, as described by Toman et al. (1946), were meas-
ured on a temporal basis by stoping a timer precisely 
when each phase ended. It was noted that my reaction time 
was 0.15-0.20 second. This time was equal to the time of 
duration of the initial shock, so that all times given in 
-Figure 7. Woodbury-Davenport shock apparatus. (Copied 
with permission of the publisher, Arch . Intl. Pharmacodyn. 
192 , 100, 1952). 
See next page for diagram legends. 
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Figure 7 diagram legends: 
S1 
S2 
S3 
S4 
S5 
T1 
T2 
T3 
c 
Ry~ 
I 
Ry2 
R1 
R2-R6 
R7 
R8-R12 
Interlock switch on caoinet door 
Master switch 
Push button to initiate timer; normally connected 
to timer 
Timer switch 5 pole, single circuit wafer type 
Current range switch, porcelain base, high voltage 
Small replacement type transformer 350-0-350 volts 
Variable autotransformer, 3 ampere capacity 
Plate supply transformer, primary 110 volts, 
secondary 2000 volts, 400 ma. 
Timer condenser, 5 mfd, 1000 volts 
0 
Sensitive relay, 10,000 ohm winding 
Heavy duty, double pole relay or contactor, 110 
volt coil 
Adjust to give 25-30 ma. through regulator tubes; 
approximately 2,000 ohms, 10 watts 
Select to give desired time of closure 
Adjust to give slight changes in timing of all 
timing positions 
Wire wound, 100 watt variable resistors with slid-
ing taps. Adjust to give desired full scale 
current. The following values are approximate: 
R8 120,000 ohms 
R9 40,000 ohms 
R10 20,000 ohms 
R11 16,000 ohms 
R12 4,000 ohms 
Meter: (Indicated by circle-enclosed arrow in lower left 
part of diagram) Any meter capable of reading rms-a-c 
volts; scale may be hand-calibrated to give desired cur-
rent rangeso 
110 \" • . \ , . 
0 0 0 
J J.'i , . ' .. \ (" 
s 2 
0 
RTM ;J 
10 1 
0 
Figure 8. Elec trical diagram of timing apparatus u sed f or 
measu rement of se i zur e component time s . 
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the text are actually timed from the end of shock adminis-
tration. The times recorded were: 1) the time to the be-
ginning of the tonic extensor phase, or extensor latency 
~; 2) the time to the end of the tonic extensor phase; 
and. 3) the time to the end of the clonic phase prior to 
post-ictal depression. 
Animals were used only once, and discarded following 
MES treatment. MES treatment and the testing of anti-
convulsant drug petencies were evaluated at the two time 
points, which appeared from our biochemical studies to re-
present the peak and trough of CNS biogenic amine levelso 
2. Pharmacological Studies and Drug Protocol 
a. Acute Toxicity of Convulsant Drugs 
The acute toxicity of convulsant drugs in mice was 
determined at six hour intervals for a period of 24 hours. 
The animals were conditioned to a normal light cycle three 
to four weeks prior to this study. Two to three groups of 
9 animals each were injected I.P. with different doses of 
the test drug. After injection, the mice were placed in 
individual cages to avoid interaction with each other. The 
drugs used are potent central stimulants, and the movement 
t 
or touch of one animal could trigger a seizure in an ad-
jacent ~nimal if aggregate housing was used. The toxic 
effects upon the animals were evaluated over a six hour 
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period, and the number of denths in that time interval was 
recorded. 
Allylglycine (Sigma Chemical Co., St. Louis, Mo.) 
was dissolved in 0.9% saline prior to use. The concen-
tration was adjusted to allow the injection of 0.1 ml. per 
10 grams of animal weight. Strychnine sulfate (Merck, 
Rahway, N.J.) was prepared in a concentrated stock solu-
tion, so that it could be diluted 1:100 prior to use. It 
was administered_py means of a 1.0 ml. tuberculin syringe 
in volumes of 0.01 ml. per gram of animal weight. The 
stock solutions were refrigerated when not in use. 
The LD50 doses of these drugs were calculated as 
described in the statistics section (vide infra). 
b. Protective Doses of the Anti-convulsant Drugs 
The PD50 (median protective dose) against MES of 
each of the following drugs was determined during antici-
pated peaks and troughs of biogenic amine levels: di-
phenylhydantoin (Parke, Davis & Co., Detroit, Mich.), 
phenobarbital sodium (Merck, Rahway, N.J.), meprobamate 
(Wyeth Laboratories, Philadelphia, Pa.), acetazolamide 
(Lederle Laboratories, Pearl River, N.Y.), and amino-
( 
oxyacetic acid hemihydrochloride (Aldrich Chemical Co., 
Milwaukee, Wisc.). Phenobarbital sodium and amino-
oxyacetic acid (AOAA) were administered in 0.9% saline 
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solution. Diphenylhydantoin, acetnzol~mide, and mepro-
bamate were dispersed in a 5% acacia suspension. When 
necessary, the pH of solutions was adjusted to a range of 
7.0-8.0 as determined with narrow range Hydrion test paper. 
Drug concentrations were adjusted so that 0.1 ml. of fluid 
would be injected for each 10 grams (mouse) or 100 grams 
(rat) of animal body weight. 
Groups of 9 mice or 7 rats each were injected I.P. 
with a series Of J>redetermined doses of the test drug, 
such that the low dose would produce protection below, and 
the high dose above, the anticipated PD50 value. In ad-
dition, a group of ten saline control mice, a group of ten 
acacia-treated control mice, or 7 saline-treated rats were 
tested with MES at the chosen time intervals. These mice 
were specially selected for a uniform body weight of 34 gm. 
Rats weighed in the range of 275-290 gm. The volume of 
saline or gum acacia administered was similar to that of 
the drug-treated animals. One hour after drug or control 
media, the animals were subjected to MES stimulation (vide 
-
supra). The timing of the seizure components of the con-
trols was recorded as well as the timing of those seizure 
phases which occurred in drug-treated animals. 
PD50's were calculated for the various drugs as de-
scribed in Chapter III E. 
c. Neurological Evo.luations of Motor and 
Reflex Activity of Rodents 
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Following injection of the anti-convulsant agents, 
animals were evaluated as follous: 1) observed activity -
a visual observation of the a.nimal's alertness, interaction 
with his environment, and a comparison to control animals 
with regard to frequency of movement; 2) balance - a test 
of the animal's ability to balance on the edge of a cage 
for at least five seconds (normal animals can perform this 
• task readily); 3) reflex activity - an evaluation of the 
animal's capability to return his hindlimb to a surface 
following its withdrawal from that surface (replacement 
is rapidly performed by a neurologically sound animal, but 
not by a neurologically deficient one). 
The summary of these evaluations is described in 
the results section. 
E. Statistical Analysis of !!!& ~ 
1. Calculation .Q! Standard Deviation, Standard Error of 
lli ~' ~ ~ Values 
The calculation of standard deviation (S), standard 
error (Sy), and arithmetic mean (Y) were all performed on 
( 
an SCM Cogito 1016 PR computer programmed with a Iota 1 
tape input accessory. The formulae used for calculation 
of these values are described below. 
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Arithmetic mean 
sum of the indol/c~:--.dcnt values = ~Y.. 
= t'henumbei;:.~ o~i-c:.~ tries n 
&(y-Y)2 
variance (S 2) = n - 1 
tthere n - 1 degrees of freedom 
and y = each entry 
standard deviation (S) =~ 
standard error of the mean =~ 
2. Calculation of ! 
The t test for non-paired data ·m::i.s used to evaluate 
the level of significance of compared samples. The data 
was entered into the SCM computer and a programmed formula 
was used to calculate t. The formula is represented below. 
Y1 y2 
t 2 2 
( !1 ~2) n1S1 + n~s2 + 
n1 + n - 2 2 
). Calculation of PD50 ~ LD50 
The statistical analysis of these parameters and 
their respective calculations were performed according to 
the method of Litchfield and Wilcoxon (1949). The method 
is as follows: 
1) an odd number of animals is always used to insure 
that the 50% value can be interpolated from the data. 
t 
2) the number of animals protected, or the number of 
deaths, at each dose level is converted to a per-
centage of the total amount of animals used at that 
dose. This is then converted to a probit value. A 
probit value of 5.000 represents tho median lethal 
dose. 
II""' 
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3) x1 = high dose (mg. /Kg.); v A2 = low dose (mg. /Kg.) 
4) Y1 = mortality rate, or protsction 
Y2 =mortality rate, or protection 
5) The slope, b, = Y1 - y 2 (Probit) 
x1 - x2 (log) 
rate from x 1 
rate from Y2 
6) Standard Deviation (S) = 1 /b ( Jn/2 ) where n = the 
total number of animals 
per dose. 
7) Log dose= x1 + (5.000 - Y1) 
• b 
8) The anti-log of the log dose is equal to the LD50 or 
the PD50 in mg./Kg. 
A specific example of this procedure (Friedman, 1966) is 
shown below: 
~ mg. LKg. Los Dose Mortalit.l Percent Probit 
X1. - 100 2.00000 y1 = 7/9 77.8 5.765 
X2 75 1.87506 y2 = 2/9 22.2 4.235 
y1 - y2 = 5.765 - 4.235 
b = = 12.1456 
X1 - X2 2.00000 - 1.87506 
S = 1/b (Jn/2) = 1/12.2456 (/9/2) = 1/25.9774 = 0.03849 
Log dose = x1 + 5.000 - Y1/b = 2.00000 + 5.000 - 1 ~:~~~ 6 
= 2.00000 - 0.06247 = 1.9375j 
Antilog of 1.93753 = 86.60 
1.93975) + 0.03849(= 1.97602 
1.939753 - 0.0)849 = 1.89904 
The antilog of 1.97602 = 90.63 
The antilog of 1.89904 = 79.26 
Difference = 15.37 
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15.37/2 = 7.685, or a st~nd:::.rd deviation of 7.685 mg./Kg. 
Therefore, the LD50 = 86.60 ± 7.685 mg./Kg. 
The same method is also uced fo::- the calculation of the 
PD50 of the anti-epileptic drugs used. 
4. Analysis .Q! Variance 
This test of significance was also used. The method-
ology and data are noted in Appendix C. 
• 
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1. Rectal Temperature 
The rectal temperature of si::::ty rats monitored every 
three hours for a twenty-four hour period is indicated in 
Figure 9. Average temperature of these nocturnally-active 
animals ranges from 37.95 ± 0.35° Co in the dark phase to 
37.25 ± 0.25° c. during the light phase. The peak tempera-
ture of 38.3 ± 0.3 is noted at 2400 hours and a trough tem-
• pera ture of 37. 1 ± 0. 3 at 0900 hours. The curve shows the 
characteristic pattern of this par~moter with a sharp in-
crease in temperature following awakening. This increase 
is maintained throughout most of the dark phase, and the 
temperature decreases sharply as the light phase approaches. 
Points recorded on the curve at the following times 
were found to be significantly different (P <0.001) from 
each other when compared by the Student t-test: 0300 hours 
vs. all points; 0600 hours vs. both 0900 hours and 1200 
hours; 0900 hours as compared with all points other than 
1200 hours; 1200 hours vs. 2100 hours; 2400 hours as com-
pared with all other points. The peak value is statisti-
cally significant with regard to all other values; and the 
t 
trough is statistically significant with regard to all points 
on the curve except that at 1200 hours. Comparisons of all 
temperature values recorded in the light phase with all those 
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Figure 9. The circad i an pattern for rectal t emperature in 
rats. Each cl ear cir cle indicates the average t emperature 
of a group of sixty r ats . The ordinate represents rectal 
temperature in d egr ees C ~ The bla c bar on the absc i ssa in-
dicates darkness. Standard d evi ations are i ndicat ed by the 
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of the dark phase also are Gt:'.tiEtico.lly sisnificanto 
2. Motor Activity 
The motor activity curves for both "normal" and "re-
verse" cycled mice are indicated in Figure 10. The activ-
ity is expressed as a percent of the twenty-four hour av-
erage because of the variability of the rate of motor ac-
tivity in the individual. animals. This procedure for ex-
pressing data allows one to compare the activity of each 
• animal with that of others whose rate of activity might 
differ markedly. 
Motor activity rises sharply following the onset of 
the dark phase. Both mice and rats are considered to be 
::.i.octurnal animals, and this curve is characteristic for 
;,hese species. ~igu.re 10 cleai"ly shows that reversal of the 
light program reverses the motor activity rhythm. 
Peak motor activity on the normal cycle occurs at 
2400 hours (266%), and trough activity at 1800 hours (23%). 
The 2400 hour value is significantly greater (P <0.001) 
than all other curve values. Peak motor activity on the 
reverse cycle also occurs during the dark phase at 1200 
hours (226%) while a trough occurs at 2400 hours (41%). 
t 
This peak value is also significantly greater (P < 0.001) 
-;;han all other values of the curve. 
11) 
~ Normal Cyc le 
~I I I~ Reverse Cyc le 
250 
1200 1800 2400 0600 1200 
N 
R 
2400 0600 1200 1800 2400 
TIME, hours 
Figure 10. The motor activity of mice on "normal" and "re-
verse" cycl es . The ord i nate indicates the percent of av-
erage 24 hour activity. The black~ on the absc i ssa in-
dicat es the period of darkness . Time in hours is i nd icat ed 
f or both "normal " (N) and 11 r ev ers e" (R) cycles. The open 
circl es represent N animals, and t he fill ed circles the R 
ani mals. The vertical brackets deno te the standard deviation 
(n = 6 animals per point ) ; the standar d d eviation of the 
2400 N and 1200 R points are 266 ± 57 and 226 ± 46 r espec-
tively. 
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Inhibi to:r~ Trs:~,eri tters 
1. Dopamine 
The dopamine (DM) levels of the corpus striatum of 
"normal" cycle rats are indicated in Figure 11. Levels 
_ rise during the dark phase to a peak at U300 hours. There-
after, they decrease steadily as the light phase approaches 
and finally trough at 1500 hours. The DJvI concentrations 
range from 3.46 l 0.08 micrograms/gram of uet tissue weight 
(WTW) to 6.82 + 0.24 mcg./gm. WTW. The peak value is sig-
nificantly different (P<0.05) from both the 1500 hour 
point and the 1800 hour point. The trough is also signif-
icantly different from the 0300 and 0600 hour values 
(P<0.05). 
The study depicted by Figure 11 was one performed in 
December, 1968, and the DM levels (assayed by the Sourkes 
and Murphey technique) were found to be much lower than 
those of a subsequent "reverse" cycle study (for discussion, 
see section C-1 of this chapter). DM levels were deter-
mined again in "normal" cycle animals in June, 1970. This 
study (Figure 12) includes measurement of DM levels in the 
upper and lower brainstem as well as in the corpus striatum 
(assayed by the Ansell and Beeson procedure). 
DM levels in the corpus striatum peaked during the 
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Figu e 11. The circadian pa ttern for dopamine l evel s in the 
corpus striatum of the rat (D ecember )o The ordinate indi-
cates the DM level in tissue in mcgo / gm . WTW. Time i s in-
~ dicated on the abscissa . The black bar on the absc issa in-
dicates the dark phase of the photoperiod o Vertie bra ck-
~ indicate the standard error of the mean for the respec-
tive values (n = 6 animals pe· poi t). 
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Figure 12. Dopami ne levels in the rat corpus striatum (CS), 
upper brainstem (US), and lower brainstem (LS) in a 24-
hour period (June). 
DM in mcg. / gm. WTW . 
The ordinate represents the l evel of 
Time is represented on the abscissa. 
~ 
The bl ck ~ on the abscissa indicates the dark phase of 
the p~otoperiod . The ve tical br c ts indicate the stan-
dard d eviation of the r espective l evel s (n = 6 animals per 
point ). 
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dark phase as in the previous study; however, this study 
was conducted with four sample period:::/24 hours instead of 
8/24 hours as in the former study. The peak DM levels ::ere 
obtained at 0600 hours, and the trough value at 1800 hours. 
DM levels of the corpus striatum ranged from 4.81 ± 0.71 
mcg./gm. WTW (1800 hours) to 7~99 ± 0.87 mcg./gm.. WTW (0600 
hours). The peak value was significantly greater (P <0.01) 
than both DM values of the light phase. 
The DM lev.is of the un1Jer b'.':'.'ninstem also peak dur-
ing the dark phase at 0600 hours, and the trough value, as 
in the case of the corpus striatum, '\·ras noted at 1800 hours. 
The DM levels varied from 0.46 ± 0.16 mcg./gm. WTW (1800 
hours) to 1.2j ± 0.41 mcg./gm. WTW (0600 hours). The peak 
value was found to differ significantly (P < 0.05) from both 
values obtained during the light phase. In the lower brain-
stem, DM concentrations were found to have a similar pat-
tern to those of the corpus striatum and the upper brain-
stem; however, the trough levels occurred at 1200 hours. 
The 1200 hour value was significantly lower (P<0.05) than 
both values obtained during the dark phase. Levels in this 
tissue ranged from 0.25 ± 0.11 mcg./gm. WTW (1200 hours) to 
0.54 ± 0.23 mcg./ gm. WTW (0600 hours). 
2. NorepineRhrine 
The levels of NE obtained during a 24-hour period, 
1'18 
are indicated in Figure 13. J:TE ancl Dl!f levels 1:1ere sampled 
in the same tissues in order that -"1:;he levels of these two 
amines could be compared. 
NE levels in the corpus striatum were maximal during 
the dark phase with a peak at 0600 hours. A significant 
difference (P <0.01) was obtained w·hon the peak value was 
compared with values obtained for either of the points oc-
curring during the light phase. The level of NE at 2400 
hours (0.24 .± 0.01.: mcg./gm. WT1:l) was significantly higher 
(P <0.01) ·when compared with the levels of samples obtained 
for either point during the light phase. The levels ranged 
from o.06 ± 0.02 mcg./gm. (1800 hours) to 0.24 ± 0.07 
mcg./gm. WTW (0600 hours). 
The pattern of NE levels of the upper brainstem was 
similar to that of the corpus striatum. Maximal levels 
were noted at 0600 hours with a trough at 1200 hours. Each 
point of the dark phase was greater and significantly dif-
ferent (P<0.01) from each point of the light phase. 
Levels varied from a trough value of 0.95 ± 0.24 mcg./gm. 
WTW (1200 hours) to a peak value of 1.85 ± 0.34 mcg./gm. 
WTW (0600 hours). 
NE concentrations( in the lower brainstem exhibited 
a unimodal pattern; however, in this case, the peak levels 
were noted at 2400 hours and a statistically significant 
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Figure 13. Norepinephrine l evels in the rat corpus striatum 
( CS ) , upper brainst em (US) , and 101·1er brains tem (LS ) in a 
24-hour period. The ordinate indicates the level of NE in 
mcg ./gm. WT\\. Time is not ed on the abscissa . The bla ck 
t 
~ on the abscis s a indicates t he dark phase of the photo-
period. The vertical brae et§ indicate the standard de-
viation of the r espective l evels (n = 6 animals per point ). 
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( P <0.01) trough uas obtained at 1200 hours. The cone en-
trations varied from a trough value of 0.64 ± 0.03 mcg./gm. 
WTW (1200 hours) to a peak value o:f 0.88 ± 0.12 -ccf!,./C':Il• 
WTW (2400 hours). 
It is apparent in the tissues examined that DM and 
NE level patterns are similar. 
). Serotonin 
The circadian patterns for 5-HT levels in the corpus 
• striatum, upper brai.:.lstem, and lo;,·1cr brainstem are depic-
ted in Figure 14. 5-HT levels of the corpus striatum fol-
low a pattern inverse to those of the catecholamines. This 
pattern is marked by a trough in the dark phase: both 
points of this phase are significantly different (P<0.05) 
from the peak value. 5-HT levels in the corpus str:_a.-~t."'..fil 
ranged from 0.46 + 0.15 mcg./gm. WTW (2400 hours) to Oo94 
± 0.30 mcg./gm. WTW (1800 hours). 
A similar pattern for 5-HT levels was noted in the 
upper brainstem. ·Levels varied in a circadian fashion with 
a peak value at 1800 hours and a trough value at 0600 hours. 
Values obtained for both points of the dark phase were sig-
nificantly different (P<0.05) from the peak value. Levels 
ranged from o.65 + 0.16 mcg./gm. WTW (0600·hours) to 0.93 
± 0.14 mcg./gm. WTW ( 1800 hours). 
The pattern of 5-HT levels in the lower bra.instem 
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Fi gure 14 . Serot onin l evels in the ra t c orpus striatum 
(CS) , upp er brainstem (US ) , and lower brai nstem (LS ) over 
1 21 
a ~4-hour period . The ordinate i ndicates t he t i ssue l evel 
of 5-HT in mcg./gm . WTW. ( Time i s noted on t he abscissa . 
The black bar on the abscissa indicates the dark phase of 
the photoperiod . The vertic ind icate the s t an-
dard d viation (n = 6 animals per point )e 
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differs markedly from those described above for this amine. 
A un.j_c:10dal rhythm was obtained with a peak at 0600 hours 
and a trough value at 1200 hours. The p·::iak value was sig-
nificantly different (P<0.05) fro:'l either of the points in 
the light phase. The concentrations varied from 0.81 ± 
0.26 mcg./gm. WTW (1200 hours) to 1.25 ± 0.26 mcg./gm. WTW 
(0600 hours). 
4. 4-aminobutyric Acid (~) 
The GABA pa~terns in the cortex and cerebellum are 
indicated in Figure 15. The cortical rhythm peaks during 
the dark phase at 0600 hours and troughs in the light phase 
at 1200 hours. The significant difference between these 
two points is only borderline (P<0.10). The study repre-
sented in Figure 15 was performed in June, 1970. A sim-
ilar pattern was obtained in a study performed in March, 
1969 (cf. Appendix A). However, the levels were propor-
tionately lower (perhaps because GABA levels exhibit 
seasonal alteration). Cortical GABA levels varied from a 
trough value of 2.68 ± 0.33 mct-1./gm. WTW ( 1200 hours) to 
a peak of :;.15 ± 0.45 mcM./gm. WTW (0600 hours). 
The GABA levels of the cerebellum also exhibit a 
t 
unimodal pattern with a peak in the dark phase at 0600 
hours. The difference between peak and trough values is 
significantly different (P < u.01). Levels varied from a 
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Figure 15 . GABA levels in the rat cort ex (CTX) and cerebel-
lwn (CBLM ) over a 24-hour period. The ordinate r epresents 
the tissue level of GABA in mcM. / gm. WTW . Time is repre-
sented on the abscissa . The black area on the abscissa in-
~ 
dica~e s the dark uh .s e of the photoperiod. Vertical brack-
~ i dicate the standard deviation (n = 6 animals per 
point). 
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trough of 1.80 + 0.38 mcM./gm. \'JT:·; ( 1200 hours) to a peak 
value of 2.76 ± 0.53 mcM./gm. UT\'! (0600 hours). 
GABA patterns in the corpora quadrigcmina and in the 
thalamus-hypothalamus are displayed in Figure 16. GABA 
levels of the corpora quadrieemina exhibit a circadian pat-
tern with a peak during the dark phase. Levels rise gradu-
ally, peaking late in the dark phase at 0600 hours; and 
they decrease to a trough value at 1500 hours. The peak 
value is significantly different (P < 0.01) from all other 
values except the 0900 hour point. The trough value was 
significantly di,fferent (P <0.01) for all points except the 
1800 hour value. Levels ranged from a trough of 4.28 ± 
0.51 mcM./gm. WTW (1500 hours) to a peak of 6.66 ± 0.45 
mcM./gm. WTW (0600 hours). 
GABA levels of the thalamus-hypothalamus exhibited 
a multi-modal rhythm with a definite increase in concen-
trations during the dark phase. The saw-tooth pattern of 
this rhythm is distinctive, and a statistically significant 
difference (P<0.05) exists between either the 2400 hour 
point or the 0600 hour point and the 0300 hour point. The 
0600 hour point is significantly different (P<0.05) from 
all oth£:r points except the 2400 hour value. Levels ranged 
from a trough value of 3.82 ± 0.61 mcM./gm. WTW (2100 
hours) to a peak value of 5.48 ± 0.29 mcM./gm. WTW (0600 
hours). 
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Figure 16. GABA l evels in the r at corpora quadrigemina 
1 25 
(CQ) and the thal amus-hyp othal amus (TH-HT ) express d as a 
function of time. The or i a , and the a scissa are similar 
to those of the previous figure. The ..;,,..;;..;;.o...;;.--.~ ~-...---..;;...-..-. 
dicate the standard deviation (n = 6 animals per point ). 
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Glycine 
The glycine patterns in the rat hindbrain are indi-
cated in Figure 17. In the pons, the glycine levels rise 
to a peak late in the derk phase, then decrease to a trough 
in the early light phase. The peak value is significantly 
different (P < 0.001) from both of the values obtained in 
the light phase. It is also significantly different 
(P < 0.01) from the other point measured in the dark phase. 
The levels ranged from a trough value of 2.04 ± 0.37 mcM./ 
• 
gm. WTW (1200 hours) to a peak of 3.56 ± 0.23 mcM./gm. WTW 
(0600 hours). 
Glycine levels, of the medulla do not fluctuate as 
markedly as those of the pons. Levels of this region do 
not exhibit any significant diffeTence when various time 
points are compared. The levels ranged from 2.91 ± 0.56 
mcriJ:./gm. WTW (1200 hours) to 3.45 ± 0.28 mcM./gm. WTW 
( 1 800 hours) • 
Glycine level patterns in the spinal cord regions 
are depicted in Figure 18. The patterns of the cervical 
and lumbar enlargements are similar to each other, but 
markedly different from the pattern observed in the thor-
acic cord. The thoracictcord pattern resembles that seen 
in the pons, with a sharp peak at 0600 hours followed by a 
rapid fall in levels to a trough at 1200 hours. The peak 
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Figure 17. Glycin~ l evels i n the r a t pons and medulla 
(MED ) expressed as a function of t i me . The ordina t e de-
picts the tissue l evels of glycine in mcM. / gm. WTW. Time 
is noted on the abscissa . The bl ack ~ on the absc i ssa 
ind i cates the dark phase of the photoperiod . Vertical 
brackets indicate the standard deviation (n = 6 ani mals 
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Fi gure 18. Glycine l evels in the r at cervical cord (CV), 
tho acic cord (TC), and l umbar cord (LC) expressed as a 
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sented in t he previous figure. The vertical braccets in-
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and trough values in the thoracic cord are significantly 
different (P < 0.001) from each other. Glycine levels 
re.::1ged from 1 • 77 .:!: 0. 21 mcH. /gm. UTW ( 1 200 hours) to 3. /:.4 
± 0.23 mcM./gm. WTW (0600 hours). 
Glycine levels in the cervical enlargement exhibit 
a circadian pattern with a peak at the end of the dark 
phase. The peak is significantly different (P < 0. 01 ) from 
the trough value. However, levels between the points at 
0600, 1800, and 2400 hours are not significantly different • 
• 
Concentrations ranged from 2.96 ± 0.23 mcM./gm. WTW (1200 
hours) to 3.61 ± 0.30 mcM./gm. WTW (0600 hours). 
The glycine pattern in the lumbar cord is similar 
to that of the cervical cord, except that the peak value 
occurs at 2400 hours. The peak is not significantly dif-
ferent from the level obtained at 0600 hours. However, it 
is significantly different (P < 0.01) from the trough value. 
The levels ranged from 2.96 ± 0.50 mcM./gm. WTW (1800 
hours) to 4.00 ± 0.30 mcM./gm. WTW (2400 hours). 
The cumulative glycine levels in either the dark or 
light phase for the tissues above are indicated in Table 1. 
The medullary glycine levels during light and dark phases 
are for all practical pu~poses equivalent. Although gly-
cine levels in both cervical and thoracic cord are higher 
in the dark phase than those of the light phase, these 
levels are not significantly different from one another. 
PONS 
LIGHT 
PHASE 
2. 36 ± 0.47 ·)(-
CERVICAL CORD 3.23 ± 0.55n.s. 
THORACIC CORD t'.32 ± 0.68n.s. 
LUMBAR CORD 3.12 ± 0.64 ** 
DARK 
PHASE 
3.03 ± o.67 
3.26 ± 0.69 
3.57 ± o. 38 
2.78 ± 0.81 
3. 94 ± 0.10 
·130 
Table 1. Cumulative glycine levels in the rat pons, med-
ulla, cervical cord, thoracic, and lumbar cord in mcM./gm. 
WTW ("normal"· cycle). Each phase consists of 12 hours. 
Levels are expressed in micromoles/gram ± standard devi-
ation (n = 12 animals per entry). 
* 
p <0.05 between light and dark phases 
** 
p < 0.01 between light and dark phases 
n.s. Difference between light and dark phases,. not statis-
~ 
tically significant. 
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Significant differences beti·ICon dc.rk and light phase levels 
of glycine were obtained in the pons (P < 0.05) and the 
lumbar cord (P < 0.01). Table 1 denotes the rostro-caudal 
gradient differences in glycine concontration described 
by Aprison and co-workers (1968; 1969b). The levels of 
glycine are generally higher in the medulla than in the 
' 
pons, and levels in the thoracic cord are markedly lower 
than those of the cervical or lumbar enlargements • 
• C. Effects .Q.f Photouoriod Reversal .Q!1 ~ 
·Levels of Putative Transmitters 
1. Dopamine 
DM levels of the rat corpus striatum of animals on 
a "reverse" cycle display a circadian periodicity (Figure 
19). Levels rose th~oughout the dark phase to a peak at 
1800 hours and a trough at 0300 hours. The peak is sig-
nificantly different (P < 0.001) from the trough value. 
Levels of DM ranged from 6.79 ± 1.34 mcg./gm. WTW (0300 
hours) to 11.12 ± 0.47 mcg./gm. WTW (1800 hours) and were 
considerably higher than those of the normal cycle. A 
significant difference (P < 0.001) was obtained between com-
parable levels of the two cycles. Since the "normal" 
cycle study was performed in mid-summer, the possibility 
of a seasonal rhythm must be considered in accounting for 
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Figure 19. DM l evels of the rat corpus .striatum as a func-
tion of time ("reverse" cycl ) . The ordinate represents 
the level of DM in mcg./gm. WTW.. Time i s r epresented on 
the abscissa . The black ~on t he abscissa indicates the 
dark period . Vertical beackets i ndicate the standard error 
of the mean (n = 6 animals per point ). 
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this difference in levels. 
In an attempt to exclude the seasonal factor, the 
study was repeated and Dr.I levels "t-lOre determined :::;j_r.1ul-
taneously in animals on tho "normal" and "reverse" cycles 
(this combined study was performed in June, 1970, cf., 
Figures 12 and 20). The study was extended to include DM 
levels of the upper and lower brainstem as well as those of 
the corpus striatum. 
The Dr.I lev~s of the corpus striatum describe a 
unimodal circadian pattern with a peak at 1200 hours in the 
dark phase. This point is significantly different (P < 0.001) 
from either point obtained in the light phase. The levels 
ranged from 5.59 ± 0.55 mcg./gm. WTW (0600 hours) to 8.74 
± 0.55 mcg./gm. WTW (1200 hours). This rhythm appeared to 
be exogenous since it was reversed by photoperiod inversion. 
The DM rhythms in both areas of the brainstem were 
distinctly different from that of the corpus striatum. 
Brainstem levels decreased during the dark phase of the 
photoperiod; these rhythms, apparently are endogenous, as 
the patterns were not reversed by photoperiod inversion. 
These rhythms are similar to those of Figure 12 when com-
pared on the basis of ti~e and not on the basis of photo-
period interval. 
In the case of the upper brainstem, the trough is 
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Figure 20. DM l evel s in the rat corpus striatum (CS ) , up-
pe brainstem (US ), and lower brainstem (LS) expressed as 
a func t ion of time ( °'rever se" cycl e ) . The ordin te r epre-
sents t he t i ssue level of dopamine in mcg . / gm. WT'f. Time 
i s no ted on the abscissa . The b ack ~ on the abscissa 
i ndicat es the dark pha se of the photoperiod . The vertical 
brae ets indicate the standard deviation ( n = 6 animals per 
point) . 
r 
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significantly different (P<0.01) =ron either point ob-
tained in the light ph2.se. D:-1 levols of th;:; upper brain-
sten ranged from 0.42 ± 0 .. 08 ccg./c;:u.o \'!TU ( 1200 hours) ·:;o 
0.93 ± 0.23 mcg./gm. WTW (0600 hou:cs). 
The trough in DM concentrations of the lower brain-
stem is highly significant statistically (P < 0.001), when 
compared with the points obtained during the light phase. 
DM levels in this region ranged from 0.42 ± o.os mcg./gm. 
UT';! ( 1200 hours) ~o 0.82 ± 0.10 mcg .. /gm. WTW ( 0600 hours). 
In summary, DM levels o~ the corpus striatum apparently are 
exogenousl~ controlled since they follow alterations in 
photoperiod, while those of the upper and lower brainstem 
apparently are endogenousli controlled, since they resist 
a change due to reversal of photoperiod. 
The cumulative levels of DM during the respective 
phases of both 11 normal 11 .and "reverse" cycles are indicated 
I 
in Table 2. In the corpus striatum (column 1), the DM 
levels are elevated significantly (P <. 0 .05) in the dark 
phase of the "reverse" cycle over those of the dark phase 
of the "normal" cycle. In a similar comparison of the 
light phase levels significance was ·not proven (P< 0.10). 
As can be seen in Table 2, levels in the dark phase of 
either cycle are significantly different when compared with 
those of the light phase. 
A con?arison of DM levels of the upper brainstem 
CYCT,E PHASE Q§. !I§. IiS 
--~~,-
LIGHT 5.27 ± 0.88 0.52 ± 0.17 0.27 ± 0.13 
NORMAL *"':<-* * *** DARK 7.19 ± 1. 35 0.93 ± 0.45 0.55 ± 0.23 
LIGHT 5.90 ± 0.65 0.84 + 0.21 0.82 ± 0.08 
REVERSE *** *·lHE· *** • DARK 8.56 ± 1.01 0.47 ± 0.14 0.43 ± 0.09 
Table 2. Cumulative dopamine levels in corpus striatum 
(CS), upper brainstem (US), and lower brainstem (LS). 
Levels are expressed in micrograms/gram ± standard de-
viation, (n = 12 an;i_mals per point). 
* One asterisk indicates a P-valuo of less than 5%. 
*** Three asterisks indicate a P-value of less than 0.1%. 
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(column 2) in the light and dark phases of either "normal" 
or "reverse" cycles indicates that they are significantly 
different from each other. The failure of this rhythm to 
exhibit reversal is detected by the higher levels found in 
the ligh,t phase of the "rcverscn cycle. In other words, 
relative. to clock ~ levels arc not significantly changed. 
Comparison of the total levels of DM in the upper brainstem 
of animals on the "normal" cycle versus those on the "re-
verse 11 cycle indioe.tes that they are not significantly dif-
ferent. 
Comparison of DM levels of light versus dark phase 
of either cycle in the lower brainstem indicates a highly 
significant difference (Table 2). However, in this case, 
DM levels are also significantly higher when the same 
phases of the "reverse" cycle are compared with those of the 
"normal" cycle. 
In summary, after photopcriod reversal increased 
levels of DM are found in the corpus striatum and lower 
brainstem, but not in the upper brainstem. 
2. Norepinephrine 
NE patterns obtained in the various brain areas 
studied for animals on a "reverse" cycle are depicted in 
Figure 21. Peak and trough NE levels of the corpus stria-
tum are not significantly different from each other 
e 
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Figure 21 . NE l evels in the r a t corpus striatum (CS ) , 
upper brains tem (US ) , and lower brainstem (LS ) expr essed 
as a funct ion of the tie of day ( r c rer se cycl e ) . The 
o dinat e r epresents NE cont ent, mc 0 0/ gm o i• TW. Time and 
p ases are as in previous figures . in-
dicate the standar d evia tion ( = 6 ani mal s per point ) . 
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(P < 0.10). Levels ranged fron Oo08 ± 0.03 mcg./gm. WT\·[ 
(0600 hours) to 0.15 ± 0.08 mc:s,./{!,rD.. WTH (1200 hours). 
Although only borderline significance was attained, the NE 
levels of this area exhibit a pattern similar to that of 
DM on the "reverse" cycle. 
The NE patterns in the upper and lower brainstem 
are in sharp contrast to those obtained in the corpus stri-
a tum. NE levels of both brainstem areas trough in the dark 
• phase. In the upper brainstem, the minimal point is sig~ 
nif-_cantly different (P <0.05) from those of the light 
phase. Levels of NE in this area ranged from 1.31 ± 
0.14 mcg./gm. WTW (1800 hours) to 1.80 ± 0.19 mcg./gm. WTW 
(0600 hours). 
NE levels of the lower brainstem exhibit a signifi-
cant (P <0.01) trough during the dark phase. NE levels 
ranged from 0.54 ± 0.24 mcg./gm. WTW (1200 hours) to 1.15 ± 
0.17 mcg./gm. WTW(2400 hours). These brainstem rhythms 
appear to be unaffected by inversion of the photoperiod and 
appear to be free-running, or endogenous rhythms. 
Cumulative NE levels in these tissues are presented 
in Table 3. The light/dark phase comparisons of both cycles 
in all areas studied are significantly different except for 
2.evels in the corpus striatum on the "reverse" cycle. NE 
levels in the corpus striatUr:J. during the dark phase of the 
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CYCLE PHASE cs us I& 
LIGHT 0.07 ± 0.03 1.05 + 0.22 0.71 ± 0.10 
NORMAL *** "K** * DARK 0.24 ± 0.07 1.74 ± 0.27 0.83 ± 0.11 
• 
LIGHT 0.08 ± 0.06 1.70 ± 0.25 1.04 ± 0.17 REVERSE n.s. *** *** DARK 0.13 ± 0.07 1.35 ± 0.24 0.71 ± 0.24 
Table 3. Cumulative NE levels in rat corpus striatum (CS), 
upper brainstem (US), and lower brainstem (LS). Each 
phase consists of 12 hours. Levels are expressed in 
micrograms/gram± standard deviation (n = 12 animals per 
entry). 
* One asterisk indicates a P-value of less than 5%. 
*** Three asterisks indicate a P-value of less than 0.1%.,,. 
n.s. Non-significant diff~rence 
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Figure 22. 5-HT levels in the rat corpus striatum (CS), 
upp er brainstem (US), and 10 1er brainst em (LS) expressed 
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as a function of time of day ( reve· .. s e cycle). The ordinate 
represents 5-HT content in mcg./gm. WTW . Time and phases 
are as in previous figures. Vertica bra.ckets indicate 
t standard deviation (11 = 6 ani mals per point). 
r ; 
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(1200 hours) to a peak value of 0.86 ± 0.17 mcg./gm. (060( 
h.)U:.'.'S). These two values are significantly different at 
significance level. 
5-HT levels in the upper brainstem also exhibit a 
unimodal circadian pattern uith a trough in the dark phase. 
Both values of the dark phase are significantly different 
(P <0.05) from the peak value. Levels ranged from 0.62 ± 
0,07 mcg./gm. WTW (1200 hours) to 0.82 ± 0.07 mcg./gm. WTW 
(2400 hours). • 
5-HT levels in the lower brainstem do not vary sig-
nificantly over 24 hours. Photoperiod reversal apparently 
counteracts the rhythm obtained on the "normal" cycle. The 
levels in this area ranged from 1.04 ± 0.35 mcg./gm. WTW 
(1200 hours) to 1.41 ± 0.31 mcg./gm. WTW (2400 hours). 
Cumulative 5-HT levels are compared in Table t;" 
Statistically significant dark/light differences were found 
for all comparisons of 5-!IT on the "normal" cycle, but only 
for the upper brainstem on the "reverse" cycle. Levels of 
5-HT are generally higher in the light phase except in the 
lower brainstem on the "normal" cycle. When similar phases 
of different cycles are compared, the only significant dif-
( 
ference (P<0.01) found occurs in a comparison of the levels 
of the "normal" light phase to those of the "reverse" dark 
phase in the lower brainstem. Reversal of the illumination 
r 
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CYCLE PHASE Q§. us I& 
• LIGHT 0.81 ± 0.29 0.85 ± 0.16 0.84 ± 0.21 
NORMAL *** * * DARK 0.49 ± 0.15 0.67 ± 0.13 1.10 ± 0.29 
LIGHT 0.76 ± 0.24 0.80 ± 0.09 1.28 ± 0.28 REVERSE n.s. *** n.s. 
DARK 0.60 ± 0.28 o.67 ± 0.11 1 .18 ± o. 31 
Table 4. Cumulative serotonin levels in corpus striatum 
(CS), upper brainstem (US), and lower brainstem (LS). Lev-
els are expressed in micrograms/gram ± standard deviation. 
Each phase consists of 12 hours light or 12 hours dark. 
* One asterisk indicates a P-value of less than 5% 
*** Three asterisks indicate a P-value of less than 0.1% 
n.s. Non-significant difference 
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schedule apparently affects 5-HT levels in a different man-
ner than it does catecholamine levels. 
4. 4-amino bu tyri.2 11£.!£. ( G.~::BA) 
The effects of photoperiod inversion on GABA levels 
are shown in Figure 23 and 24. 
The GABA rhythm of the frontal cortex (Figure 23) 
shows a trough in the light phase with a gradual rise to a 
peak late in the dark phase. In contrast to the rhythm of 
• cortical GABA levels on the "normal" cycle, the reversed 
rhythm is highly significant (P<0.01) when peak and troug~ 
values are compared. The levels ranged from a trough 
value of 2.24 ± 0.35 mcM./gm. WTW (0600 hours) to a peak 
value of 3.00 ± 0.23 mcM./gm. WTW ( 1800 hours). 
GABA levels of the cerebellum in animals on the re-
verse cycle exhibit a rhythm similar to that of cortical 
GABA i.e., a unimodal pattern with a peak late in the dark 
phase. A significant difference (P <0.05) between the peak 
and trough values was obtained. The range of GABA concen-
trations varied from 1.90 ± 0.24 mcM./gm. WTW (2400 hours) 
to a peak of 2.35 ± 0.34 mcM./gm. WTW (1800 hours). 
On the reversed cycle, GABA levels of the corpora 
~ 
quadrigemina (Figure 24) exhibit an unusual circadian pat-
tern. Both the peak and trough occurred during the dark 
>~:.ase. It suggests the possibility that the rhythm of the 
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Figure 23. The level s of GABA in the frontal cortex (CTX) 
and cerebellum (CBLM ) express ed as a funct ion of the time 
of day ( ttrever se" cycl e ).. The ord · ate r epr sents the 
tiss\.: e l evels of GAB in mc1 .. / gm. · W.. Time i s noted i n 
_._..;;:..;...;~~a~ The ~ ar on the abscissa indicates the 
dark phase of the photoperiod .. indicate 
th z tandard deviation (n = 6 animal s pe point ) .. 
p 
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Figure 24. The levels of GABA in the corpora quadrigemina 
(C Q) and the thalamus- hypothal amus (TH-HT ) expressed as a 
functi on of time of day ( "reverse 0' cycle). The ordinate , 
abscissa , and verti~ brackets are as in the previous 
figure . 
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co::po:::a quadrigemina resists rcve:.nsal, and that if th0 
period of adaptation were increased, a more defined rc~ar-
sal rhythm would be obtained. GABA levels throughout -~lie 
light phase seem remarkably stable. They fall at the onset 
of the dark phase, and rise sharply to a peak at 1500 hours. 
The trough value at 0900 hours is significantly different 
(P <0.05) from all other points in the dark phase. Levels 
varied from 3.77 + 0.33 mcM./gm. WTW (0900 hours) to 5.66 
-. 
± 0.62 mcM./gm. WTW (1500 hours). 
The GABA pattern for the thalamus-hypothalamus is 
also different from previous rhythms shown in Figure 24. 
As on the "normal" cycle, the levels fluctuate in a saw-
tooth fashion (Figure 25). This rhythm possibly is an 
endogenous six hour ultradian rhythm superimposed on an 
exogenous circadian pattern. There is significant dif-
ference (P < 0.01) between peak and trough values in this 
case. The levels ranged from 3.30 ± 0.27 mcM./gm. WTW 
(0900 hours) to 4.11 ± 0.67 mcM./gm. WTW (2400 hours). 
Cumulative GABA levels are compared in Table 5. The 
light/dark phase comparisons for each tissue region are 
presented. The only region exhibiting a significant, read-
ily reversible rhythm, was the cerebellum. Comparison of 
"normal" and "reverse" cycle levels in the cerebellum in-
dicates no significant differences. Levels of cortical 
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Figure 25. The levels of GABA i n the thalamus- hypothala-
mus on both the "normal" (I) and 11 reverse" (II) cycles 
which are i nd icated on the abscissa. The orclin_ate and 
<' 
vertical brackets are as in the previous figure. Clos ed 
14S 
circles and solid lines r epresent t h e normal c y cle rhythm, 
and open circles and dotted lines t he reverse c ycle rhythm . 
CQ 
TH-HT 
CTX 
CBLM 
CQ 
TH-HT 
CTX 
CBLM 
LIGHT 
PHASE 
5.24 ± 0.49 
*-K* 
4.45 ± 0.34 
** 
2.78 ± 0.29 
n.s. 
2.00 ± 0.44 
•LIGHT 
PHASE 
4.79 ± 0.21 
2.38 ± 0.34 
* 
n.s. 
n.s. 
* 
1.91 + o.~6 
- * 
NOlli·lAL CYCLE 
REVERSE CYCLE 
DARK 
PHASE 
2.94 ± 0.42 
2.47 ± 0.51 
DARK 
PHASE 
4.64 ± 0.41 
3.70 ± 0.32 
2.71 ± 0.42 
2.21 ± o.,o 
Table 5. Cumulative 4-aminobutyric acid levels in the 
corpora quadrigemina (CQ), thalamus-hypothalamus (TH-HT), 
frontal cortex (CTX), and cerebellum (CBLM). Levels are 
expressed in micromoles/gram ± standard deviation (n = 12 
animals per entry). Each phase consists of 12 hours light 
or 12 hours dark. Significance is indicated by asterisks 
t 
as in previous tables. "n.s." indicates non-significant 
difference. 
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GABA on the normal cycle arc significG.ntly higher ( P < 0 6 01) 
than those of the "reverse" cycle. Comparisons of levGls 
of similar phases of different cycles in the ~orpora ~uad-
riscmina and thal~mus-hypothalamus indicate that the nor-
mal cycle levels are significantly higher (P <0.001) than 
those of the "reverse" cycle. 
D. Resuonse to MES as a Function of Time: Vehicle Controls 
•• The duration of various components of MES seizures 
during a normal cycle in control animals are presented in 
Table 6. Both saline and the suspending agent, 5% acacia, 
were evaluated in order to determine effects of the 
vehicles. All mice used in these groups had been careful-
ly selected for a single body weight ( 34 grams) to facili-
tate the detection of small changes in the time course of 
the seizure pattern. 
Each animal exhibited a full tonic-clonic type 
seizure. Two deaths o.ccurred in every group of ten, except 
the 0600 hour acacia group, in which one death occurred. 
Animals whi9h died during the seizure were excluded from 
these statistics. All animals exhibited post-ictal de-
pression and short-term refractoriness (30-45 seconds) to 
subsequent shock. The onset time of tonic extension 
(extensor latency) in the saline-injected group was 
EXTENSOR TONIC 
TIME TREATMENT LATENCY, EX':L·Di'TSION, 
.SECONDS SECOl:TDS 
0600 0.9% Saline 1.86 ± 0.28 13.74 ± 1.52 
1800 0.9% Saline 0 2.17 ± 0.32 13.29 ± 0.86 
0600 5% Acacia 2.17 ± 0.36 15.77 ± 1.13 
1800 5% Acacia 2.12 ± 0.31 14.88 ± 1.41 
CLONUS, 
SECOlU)S 
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6.10 ± 1.44 
7 .69 ± 2.83 
6.79 ± 2.59 
6.58 ± 2.06 
Table 6. Time, in seconds, for seizure components of 
normal sal.iil;-e and. 5% acacia-treated control mice at 0600 
and 1800 hours. Values are expressed ± standard deviation 
(n = 8 for all groups except the 0600 hou:r acacia group, 
in which n = 9). 
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decroased (P < 0.05) at 0600 hours uhcn compared with the 
group at 1800 hours. However, there i:rn.s .no significD.i'l.t 
dif~c~ance between th~ae groups in the duration of tonic 
e::-::;c::;.sion or of clonus. Seizure component times of the 
acecia-treated groups were not significantly different in 
a si~ilar comparison. 
An evaluation of seizure component times of saline-
treated animals versus those of acacia-treated animals at 
similar times revelled significant differences (P <0.05) 
in the duration of tonic cxten~ at 0600 and 1800 hours, 
and the duration of ~~ ~ncy at 0600 hours. 
The minimal electroshock threshold (Swinyard, et al., 
1952) was determined at 0600 and 1800 hours. The minimal 
seizure pattern is generally of the alternating limb-clonic 
tyye, although some mice will exhibit a tonic-clonic pattern 
at these low currents. The minimal threshold current was 
9.67 ± 1.10 ma. at 1800 hours (n = 9), and 10.29 ± 0.98 ma. 
at 0600 hours (n = 9); however, those values did not differ 
significantly from each other. The percent of mice dying 
at 10 ma. of current was higher at 0600 hours (33%), than 
e~J.; 1800 hours ( 11%), .but this difference was also not sta-
. ~ 
tistically significant when tested by the Chi-square method. 
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E. Circadian Variations :i.n 1h£ lifli.£.acy of Drugs 
1. Convulsa.nt Drugs 
a. Allylglycinc 
The circadian toxicity (LD50) of two potent central 
stimulants is graphed in Figure 26. The lethality of allyl-
glycine was significantly higher (P <0.05) in the light 
(especially at 1800 hours) than in the dark phase. Animals 
receiving allylglycine exhibited signs of increased motor 
• 
activity and hyperexcitability that led to convulsive epi-
sodes in a majority of them. Animals which convulsed ex-
hibited a typical seizure pattern of clonic movements of 
the limbs followed by flexion and extension (and sometimes 
a short clonus). When death occurred, it generally follow-
ed repetitive convulsions of the clonic-tonic type, with 
the animals dying in extension. All deaths occurred within 
ninety minutes after injection of the compound. 
b. Strychnine Sulfate 
The pattern for strychnine sulfate toxicity was 
similar to that of allylglycine. A significant difference 
(P<0.05) occurred between the LD50's at 0600 and 1800 
hours. The toxicity of this compound is maximal during the 
light phase, and minimal in the dark phase of the illumina-
tion cycle. After receiving the drug, all animals exhibited 
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igure 26. The circadian toxic ity of tl1 0 convulsant drugs, 
a lylgl ycine and s trychni ne sulfate o The ordinate depicts 
t he dose of each r espective drug i n m0 ~/Kg o The abscissa 
i nd i cates the time of day CST 9 wi th the a mark i ng 
the dark phas e of t he phot operiod . Vert · ca 
di · . . .:1.1 e t:-.. -: s tan ard deviat i on ( n = 18 animals per deter-
min- . i on cf L 50 ) . 
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tcr:.ic extension terminating in death. All deaths occurred 
within ninety minutes after injection of the drug. 
2. Anti-convulsant DruP.s 
a. Acetazola~ide 
The PD50's with respect to MES for acetazolamide in 
• 
bo-!:h light and dark phases are indicated in Tables 7 (mice) 
and 8 (rats). Animals receiving this drug could not be 
differentiated from control animals \·Ji th regard to motor 
function. No changes in neurological functions were evi-
dent. The PD50 of the drug did not vary significantly be-
tween the test times. Table 9 (mice) and Table 10 (rats) 
indicate the seizure component times in those drug-treated 
animals that exhibited seizures at the low dosage level. 
After acetazolamide, the extensor latency time was signifi-
cantly elevated (P < 0.001) from that of control animals of 
. 
'both species in both phases. In mice, tho duration of 
clonus was significantly increased (P< 0.05) from values 
in the light phase (1800thours). Other times of rodent 
seizure components were not significantly different from 
control. 
TIME 
DRUG 0600 (dark) 1800 (light) 
Ac etazol amide 84.45 ± 15.35 l"lo G • 91.00 ± 40.43 
Diyhenylhydantoin • 9.79 ± 2 .18 n.s. 9.26 ± 1.48 
Meprobamate 187.40 ± 8.30 *•ri- .. ~ .. 152.90 ± 9.70 
Phenobarbital Sodium 2:;.68 ± 4.40 n. s. 23.04 ± 1 • 01 
Ta:::;::._.:; 7. The PD50 of anti-convulsant drugs in mice during 
light or dark phase of the illumination cycle. Values are 
expressed in mg./Kg., I.P., ±standard deviation (n = 18 
mice per determination). 
*** = p <0.001 
n.s. = non significant difference 
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DRUG 
Acetazolamide • 
Diphenylhydantoin 
Tnrn 
0300 (dark) 
9.80 ± 6.30 n.s. 
8.47 ± 4.39 n.s. 
Meprobamate 90.82 ± 26.50 x 
Phenobarbital Sodium 5.85 ± 2.86 n.s. 
1500 (light) 
i 0.88 ± 
8.47 ± 
3.22 
4.39 
76.98 ± 10.12 
5.85 ± 2.86 
Table 8. The PD50 of anti-convulsant drugs in rats during 
the dark or light phase of the illumination cycle. Values 
are expressed in mg./Kg., I.P., ±the standard deviation 
(n = ·14 rats per determination). 
x = p<o.10 
n.s. = non-significant difference 
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Table 9. Time, in seconds, for seizure components of normal saline control 
and drug-treated mice ·which still showed convulsions. Values are expressed 
± standard deviation. 
TIME 
0600 
1800 
0600 
DRUG TREATHENT n EXTENSOR LATENCY 
.. 
1800 
0600 
1800 
0600 
1800 
0601) 
1800 
Saline, 0.9% 
Saline, o. 91~ 
Acetazolamide, 
80 mg./Kg • 
Acetazolamide, 
80 mg./Kg. 
Diphenylhydantoin, 
8 mg./Kg. 
Diphenylhydantoin 1 
8 mg./Kg. 
Neprobamate, 
180 mg./Kg. 
10 
10 
5 
5 
6 
6 
6 
M:eprobamate, 5 
150 mg./Kg. 
Phenobarbital Sodium, 6 
20 mg./Kg. 
Phenobarbital Sodium, 8 
20 mg./Kg. 
1.86 .:!: 0.28 
• 2.17 ± 0.32 
3.86 .:!: 0.61 
3.64 ± 0.49 
4.00 ± 0.55 
3.95 ± o.67 
4. 57 -:- 0. 50 
3.92 ± 1.36 
3.87 i 0.54 
4.58 ± 1.55 
TONIC EXTENSION 
13.74 .± 1.52 
13.29 + 0.86 
CLO NUS 
6. 10 + 1 • 44 
7.69 -r 2.83 
13.06 ± 3.54 10.70 + 4.}0 
11.72 ± 3.30 11.94 + 3.78 
6.85 ± 2.73 27.87 ±13.03 
10. 9 5 -:- 4. 13 16. 1 6 -,· 5 . 58 
7.92 ± 1.16 12.82 i 5.15 
9.14 ± 3.S5 10.72 ± 2.33 
7.08 .± 2.38 14.38 .± 3.52 
7.63 ± 4.07 18.85 ± 4.43 
lllll!ll•··•;;;w*""''"''" MotG•-wc::swJW.MQUi$WIAUL$1£1Jt.Z4WSJI~ 
Table 10. Time, in seconds, for seizure components of normal saline-~ coll"L~l'o1 
and those drug-treated rats which still showed convulsions. Values arc exp:r:es-
sed + standard deviation. 
THIE DRUG TREATMENT n EXTENSOR LATENCY TONIC EXTENSION CLONUS 
0300 Saline, 0.9% 7 1. 98 + o. 10 10.72 + 1.62 17.48 + 7.30 
-
-• 1500 Saline, 0.9% 7 1.95 + 0.10 
.... 
11. 42 + 1.03 16. 11 + 
-
5.51 
0300 Acetazolamide, 
.. 8 mg, /Kg. 
4 3.87 .± 0.90 8.85 -i- a.so 22.47 -1- 11. 13 
1500 Acetazolamide, 5 3.12 + 0.24 9.72 -:- 2.21 20.44 + 10.58 8 mg./Kg. -
0300 Diphenylhydantoin, 5 2.82 .± o.63 10.52 + 1.59 25.36 -~ 10.31 5 mg./Kg. -
1500 Diphenylhydantoin, 5 3.28 + 0.44 7.08 -'- 2.31 28.36 -:- q .,,.r ' _:, • .) 0 5 mg./Kg. - -
O:JOO Meprobamate, 
67 mg./Kg. 
5 3.70 .± 0.55 8.40 + 
-
1. 53 21.74 + 
-
5.97 
1500 Meprobamate, 5 3.24 .± 0.37 8. 4-6 + 2.76 26.04 -:- 4.23 67 mg./Kg. -
0300 Phenobarbital Sodium, f; 3.90 -: .. o.67 7.95 + 2.05 24.10 -f- 5.76 5 mg./Kg. - -
1500 Phenobarbital Sodium, 4 3.77 .± 0.38 7.15 + 2.23 29.37 + 8.44 
-5 mg./Kg. 
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. There was no significa.n.t di:Z:fc::. .. ·.:::1cc: in seizure com-
ponent times between acetazo12~oidc-t1".::c.:~cd rodents in light 
or dark phases. 
b. Diphenylhydantoin 
Rodents receiving diphenylhyd~ntoin exhibited normal 
motor activity and no apparent neurological deficits. The 
PD50 of 1iphenylhydantoin in the dark phase did not differ 
significantly from that of the light phase in either species 
(Table 7 and 8). • 
Seizure component times of convulsed animals, are 
indicated in Tables 9 and 10. Exten~ l~tencI and duration 
of clonus times in both phases were significantly increased 
(P < 0.001) above those found in the control mice, while 
the duration of tonic extension was decreased significantly 
(P<0.05). In rats, extensor latenc;y: time was increased 
significantly (P ( 0.001) from that of control, but the 
time of clonus was significantly increased (P < 0.05) only 
during the light phase. 
A comparison of seizure component times in the di-
phenylhydantoin-trea ted rats of different phases indicated 
that the extension phase was significantly decreased 
~ 
(P<0.01) in the light phase. A similar comparison in mice 
indicated only borderline significance ( P < 0 .10) in the 
following parameters: increased duration of tonic 
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EXTENSOR TONIC 
DOSE _!:}\.TEW CY E!'"''i']N$~!_071 CLOllUS 
mg. /Kg. seconds second.s seconds 
5 2.,0 ± 0.66 13. 30 ± 1.45 19.48 ± 18.19 
1.68 ± 0.13* 17. 3G ± 3.30* 5.66 ± 4.17 
20 2.2G ± 0.15 15.18 ± 1.98 8.48 ± 2.74 
30 2.44 ± i.23* 15.40 ± 0.97* 7.40 ± 1.80 
50 2.46 ± 0.86 21.15 ± 2.40*** 10.55 ± 2 .. 90* 
100 2.53 ± 0.58* 24.03 ± 6.39*** 8.47 ± 1.42 
Table 11. The effects of I.P. doses of AOAA on various com-
ponent times of MES seizures in mice. Drugs were adminis-
tered at 1200-1400 hours. Testing was begun at 1400 hours, 
and concluded at 1600 hours. Values are shown in seconds 
±their respective standard deviation (n = 5). Signifi-
cance against pooled saline controls from 0600 and 1800 
hours is indicated by: 
* p <0.05 
*** P<0.001 
El:TE:,TSOR Tr,-.-TTf"J \,.,....;.., .LV 
LATENCY ~~~£l-Te}_QN CI, ONUS 
post drug, m:in. seconds seconds seconds 
CONTROL 2.02 ± 0.27 13. 57 ± 1 • 1 9 6.90 ± 2.10 
30 1.97 ± 0.10 17.90 ± 4.40 6.15 ± 0.85 
60 2.10 ± 0.75 ·15. 90 ± 1.65* e.·10 ± .•• 90 
90 2.1~ ± 0.)5 16.2~ ± ~.00* 8.10 ± 1.55 
120 2.43 ± 0.(:!5 19.GJ ± 1.65*** 6.44 ± 1.55 
AOAA average 
(n = 12) 2. 31 ± 0.36 17. 31 + 2.42*** 7 .19 ± 1.46 
Table 12. The effects of AOAA, 50 mg./Kg., I.P., on MES 
seizure component times at various times after adminis-
tration in mice. Values are expressed in seconds ± stan-
dard deviation (n = 3). Averaged saline controls are in-
cluded for comparative purposes. 
* = p <0.05 
*** = P<0.001 
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Table 13. Seizure component times, in mice, during both lic;ht (1800 hours) and 
dark (0600 hours) phases of the illumination cycle follovrints AOAA hemi-hydro-
chloride administration, 50 or 70 mg./Kg. Values are expressed in seconds .± 
standard deviation. 
-::- = p 0.05 .,~ .. ~,{- = p 0.01 
0600 
1800 
0600 
1800 
0600 
1800 
DRUG 
TREATll'iENT n 
"0.9% Saline, I.P. 7 
0.9% Saline, I.P. 6 
AOAA, 50 mg./Kg., 6 
I.P. 
J.i.01\.i\ 9 50 mg. /Kg., 5 I.P. 
AOJ.'1-A, 70 mg. /Kg., 7 
I.P. 
AOAJ\, 70 mg. /Kg., 7 
I.P. 
-lHH~ = p 0. 001 
EXTENSOR 
LATENCY 
-seconds 
2.24 .± 0.44 
2.53 .± 0.73 
3.37 ± 0.82 7~ 
3.32 .:!: 0.91 
3 • 69 .±; 0, 41 ·::--:H:· 
3. 56 .± 0, 74-x· 
• TONIC 
EXTENSION 
seconds 
13.94 .± 1.88 
11.80 :!: 2.52 
14.37 .± 4.57 
12.38 + 3.33 
1 6 • 4 6 .:!: 2 .• 2 2-::--::-
CL01ms 
seconds 
8.66 + 0.91 
9.17 .:!: 1.00 
11.68 + 2.73 
8.45 -r- 3.26 
10,02 T 1,48 
10.72..:. 2.66 
r 
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CHAPTER FIVE 
GENERAL DISCUSSION 
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A. Possible Relationshins of Circadian Rhythms in lli 
Levels of Putative Inhibitor~ Transmitters 12 
Physiological Parameters 
Several types of 24-hour patterns in the concentra-
tions of the putative CNS neurotransmitter substances 
studied can be described. These include: 1) Type I: a 
-
circadian pattern ~ !: maximum .!!! ~ ~ phase as seen 
with the 1 evel s of. DM and NE in the CS , US , and LS , of 
5-HT in the lower brainstem, of GABA in the cerebral cor-
tex, cerebellum, and corpora quadrigemina, and of giycine 
in the pons an,d spinal cord regions examined. This pat-
tern was also obtained with r~ctal temperature, and motor 
activity, . 2) Type' II: !: circadian pattern with!: maximum 
. . in 1h! light phase as noted in the case of the 5-HT levels 
of the corpus striatum and upper brainstem, 3) Type III: 
!: "sawtooth" fluctuation apparently ~uperimposed .Q!! !: 
circadian pattern as noted in the case of the GABA levels 
of the thalamus-hypothalamus, 4) Type IV: !: relatively 
stable pattern noted in glycine levels of the medulla. 
1. Dopamine 
The DM content of all examined tissues exhibited a 
Type I circadian pattern {Figures 11 and 12). This pattern 
differed from that described by Scheving and co-workers 
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(1968a), who found that DM content of the whole~ brain 
varied in an ultradian fashion. It is apparent from this 
difference that DM rhythms noted in the specific brain 
areas studied are not typical of all brain regions.· 
The brain regions used for this study of circadian 
DM content were selected because they represent a probable 
site of adrenergic pathways. The corpus striatum, which 
plays an important role as a "relay center" in the extra-
pyramidal motor sy~tem (Crosby ~ .!.!·, 1962), was shown to 
contain extremely high concentrations of DM (Carlsson, 
1959). Subsequent studies demonstrated the presence of a 
nigro-neostriatal pathway, which influences DM levels of the 
corpus striatum (Anden ~ .!.!•' 1964). A transmitter role 
for DM in this region has been proposed because DM fulfills 
certain necessary criteria: the presence of degradative 
enzymes (Bogdanski ~ ~·, t 957; Axelrod ·n .!.!•, 1959), the 
:: presence and accumulation of DM in the varicosi ties of fine 
neurons (Fuxe ~ !!J.,., 1964), an inhibitory action of DM on 
spontaneous firing induced by DL-homocysteic acid (Bloom 
and Salmoiraghi, 19~5; York, 1967), ~vitro DM release 
from DM-storing vesicles isolated from porcine caudate and 
lentiform nuclei (Philippu and Heyd, 1970) and.!!! .Y.!.Y.Q DM 
release from the cat caudate nucleus (Riddell and Szerb, 
1971). In light of the circadian changes in DM content in 
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this region, it is tempting to consider that these circad-
ian fluctuations are occurring concomitantly with changes 
in the overall level of inhibition originating in this 
area. This supposition becomes more plausible when' one con-
siders that trough levels of DM are noted during the sleep-
ing phase of this nocturnal species, a time when motor ac-
tivity is at a nadir (Scheving et al., 1968a). 
--
The adrenergic pathways that have been mapped in the 
• 
upper and lower brainstem appear to be noradrenergic rather 
than dopaminergic (~infra). The role of DM in these 
tissues is probably that of a precursor rather than a trans-
mitter, and its fluctuation reflects circadian fluctuations 
t· in enzyme activity (Figure 13). The tyrosine hydroxylase 
~~ 
step of catecholamine biosynthesis has been shown to be the 
rate-limiting step (Spector,!!!~., 1965). McGeer and 
McGeer (1966) demonstrated that the activity of this enzyme 
is maximal in the rodent pineal during the dark phase. 
Thus, regardless of DM'S role in neurotransmission, its 
levels could be increased by augmented nocturnal tyrosine 
. hydroxylase activity. However, it is also possible that 
increased DM content noted d~ring the dark phase reflects 
~ 
an increased content of DM precursors. In this regard, 
Wurtman and co-workers (1968) have noted a circadian rhythm 
in the levels of phenylalanine and tyrosine in blood. In 
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actuality, both factors mentioned could be coupled to set 
the pattern in DM content. 
An additional controlling factor in the regulation 
of DM levels could be attributed to the activity of the de-
gradative enzymes of catecholamine biosynthesis.· Piepho 
and Friedman (1968) demonstrated an inverse relationship 
between the striatal levels of DM and its primary metabo-
lite, HVA (cf. Appendix B). The aforementioned study sug-
gests that fluctuations occur in the activity of either 
MAO, COMT, or both. 
The pharmacological implications of this rhythm in 
DM content are of considerable interest. Oxotremorine, a 
parkinsonomimetic agent that alters striatal DM content 
(Friedman and Anton, 1967), exhibits peak toxicity at noon 
in animals on a similar 12:12 light/dark regimen (Walker, 
1969). The peak toxicity of this substance occurs at a 
time when the striatal DM content is minimal, thus re-
emphasizing the role of DM in the parkinsonomimetic action 
of oxotremorine. More recently, Speciale and Friedman 
(1971) noted a circadian pattern in the sleeping time fol-
lowing a 350 mg./Kg. dose of the hypnotic agent, gamma-
~ 
butyrolactone (GBL). Increased levels of CNS DM have been 
noted following treatment with this agent (Roth and Suhr, 
1970; Aghajanian and Roth, 1970). However, the maximum 
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sleeping time noted with GBL occurred at 1800 hours, a 
time when the DM content of the brainstem and corpus stri-
atum is minimal. It appears that if the action of GBL is 
directly related to DM content, this action is exerted in 
a brain region other than those studied. However, ·GBL 
also effects carbohydrate metabolism (Leonard and Watkinson, 
1971), and this effect may be involved in the mechanism of 
its hypnotic action (cf. Discussion, V-A-4) • 
• 
2. Norepinephrine 
The NE content of brain regions studied varied on 
a Type I circadian basis (Figure 13). Friedman and co-
workers (1968) demonstrated a similar pattern in the rat 
caudate nucleus and midbrain; .this rhythm has recently 
been confirmed in the hypothalamus and caudate nucleµs 
(Walker _2! &·, 1971). The latter workez:s also noted a 
correlative circadian pattern in the number of granular 
catecholamine-storing vesicles in the pre-synaptic nerve 
terminals of these areas. 
The pattern of striatal NE content has a time course 
similar to that of DM in this tissue. A functional role 
of NE in this area ~as been questioned because of the rel-
atively small amount of NE found here {Bertler and Rosen-
gren, 1959); however, NE may have a definite role in this 
region and may be synthesized as required (Phillis, 1970). 
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Regardless of its actual role, it is apparent that this NE 
rhythm follows that of DM. The conversion of DM to NE 
proceeds readily in the striatum due to high dopamine-beta-
oxidase ac ti vi ty there (Kaufman and Friedman, 1965) '• The 
striatal NE rhythm might be attributed to the interference 
of high DM concentrations in the fluorimetric assay of NE· 
However, using the Ansell and Beeson technique, comparable 
levels of a DM standard- solution caused no increase in 
fluorimetric readfngs.over that of a reagent blank when 
treated and quantified in the NE procedure. Thus, the 
rhythm is not an artifact of the analytical method. 
The twenty-four.hour patterns of brainstem NE con-
tent also represent Type I patterns. The upper brainstem 
rhythm 'is more marked than that of the lower brainstem. 
This relationship is similar to that noted for DM in these 
regions. The hypothalamus contains the highest NE levels 
of the CNS (Glowinski and Iversen, i 966). 1.B vivo release 
of NE has recently been demonstrated. in the cat hypothala-
mus (Philippu ~al., 1970). This area has been implicated 
in the control of body temperature by the work of Feldberg 
and his co-workers (1964), who found that application of 
~ 
NE close to the cat hypothalamus decreases body temperature. 
The present study in rats indicates that peak NE levels are 
found at a time when body temperature is also maximal, 
176 
which would seem at odds with Feldberg's finding. However, 
the measurement of total tissue levels of NE does not rule 
out the possibility of a highly localized adrenergic con-
~~ 
t trol of temperature, which could not be detected by· the 
&·· 
quantitative methods used in the current study. Further-
more, localized applications of neurotransmitter sub-
stances produce sudden changes in concentration in the face 
of endogenous transmitter currents, and the time course of 
these effects is d'istinct from those observed in circadian 
studies. 
Noradrenergic mechanisms have also been implicated 
in the central regulation of food intake in the hypothala-
mus (Grossman, 1962; Booth, 1968). The NE rhythm found.is 
in keeping with the postulated role of this area in satiety. 
Hillarp and co-investigators (1966) demonstrated 
several noradrenergic pathways in the upper brainstem area. 
Ascending neurons of group A1 extend rostrally in the re-
ticular formation to the median forebrain bundle, hypothal-
amus, and parts of the limbic system. These pathways 
appear to be important in the function of the waking animal, 
and higher NE concentration would be necessary in these 
~ 
areas during the waking hours to maintain the alert state. 
The NE rhythm of the lower brainstem (pons-medulla) 
also peaks during the phase of maximal motor activity. 
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Fluorescence microscopic techniques have also been used to 
f, map noradrenergic systems of the lower brainstem. Hillarp ~-
~ and co-workers (1966) found that the majority of NE-con-
taining nerve cell bodies are found in the pons and' medulla. 
Descending neurons of group A2 extend caudally from the ven-
trolateral reticular formation via the anterior and lateral 
funiculi. These fibers give rise to NE-containing nerve 
terminals in the spinal cord (Dahlstrom and Fuxe, 1964) • 
• Some possible roles of NE in motor function have been de-
scribed (a review of these spinal cord actions of NE is 
available, cf. Phillis, 1970). The increased NE content of 
the pons-medulla during the dark phase is concurrent With 
the peak of locomotor activity in these nocturnal animals. 
This result is not unexpected when one considers the 
physiological implications of the research of the Swedish 
' . 
workers regarding these descending pathways. 
Control of these NE rhythms might be attributed to 
biochemical mechanisms similar to those described for DM 
(cf. Discussion, V-A-1). The time course of the NE rhythms 
in this study is similar to that of rat pineal gland NE 
(Wurtman .,!!! !!!.•• 1967). The latter rhythm is thought to 
( 
be controlled by light impulses impingfng upon the retina, 
and it is abolished by blinding. The actual biochemical 
control of the rhythm in the current study oould be similar 
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to the mechanism controlling the pineal rhythm, viz., al-
terations in tyrosine hydroxylase activity. Another pos-
sible mechanism of control for the fluctua~ions o.f Nli: might 
lie in altered activities of the degradative enzymes, MAO 
and COMT. 
The pharmacological significance of the NE rhythm is 
demonstrated by studies such as that of Black and co-work• 
ers (1969). They found that the depletion of NE in the rat 
• brain by reserpine va~ies.in a circadian fashion, with a 
greater NE depletion occurring during the dark phase. This 
is plausible if one. considers that depletion of NE by re-
serpine occurs via a decreased granular binding capacity. 
Since more NE is available in the dark phase, a larger 
amount will be unbound by reserpine leading to a greater 
percentage of depletion. Studies of this type aid in clar-
ifying one source of biological variation, so that measures 
can be taken in future scientific protocol to limit vari-
ability of this nature. 
}. Serotonin 
The patterns of 5-HT content in the corpus striatum 
and upper brainstem exh~bited an inverse relationship to 
those noted for the catecholamines, viz., a Type II cir-
cadian pattern as seen in most 5-HT studies in rodents 
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(cf. II-B-6). In contrast, the 5-HT content of the lower 
brainstem exhibited a Type I circadian pattern similar to 
that obtained with the catecholamines (Figure 14) • 
. The striatal 5-HT rhythm is similar in time course 
to that previously described in this laboratory (Friedman 
and Walker, 1968). The corpus striatum has the highest 
activity of trypto;phan-5-hydroxylase (Peters~~., 1968), 
the rate-limiting enzymatic step in 5-HT biosynthesis 
(Garattini and· Val•zelli, 1965). However, recent reviews 
of CNS neurotransmitter activities fail to mention any ac-
tion of 5-HT on the neurons of this region (Curtis, 1969; 
Phillis, 1970). Dah1strom (1969) has described an ascend-
ing pathway from the pons-medulla that terminates in the 
striatal region, but the function of this pathway is not 
specified. It is plausible that this latter pathway could 
be a part of the trophotroph~c system, in which 5-HT is the 
postual ted transmitter (Brodie and Reid, 1968). This system, 
when activated, leads to increased parasympathetic output, 
drowsiness, sleep, and decreased motor activity;·all of 
these parameters are maximal during the sleeping phase in 
mammals. The present study demonstrates that these func-
( 
tions attributed to the trophotrophic system do occur when 
5-HT levels are maximal in the cs. 
The 5-HT rhythm of the US is quite similar to that 
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of the CS. The peak in 5-HT levels occurs at a time when 
body temperature and motor activity are minimal. The pos-
sible roles of 5-HT in the various stages of sleep have 
been described by s~veral authorities (Koella and Czicman, 
1966; Koella, 1968; Pujol~.!!.!,., 1971). Koella (1968) 
postulated that 5-HT receptor sites are present in the 
vicinity of the area postrema; once stimulated, ascending 
hypnogenic pathways, presumed to be serotonergic, are ac-
tivated. An ascent.ing serotonergic pathway has been demon-
strated histochemically; it ascends from the rostral raphe 
nuclei to the diencephalon and telencephalon (Fuxe !1 !Y:_., 
1968). The diurnal increase in 5-HT levels of this area 
coincides with the sleeping phase of rats. 
In addition to the aforementioned functional role of 
5-HT in the US, Scapagnini and co-investigators (1971) pos-
tulated that serotonergic· pathways in the limbic regions 
play a role in the regulation of pituitary-adrenal function. 
A parallelism has been described in the rhythms of 5-HT 
content and plasma corticosterone in the cat. It is also 
interesting to note that US 5-HT levels peak when body 
temperature is minimal (cf. Figures 9 and 14). This seems 
to be in contrast to the relationship suggested by Feld-
berg and Myers (1964) which propose a direct relationship 
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between 5-HT levels and body temperature. However, Bruin-
vels (1970) has demonstrated that intra-cisternal injec-
tion of 5-HT produces a dose-dependent hypothermia. This 
latter study is in better agreement with the 5-HT data of 
the current study than is. the data of Feldberg and Myers 
(1964). 
The 5-HT rhythms of the LS exhibit a Type I pattern 
similar to that of the catecholamines of this area, 
• (Figures 12, 13, and 14). This 5-HT rhythm is in marked 
contrast to those obtained more rostrally in the CNS (Quay, 
1968; Friedman and Walker, 1968). Dahlstrom and Fuxe (1964) 
. 
demonstrated the presence of 5-HT terminals in the motor 
nuclei of cranial nerves V and X, and in the nucleus of 
the tractus solitarius; they also describe a descending 
system between the caudal raphe nuclei and the lumbosacral 
areas of the spinal cord. In view of the probable role of 
such a system in motor function, a pattern of maximal levels 
during the period of greatest motor activity is not sur-
prising (Figure 10). The depressant actions of 5-HT on 
dorsal root potentials, spinal cord reflexes, and inter-
neuronal pathways have been recently reviewed (Phillis, 
f 
1970). 
Control of the 5-HT rhythms could involve one or 
more of the following mechanisms. It could occur via the 
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pineal gland, which exhibits a rhythm in 5-HT content sim-
ilar to that noted in the CS and US (Quay, l963a). This 
pineal rhythm appears to be regulated via alterations in 
the level of 5-HTP decarboxylase, the activity of which 
varies according to the amount of light in the environment 
(Snyder ,tl &·, 1965a&b). 'The 5-HT rhythm of the LS could 
be regulated by the pineal rhythm of melatonin, which has 
a similar time course. This latter rhythm appears to be 
controlled by alt:rations in the activity of HIOMT, which 
~ is inhibited by light (Axelrod!.! !!1•, 1965). One can 
postulate that the 5-HT rhythm of the LS might also be 
controlled by a fluctuation of MAO activity (vide supra), 
or by an alteration in the dietary intake of tryptophan, 
as increased plasma tryptophan has been shown to increase 
brain tryptophan concentrations, which in turn leads to in-
creased brain 5-HT levels (Fernstrom and 'Wurtman, 1971). 
4. 4-aminobutyric !£!!! 
The only biorhythm that has been described so far 
for GABA levels was demonstrated in 1969 (Piepho and 
Friedman, 1969). This previous report described circadian 
and ultradian patterns in the CQ and TH-HT respectively 
(~infra). 
GABA levels of the frontal cerebral lobe exhibit a 
circadian pattern in which the difference between peak and 
18;j 
trough was of borderline statistical significance (cf. 
Figure 15,Appendix A). The rhythm however, is reproducible 
and was demonstrated in two different seasons. The noc-
turnal maximum of this.rhythm coincides with the peak of 
motor activity in the rat (Scheving ~ !!:.!.•• 1968). The 
inhibitory actions of GABA on cortical neurons have been 
amply demonstrated (Krnjevic and Schwartz, 1967; cf. Bradley, 
1969); increased levels of this inhibitory substance in this 
area could be ant11lipated with increased motor function, 
since motor pathways are associated with the frontal cortex 
(Crosby.!! !:J:.., 1962). On the other hand, one might ask 
"why GABA content is not elevated during sleep". Jasper 
and co-workers (1965) demonstrated a positive relationship 
between GABA levels in the pia-arachnoid space and the 
sleeping state. Since the brain prepa~ation used in this 
study involved a saline rinse prior to dissection, some of 
·this "released" or unbound GABA, present during the sleep-
ing state, would have been rinsed from the tissue surface. 
This procedure might have distorted the true nature of 
the tissue rhythm, and a more accurate picture would prob-
ably be obtained if tissue levels and ventricular fluid 
( 
content were both measured. 
GABA levels of the CBLM exhibit a more definitive 
rhythm than those of the cortex, but have a similar time 
-~ 
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course (Figure 15). The function of the cerebellum in 
motor coordination has been well established, and the bio-
synthesis of GABA has been confirmed in this structure 
(vide infra). Levels of GABA are quite high in the· axons 
-
of cells with proposed inhibitory function, viz. Purkinje, 
basket, stellate, and Golgi II cells. The content of GAD, 
the immediate synthetic enzyme of GABA synthesis, is also 
higher in the Purkinje cell layer (Roberts and Kuriyama, 
1968). The catab~ic enzyme of this pathway, GABA-T, also 
exhibits highest activity in the neuronal areas receiving 
inhibitory synapses, viz. Purkinje, and Golgi cells, and 
fiber terminals (Roberts and Kuriyama, 1968). The inhib-
itory actions of GABA in this region have recently been 
reviewed (Phillis, 1970); and its release has also been 
documented following stimulation of afferent tracts (Obata 
and Takeda, 1969). In view of the inhibitory role of GABA 
in this motor center, a rise in levels, concomitantly with 
augmented inhibition associated with motor activity in the 
waking phase, is not unexpected. 
The GABA rhythm of the corpora quadrigemina (Figure 
16) is similar to that of the cerebrum and cerebellum, ie. 
a Type I pattern. Relatively high GABA levels have been 
reported in this structure (Fahn and Cote, 1968), suggest-
ing a possible inhibitor7 function of GABA associated with 
r r' 
i 
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this region. The functions of the superior and inferior 
colliculi involve, respectively, the integration of visual 
and auditory impulses. Alteration in the level of inhibi-
tion in these structures might be anticipated due to the 
need for discrimination of pertinent stimuli during the 
waking phase. The GABA levels of the TH-HT exhibited a 
unique rhythm (Type III) that appeared as a "sawtooth" 
fluctuation superimposed on a circadian pattern (Figure 16). 
This type of fluc11uation might seem plausible in light of 
the multiple functions of this area (Harris, 1966). These 
include regulation of body temperature, responsiveness to 
painful stimuli, maintainence of alert behavior, modulation 
of the pituitary axis, control of the drive for food and 
water, partial input into the physical expressions of emo-
tion, and autonomic regulation. Although a circadian pat-
tern might occur in some of the aforementioned functions, 
the homeostatic nature of others might require patterns 
with shorter periods and increased frequencies. An addi-
tional consideration concerns the possible role of GABA 
in modulation of monoamine activity, since the monoamines 
NE and 5-HT are found in high concentrations in this area 
(Glowinski and Iversen, 1966; Bogdnaski et al., 1957). 
t . --
Yessaian and collaborators (1969) demonstrated in vitro 
-
that GABA releases NE from hypothalamic slices and inhibits 
e 
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5-HT release. 
The central mechanisms of GABA rhythm control could 
" :· ~ .. 
:
7
, be concerned with several parameters. Dietary intake of 
either glucose or pyridoxine (vitamin B6) could affect 
GABA biosynthesis, as GABA is the product of an oxidative 
pathway with an anabolic B6-catalyzed enzyme, GAD (Roberts, 
1960). Tower (1960) demonstrated that virtually all of 
the energy metabolism of the CNS depends on the oxidation 
• of glucose, the levels of which vary on a circadian pattern~ 
(Bahorsky and Bernardis, 1967). ·The latter investigators 
noted in the rat that the plasma glucose levels are high-
est during the dark phase, ~resumably due to increased 
feeding; levels of GABA are also maximal during this phase. 
Since vitamin B6 is intimately involved in the GABA shunt 
(Roberts.!!!!:!.•• 1964), the possibility of a feeding 
rhythm could also be implicated as a controlling factor. 
This supposition becomes more plausible in light of recent 
information that mouse brain GAD activity is higher in the 
dark phase than in the light (Roberts, personal communica-
tion). The coincident variation of a coenzyme could be 
involved in this difference in enzyme activity. 
There has been some discussion in the literature con-
cerning the mechanism of action of gammabutyrolactone, a 
sedative agent. Aghajanian and Roth (1970) have proposed 
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that dopaminergic pathways are responsible for the pharm-
acological effects of GBL, but that a time lag appears be-
tween maximal effect on DM content and the sedative re-
sponse. More recently, Leonard and Watkinson ( 1971) have 
reported that gammahydroxybutrate, the active metabolite 
of GBL, caused an increase in brain glucose levels by any 
or all of the following factors: increased glucose syn-
thesis, decreased glycolysis, or decreased amino ~ syn-
• thesis from g1ucose. The circadian pattern of GBL sleeping 
time (Speciale and Friedman, 1971) would indicate that al-
tered carbohydrate metabolism is more important than DM in 
GBL's action, since the DM rhythm was 180° out of phase 
~: 
f. with that of GBL sleeping times. In other words, DM levels 
are lowest when GBL sleeping time is longest. However, the 
GABA content is also lowest at maximal GBL sleeping time; 
thus, it appears that when synthesis of this amino acid is 
minimal, sleeping time is extended. 
The rhythm in GABA levels also seems to affect the 
convulsant actions of allylglycine (cf. discussion, section 
V-D-1a). 
5. Glycine 
Glycine content exhib.i ted different patterns in the 
t individual brain regions examined (Figures 17 & 18). Type 
I. 
F I l 
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I patterns were noted in the pons (Figure 17) and thoracic 
cord (Figure 18); the glycine content of these areas varied 
in a circadian fashion with a sharp peak late in the dark 
phase. The latter pattern has also been demonstrated for 
blood glucose levels in the rat (Friedman and Walker, 1969}, 
with the peaks of both rhythms occurring coincidentally. 
Geiger (1958) found that brain glucose levels are propor-
tional to those of the blood, and that the brain levels of 
• free amino acids are, in turn, proportional to brain glucose. 
Shank and Aprison (1970} reported that glycine synthesis 
in the CNS occurs predominently via serine conversion cat-
alyzed by serine hydroxymethyl transferase {EC 2.1.2.1). 
Furthermore, they demonstrated that glucose is the principle 
source of the carbon units of serine in the rat CNS. Thus, 
it is likely that the glycine patterns noted in the pons 
and TC reflect the pattern described ~y olood glucose ~evels, 
a pattern defined initially by glucose intake in the feed-
ing cycle of the rat. 
The glycine content of the medulla was relatively 
stable, exhibiting a Type IV pattern, in contrast to glycine 
patterns found in other CNS tissues examined. It is pos-
sible that regulation of a steady state level of glycine 
in this tissue occurs via interconversion to serine, the 
common storage form of glycine (Blakley, 1954; Kawasaki 
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et al., 1966). This stability of medullary glycine levels 
--
might be indicative of its association with a non-fluctuat-
ing medullary function. Indeed, glycine has been shown to 
:. exert a potent inhibitory influence on neurons of the cun-
1 eate nucleus (Galindo~,!!., 1967), which with their pro-
jection systems, function in the transmission of pro-
prioceptive and tactile impulses. It is quite possible 
that these systems are maintained during both sleeping and 
• waking phases witn a fairly constant level of inhibition. 
Fluctuations of glycine content of the cervical and 
lumbar spinal enlargements described a Type I circadian 
pattern (Figure 18). The pattern in these areas was not 
as sharp as that defined by the pons and TC, but the range 
in levels was still significant. The proposed role of 
glycine as a spinal inhibitory transmitter has been re-
viewed (Aprison and Werman, 1968; Werman'and Aprison, 1968). 
These investigators hav~ described higher glycine levels in 
the spinal cord enlarg~ments relative to the mass of mus• 
culature supplied by these regions (Aprison ,.!! ,!l., 1969b). 
Glycine has also been show to possess an equilibrium po-
.. tential similar to that of the physiol:ogical interneuronal 
inhibitory transmitter indicating that they are probably 
the same (Curtis et Jll., 1968a). The circadian changes 
~ in glycine co~tent parallel those of .motor activity as 
~ 
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might be anticipated due to the greater need for regulatory 
modulation during movement. This regulation would require 
some specialized control mechanisms to prevent extreme 
fluctuation as noted in the pone and TC. Some of the mech-
anisms controlling glycine content in these areas include 
interconversion to serine(~ supra), incorporation of 
glycine into protein (Mase~ ai., 1962; Sky-peck ,!U .!!l.•• 
1966; Aprison !! !!!,., 1969a), active uptake of g1ycine 
from the CSF (Apri\on !! .!!_., 1~69a), and active transport 
of glycine from CSF into blood (Murray and Cutler, 1970). 
Any or all of the aforementioned controlling mechanisms 
might aid in maintaining the constancy of glycine levels 
during motor activity, but it is not now possible to as-
sign the degree of contribution of each factor. Thus, al-
though large fluctuations in glycine content occur in the 
pons and TC where glycine probably funct~ons only in inter-
mediary metabolism, less marked variations are noted in the 
cervical and lumbar enlargements, where it appears to play 
a role in motor inhibition. 
The pharmacological implications of these rhythms 
can be appreciated when one examines the data on the cir-
( 
cadian toxicity of strychnine, a glycine antagonist- (cf. 
discussion section V-D-1b). 
B. Effects .Q!. Photope~iod Reversal .Q.U 1ill! Levels of 
Putative Qli§. Neurotransmitters 
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The technique of photoperiod reversal was utilized 
in this study to evaluate both the endogenous or exogenous 
character of the r~ythm and the effect of reversal as a 
stress on cumulative amine levels. Exogenous, or extrinsi-
cally regulated rhythms were noted in the striatal DM, NE, 
and 5-HT content, ~pper brainstem 5-HT content, and cerebral 
and cerebellar GABA content. Endogenous, or intrinsically 
controlled rhythms were demonstrated in catecholamine con-
tent of both brainstem regions. In other rhythms inves-
tigated (5-HT of the lower brainstem,collicular GABA, and 
GABA of the TH-HT), reversal appeared to cause a flattening 
of the pattern seen on a normal cycle. 
1. Dopamine 
The pattern of DM levels in the corpus striatum ap-
peared to be exogenous as it was readily reversed by photo-
period reversal (Figures 19 & 20). The exogenous nature of 
this rhythm was not surprising in light of the relationship 
of DM to the extrapyramidal motor system (cf. discussion, 
~ 
section V-A-1). Thus, atriatal. DM levels apparently peak 
during the phase of maximal motor activity regardless ot 
the light/dark cycle used. On the other hand, the rhythms 
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in DM content of both brainstem areas were found to be 
endogenous (Figure 20). It is difficult to ascribe a 
function to these latter pattern• because of the limited 
number of studies dealing with the effect of photoperiod 
reversal on physiological functions. However, it should 
be noted that brainstem NE, which is derived from DM, is 
also endogenously regulated. 
A comparison of the striatal DM content in the com-
parative phases o~the two experimental cycles reveals that 
photoperiod reversal leads to increased basal DM content 
(Table 2). In the pilot study on DM content (Figures 11 & 
19), an increased basal level of DM was noted under rever-
sal conditions. Since the possibility of seasonal varia-
tion existed in this initial study, a second study was per-
formed with rats conditioned on both cycles simultaneously 
(Figures 12 & 20). Striatal DM levels were once again high-
er on the reverse cycle, suggesting the possibility of a 
stress-induced increase. Although DM levels are stable 
under some types of stress, viz. foot-shock stress (Bliss 
~ .!J:,., 1968), oscillatory stress {Smookler and Buckley, 
1969), and aggregation {Bliss and Ailion, 1969), other 
~ 
forms produce increased DM levels. Welch and Welch {1969) 
noted increased DM levels due to a chronic fighting stress. 
Furthermore, NE turnover has been found to increase in a 
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variety of stress situations (cf. discussion, section 
v-B-2), suggesting that an increased level of DM would be 
needed to augment NE bioeynthesis. 
A comparison of brainstem DM content during the ao-
tivi ty or sleep phases reveals an interesting difference in 
the effect of photoperiod reversal on this tissue. The DM 
. content of the lower brainstem is increased during inver-
sion, but that of the upper brainstem is not. The action 
of photoperiod re~rsal on lower brainstem DM might produce 
a stress similar to that described for the cs. The lack of 
any apparent effect on the US suggests that this brainstem 
area responds differently to "inversion stress", but the 
reasons for this localized specificity in response are un-
clear. It is unfortunate that many studies dealing with 
stress involve catecholamine levels of the whole brain, or 
brainstem _!!! !Q!g_, rather than individuaJ! regions of the 
brain. Localized responses of the type demonstrated in 
this study might occur, but are obscured by homogenization 
of the whole brain. 
2. Norepinephrine 
Photoperiod reverqal has similar effects on the NE 
patterns as on those of DM (Figu~e 21). The reversal of 
the striatal pattern of ME is not surprising, as NE levels 
of this tissue ~robably follow those of DM (ct. discussion, 
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section V-A-2); thus,the reversal of the DM rhythms(~ 
supra)is of prime importance in the NE rhythm. 
-
The NE rhythms of the brainstem were unchanged by 
photoperiod reversal indicating an endogenous character. 
These endogenous rhythms might play a role in some non-
reversibl e endocrine or autonomic function, since the nor-
adrenergic pathways of the brainstem extend rostrally to 
the level of the diencephalon (Hillarp !,! _!!., 1966). The 
question of defini!l.g a non-reversible parameter is a dif-
ficult one since most studies indicate reversibility of hy-
pothalamically-controlled functions, viz. body temperature 
(Figure 9), locomotor activity (Figure 10), and ACTH re• 
lease (Krieger, 1970). It is also interesting that one of 
the previously postulated control mechanisms, pineal in-
fluence, would not appear to control this rhythm, as the 
NE rhythm of the pineal gland is affected by photoperiod 
alterations {Wurtman .!! .!J:.., 1967). Both the control mech-
anisms of, and the parameters affected by this rhythm offer 
fertile areas of future stu4y. 
Cumulative striatal NE levels are significantly 
higher during the phase of activity of the reverse cycle 
than during this phase of the normal cycle. This could 
indicate a stress factor associated with photoperiod re-
versal, as has been previously described for DM content 
' 
;-. 
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(vide supra). Changes in NE turnover have been associated 
with several stressful situations, viz. intense muscular 
-
exercise (Gordon§.! .!!l•• 1966), immobilization (Corrodi 
et al., 1968a; Welch and Welch, 1968), changes in environ-
- -
mental temperature (Corrodi ,!.! .!!•• 1968b; Simmonds and 
Iversen, 1969), chronic electroshock (Kety ,!! !J:.., 1967), 
and foot-shock treatments (Thierry et.!!•• 1968; Bliss 
et al., 1968). 
-- . 
• Two alterations in cumulative NE levels were pro-
duced by photoperiod reversal: increased minimal NE levels 
in the US, and increased maximal NE content in the LS. The 
reason for these localized increases in NE content on the 
reverse cycle remains obscure, but some stress factor in 
local brainstem pathways could explain these alterations. 
It is quite possible, if these rhythms are assumed to be 
due to increased enzyme activity, that the increased NE 
levels during the phase of maximal NE content in the LS 
merely reflect the higher DM levels of this tissue during 
reversal. 
3. Serotonin 
The effects of phdtoperiod reversal on 5-HT content 
involve reversal of the 5-HT rhythms of the CS and US, and 
a flattening of the pattern in the LS (Figure 22). 
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striatal 5-HT levels are reversed so that their maximum 
still coincides with the troughs of motor activity, or the 
sleeping phase of this nocturnal species. Although the 
role of 5-HT in this area is unclear, it is evident that 
levels follow the pattern of those in the upper brainetem, 
which appear to be involved in sleep mechanisms (cf. dis-
cussion, section V-A-~). 
A similar reversal occurs in the pattern of 5-HT 
• content in the US. This reversal strengthens those 
theories that relate 5-HT content to sleep, as reversal of 
the sleep/wakefulness cycle also occurs. Thus, maximal 
5-HT content is still noted during the sleeping phase. 
The control of these rhythms of the CS and US could be 
seated in the pineal gland, which exhibits a similar rhythm 
determined by fluctuations in the activity of 5-HTP de-
carboxylase (Snyder.!! !J.., 1965a). 
The 5-HT pattern of the LS, which was 1ao0 out of 
phase with the other 5-HT rhythms on the normal cycle, 
seemed to disappear when subjected to reversal. The aboli-
tion of the rhythm offers an intriguing possibility, that 
coinciding exogenous and endogenous patterns are present. 
These patterns might be in phase on the normal cycle, but 
out of phase on the reverse cycle. This possibility gains 
credence when one considers that Quay (1968) haa reported 
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differential 5-HT rhythms in the brainstem, an exogenous 
one in the lateral brainstem and the absence of any 5-HT 
rhythm in the medial brainstem. An additional considera-
tion involves the different pathways described by Dahlstrom 
and Fuxe (1964). They demonstrated serotonergic pathways 
from the vasopressor region of the rat medulla to the sym-
pathetic lateral column of the spinal cord, and an ascend-
ing pathw~y to the median forebrain bundle. Differential 
pathways of this t'Ype could possess differential rhythms 
depending on their function; thus, it is possible that the 
apparent loss of this rhythm actually represents the effect 
of a reversed photoperiod on an exogenous rhythm, and its 
lack of effect on an endogenous one. 
A c~mparison of the cumulative 5-HT levels of com-
parable phases indicates only one significant difference 
(Table 4) - an increased 5-HT trough level in the.LS on the 
reverse cycle. This increase further emphasizes the pos-
sibility of an endogenous 5-HT rhythm in .1!!!.!! tissue, which 
resists reversal and overrides the effects of photoperiod 
inversion. The lack of any other alteration in 5-HT con-
tent is not surprising since other studies of stress have 
indicated that 5-HT l'eveis are essentially unchanged (Bliss 
.!! !!·• 1968; Bliss and Ailion, 1969; Welch and Welch, 1969). 
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4. ~-aminobutyric Acid 
The effects of photoperiod reversal on central GABA 
levels involved some differential inversion patterns de-
pendent on the tissue under study. The inversion of the 
pattern in GABA content was marked in the frontal cerebral 
lobe and cerebellum (Figure 2}). This reversal parallels 
that of motor activity, and such a response might be ex-
pected in view of the potential roles of GABA previously 
described (cf. dis~ussion, section V-A-4). The reversed 
rhythm also coincides with the feeding rhythm, so that the 
:;. dietary intake of glucose and pyridoxine might also be in-
volved in regulation of this reversed pattern. It is also 
possible to speculate that some of the enzymes involved in 
oxidative metabolism in these areas might express photo-
dependent changes in activity. 
A "pure" circadian rhythm could not be demonstrated 
in the CQ following photoperiod reversal, although a pat-
tern with marked peak and trough was noted (Figure 24). 
The peak and trough, however, both occurred in the dark 
phase, possibly indicating a greater resistance to the 
effects of reversal in this tissue. The reason for the 
~ 
increased resistance can only be speculated upon, but it 
might be related to the high concentration of GABA in this 
tissue (Fahn and Cote, 1968), and the degree to which the 
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enzymatic activity adapts to the new photoperiod. It may 
be that adaptation of a sufficient percentage of the total 
enzyme content necessary for a clear demonstration of in~ 
version does not occur in the limited three week period of 
adaptation commonly used. The possibility of differing ad-
aptation periods for specific rhythms, depending on the 
tissue level of transmitter and the controlling factors 
involved, must be considered in studies of this type • 
• The "sawtooth" fluctuation of TH-HT GABA content pre-
viously described resists photoperiod reversal, although 
the circadian component of this rhythm appears to be re-
versed (Figures 24 & 25). This apparently is an example 
of an extreme fluctuation occurring in the presence of 
an exogenous circadian pattern. It is quite possible that 
more than one type of,rhythmic pattern in the levels of 
this putative inhibitor could occur in a.multi-functional 
area as the hypothalamus (Harris, 1966). It appears as 
.though patterns of different periods may be synchronized 
on the normal cycle, but become desynchronized on the re-
verse cycle as the ancillary fluctuations are less clearly 
defined following inversion (Figure 25) ·• 
~ 
When the cumulative GABA levels of various phases 
are. compared (Table 5), significant increases in GABA con-
tent of the normal cycle.are noted' in the CQ and the TH-Hf. 
r 
'· 
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However, the significance of this finding is suspect, since 
the studies on these two areas were conducted during dif-
ferent seasons. Seasonal fluctuations in GABA levels have 
been reported (Roberts, personal communication) due to 
· seasonal differences in the pyrido:xine content of various 
rat food formulae. These diets are made from grain sources 
~. which have different vitamin content depending on environ-
mental factors, eg. length of growing season, time of har-
.. 
vest, etc. A simi-iar comparison of GABA levels of the fron-
tal cerebrum and OBLM revealed only one significant dif-
ference - cortical GABA levels of the normal light phase 
are higher than those of the reverse light phase (Table 5). 
The range of values of cortical GABA levels was greater on 
the reverse cycle due to the fact that levels of the light 
phase had decreased leading to a significant difference be-
tween peak and trough not seen in the normal cycle. This 
r definition of the reverse cycle GABA rhythm is puzzling. 
It is possible that GABA plays some hitherto unsuspected 
role in stress-related situations, but no studies of the 
effects of stress on central GABA levels have been found 
in the literature. Moreover, GABA levels are apparently 
~ 
affected only in the cortex {of those areas examined in the 
current study). A correlative study of catecholamine and 
amino acid levels of the cerebrum during stress might aid 
in evaluating this regional difference. 
c. Evaluation .2!, Electroshock Convulsive 
Mechanisms During Different Phases 
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The effects of maximal electroshock seizure induc-
tion (MES) were evaluated in Ha/ICR mice in light and dark 
periods of the normal. cycle. Since 0.9% saline solution 
and 5% gum acacia suspension were to be used as vehicles 
for the test drug~ it was important to determine whether 
they affect control mice in the same way (Table 6). The 
evaluation involved a measurement of the timing of the 
seizure components: extensor latency, tonic extension, 
and clonic phase. These phases were used by Tedeschi and 
co-investigators (1956) in their evaluation of the effects 
of current intensity on the timing of seizure components. 
At the 50 ma. level utilized in these studies, the seizure 
times were consistent with those of the former study. 
The mechanisms underlying generalized tonic/clonic 
seizure patterns appear to be located in the spinal cord 
Esplin and Freston (1960) demonstrated tonic/clonic pat-
terns following synchronous stimulation of the cervical 
~ 
spinal cord. They proposed that the motor expression of 
the seizure involved the "sterotyped response of spinal re-
flex systems to generalized stimulation of 'the cerebro-
epinal tracts". The initial response to a massive stimulus 
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;; is one of nexion because the flexor muscles are under a 
lower degree of inhibition than are the extensors. Tonic 
. 
. i
t). flexion leads to a lessening of inhibition on the more 
powerful extensors, thus allowing this dominant muscle 
group to contract resulting in tonic extension. The ter-
minal clonic movements appear to depend on "interactions 
between the antagonistic mo~oneuron pools through inverse 
myotactic reflexes, as well as upon the nature of the 
cerebral seizure lischarges which play upon the moto-
1 
neurons". Gastaut and Fischer-Williams (1959) demon-
strated that the caudal reticular formation is the crit-
ical brainstem area for transmission of seizure· impulse 
traffic from brain to spinal cord. The mode of activation 
of the caudal reticular formation might involve either hy-
persynchronous activity or a release from higher central 
, inhibitory mechanisms. 
Circadian changes in certain types of seizure phen-
omena have been reported in various species of nocturnal 
rodents. 'The susceptibility to Indoklon-induced seizures 
has been shown to be greater in the: dark phase in both 
mice and rats (Davis and Webb, 1963; Webb and Russell, 
~ 
1966). Schrieber and Schlesinger (1971) noted a circadian 
pattern with peak susceptibility in the nocturnal. phase 
to both sound-induced and electrically-induced seizures 
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in DBA/2J and F1 hybrid mice. A similar rhythm of margin~ 
significance (P<0.1) was described in C57BL/6J mice. 
Wada and Askura (1970) have also described maximal sus-
ceptibility to audiogenic seizures in the Wistar albino 
rat during the nocturnal phase. Thus, peak susceptibility 
to these seizure induction procedures occurs during the 
dark phase in these nocturnal rodents. 
The only diurnal/nocturnal difference that was noted 
in the current stu~y utilizing control Ha/ICR !!!..£.!! involved 
a shortening of the extensor latency ~ in the dark phase 
(Table 6). A decreased latency time might be expected dur-
ing the nocturnal phase, owing to the increased seizure 
susceptibility found in this phase(~ supra). Extensor 
latency time is essentially equal to the time of the tonic 
flexion phase. Since the levels of most excitatory and 
inhibitory putative transmitter substances are maximal at 
night, impulse traffic might be transferred more readily 
in this situation in which the animal is normally involved 
in motor function. 
Some differences in seizure component times were 
also noted in comparisons of saline-treated versus acacia-
~ 
treated control animals (Table 6). Extensor latency time 
in saline-treated animals was significantly shorter at 
0600 hours, and the time of tonic extension was shorter in 
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saline-treated animals at both time points. Acacia was 
utilized in this study because of its previous use in eval-
uation of the anti-convulsant activity of meprobamate 
(Berger, 1954). The compound is commonly used for the 
suspension of insoluble substances in water; it is con-
sidered ideal because it exerts a similar osmotic pressure 
to that of serum protein (Martin.!!~., 1961). Gum 
arabic (acacia) consists mostly of arabin, the calcium 
~ of arabic aci~; upon hydrolysis, it yields arabinose, 
galactose, and arabinosic acid (Martin!!!!•• 1961). It 
appears that the components of this suspending agent, or 
perhaps the.possible alteration of calcium levels, or 
some ionic binding properties of the gum might have an 
action on the timing of the tonic extension phase. 
The lack of a:Lteration in both seizure component 
times and minimal electroshock threshold•suggest the pos-
sibility of a "homeostatic equilibrium" in the excitability 
of the CNS. As noted in the current study, levels of 
putative "threshold-elevating" substances (DM, NE, GABA, 
c; glycine)- are maximal during the dark phase. Thus, it 
' might be assumed that the threshold would also be higher 
' in this phase, but it must be remembered that CNS excita-
bility is based on the relative levels of both excitatory 
and inhibitory influences.· The level of acetylcholine in 
r . 
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the rat brain is also maximal in the dark phase (Walker, 
1969), and ACh has "threshold-lowering" actions (cf. May-
nert, 1969). The increased ACh level might offset the 
increased levels of inhibitory substances leading to a 
stability in seizure susceptibility. It is also possible 
that the level~ of another potential excitatory substance, 
glutamate, are elevated during the dark phase as the levels 
of glucose are maximal during this phase (cf. discussion, 
section V-A-5). Tie CNS levels of this amino acid trans-
mitter suspect should be proportional to the level of free 
glucose. In conclusion, the constancy of most seizure 
component times as well as of minimal electroshock seizure 
threshold might be due to a balance between the excitatory 
and inhibitory neurochemical influences on the CNS. These 
substances appear to fluctuat.e in similar circadian pat-
terns; thus, it appears t~at the measurement of any in-
dividual neurochemical component cannot serve as an index 
for the Qomplex mechanisms involved in MES seizure produc-
tion. 
D. !!!! Evaluation~ Drug Efficacy !!! Respon,!! 
12 Lj,ght £!: Darkness 
Convulsant Compounds 
a. Allylglyoine 
The peak toxicity of allylgl.yoine was found to occur 
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at 1800 hours, late in the light phase (Figure 26). This 
peak coincides with minimal levels of GABA in the whole 
rat brain (calculated from the previously noted individua1 
data), or minimal activity of GAD in the mouse brain 
(Roberts, persona1 comm:u.nication). Allylglycine was shown 
to have convuleant properties by Schneider and co-inves-
tigators (1960). Alberici and collaborators (1969) demon-
strated that the drug definitely inhibited GAD with no ai-
teration in the ac\ivity of GABA-T (this action leads to a 
;, decreased level of GABA in the rat CNS). Allylglycine was 
' 
> 
" 
found to have no effect on the metabolism of pyridoxine, 
aspartate, glutamate, glycine, glutamine, or a1anine in the 
CNS. Administration of t~is convulsant agent fµrther led· 
to a marked structural alteration in the nerve endings of 
the cerebellar Purkinje cell layer. 
The peak toxicity of allylglycine·also occurs co-
incidentally with minimal glycine content in the lumbar 
spinal cord. Recent evidence presented by Roper (1970) has 
indicated a similar membrane receptor site for both glycine 
and allylglycine in the Mauthner cells of the goldfish. 
Thus, it is possible that a competition of a similar nature 
~ 
could occur in the mammalian sp~nal cord. 
The minimal toxicity of allylglycine was noted dur-
ing the dark phase, when levels of .l!.2!b GABA and glycine 
r 
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are maximar. From these results, it is impossible to 
assess the relative importance of either transmitter sus-
pect in-the action of allylglycine; however, both compounds 
might be involved (vide supra). In contrast to electro-
shock, a circadian pattern was obtained with this convul-
sant agent. Thie response is probably seen because, unlike 
; electroshock, allylglycine affects one, or possibly two, 
inhibitory systems. Thus, it is capable of upsetting the 
• balance of excitatory and inhibitory CNS factors, result-
ing in a differential pattern of toxic actions. 
b. Strychnine Sulfate 
The circadian toxicity curve of strychnine sulfate 
is similar to that of allylglycine (Figure 26). Peak tox-
icity of strychnine was also noted at 1800 hours, when 
glycine levels of the lumbar spinal cord are minimal. The 
role of glycine as an inhibitory transmitter in this latter 
region has been extensively investigated (cf. Aprison and 
,, Warman, 1968). Strychnine has been shown to supress re-
versibly both post-synaptic inhibition in the spinal cord 
and the hyperpolarization of spinal neurons due to the 
iontophoretic application of glycine (cf. Curtis~ 1969). 
" 
Thus, it appears that the glycine levels of the spinal 
cord influence the toxicity of strychnine, a supposition 
borne out by a comparison of their respective circadian 
r 
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patterns. ...I.n contrast to the actions of allylglycine, 
strychnine has been shown to have no actions on the effects 
elicited by iontophoretically-applied GABA (cf. Curtis, 
1969), so the effects noted here can be more directly re-l lated to glycine content. 
i 
In contrast to the rhythm noted in this study, Tsai 
and co-workers (1970) reported a circadian toxicity curve 
for strychnine in which maximal toxicity occurred during 
the dark phase in -rats on a programmed L/D cycle. It 
should be emphasized that these investigators did not ~so-
late the strychnine-treated rodents, so that greater inter-
. . 
action would be expected during the dark phase. This en-
hanced interaction of animals housed together would lead 
to increased seizure su~ceptibil.ity. The mice in the cur-
rent study were isolated following strychnine injection 
(cf. Methods section, II-D-2-a), therby preventing the 
aggregation effect and allowing a truer appraisal of the 
pharmacological actions of the drug. 
2. Anti-convul.sant Compounds 
a. Acetazolamide. 
The anti-convulsant action of acetazolamide did not 
vary appreciably when tested during different phases of 
the illumination cycle in either the mouse (Table 7) or 
the rat (Table 8)-. The anti•oonVUleant action ot 
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acetazolamide has been postulated to occur via various 
mechanisms (cf. Millichap, 1965, 1969). The most inves-
tigated of these mechanisms involves the inhibition of 
brain carbonic anhydrase by acetazolamide which leads to 
increased co2 levels in the CNS, a decreased blood pH, and 
a decreased seizure susceptibility (Millichap, 1969). This 
increased brain co2 level is accompanied by an increased 
CNS ratio of extracellular/intracellular sodium ions, 
• 
which stabilizes the neuronal membranes and limits aberrant 
discharges. Additional studies have demonstrated that 
acetazolamide decreases the uptake of radioactive sodium 
by brain cells (Millichap, 1965). It is difficult to eval-
uate the role of light programming on this mechanism, since 
the possibility of rhythms in brain carbonic anhydrase ac-
tivity has not been investigated. However, the stability 
. 
of dosage demonstrated would indicate that either carbonic 
anhydrase activity is relatively unvarying, or that 
acetazolamide is detoxified at a rate that varies in op-
position to carbonic anhydrase activity. Acetazolamide 
is rapidly absorbed, well distributed and excreted mainly 
in an unchanged form in the urine (cf. Millichap, 1965). 
~ 
Thus, a circadian pattern in urinary excretion, which is 
greater in the dark phase in nocturnal species (Zsoter and 
Sebok, 1955; ct. Mills, 1966), might be expected to 
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increase acetazolamide clearance duriµg this phase. 
.. 
Two ancillary mechanisms for the action of acetazol-
. ~" 
~·· amide involve putative CNS neurotransmitters. Woodbury 
and Esplin (1959) demonstrated that acetazolamide admin-
istration results in increased levels of glutamic acid, 
glutamine, and GABA. Thus, if the action of aoetazolamide 
depends on GABA, a maximal response might be expected dur-
ing the dark phase (when CNS levels of GABA are maximal) • 
• However, it most oe rememQered that excretion of acetazola-
mide might be maximal in the dark phase (.!19:.! supra), and 
would thereby "neutralize" the rhythmic fluctuations in 
i' response. Gray and Rauh ( 1971) indicated an involvement 
of the monoamines NE and 5-HT in the anti-convulsant action 
of carbonic anhydrase inhibitors. These researchers claim 
that a reduction of anti-convulsant potency accompanies de-
pletion of the monoamines by synthesis inhibitors. However, 
.~ more recently, Koslow and Roth ( 1971) have shown that mono-
amines are probably not involved in this action because the 
anti-oonvulsant action of acetazolamide was similar in re-
serpinized and control animals. The fact that NE and 5-HT 
rhythms are 180° out of phase with each other complicates 
~ 
any assessment of the role of monoamines in the anti-con-
vu.lsant action of acetazolamide. 
Acetazolamide increased the extensor latenc7 time 
'• .. 
' 
; . 
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over that of control animals in both phases of the illumin-
ation cycle (Table 9 & 10). This result was not surpris-
ing since similar changes are commonly noted in the labor-
atory evaluation of anti-convulsant agents (cf. Millichap, 
1965). Acetazolamide also increased the time of clonus in 
mice during the light phase (when compared to control). 
This phenomenon is seen with other anti-convulsants, eg. 
diphenylhydantoin, and is said'to be related to the ability 
of a compound to p'°event the spread of seizure impulses 
(cf. Millichap, 1965 and Woodbury, 1969). The factors be-
hind this increased clonic time in the mouse during the 
light phase remain unclear. · 
b. Diphenylhydantoin 
As in the case of acetazolamide, there was no dif-
ference in the PD50 dose of diphenylhydantoin between 
~ phases in either species studied (Tables'7 & 8). Diphenyl-
hydantoin is well absorbed, and is distributed readily to 
most tissues. Due to extensive protein binding, only 
20-~5% of the drug exists in the free form in plasma. A 
large percentage of the total dose (95%) is metabolized 
in the liver, with the major metabolite being the p-
' hydroxyphenyl derivative. The anti-MES activity of di-
;_· 
phenylhydantoin is due to its ability to prevent the 
spread of the seizure by blocking post-tetanic potentiation 
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(PTP). The blockade occurs by stimulating "sodium pump" 
activity (Woodbury and Kemp, 1971). The lack of any cir-
cadian response is unexpected in view of the work of 
Radzialowski and Bousquet (1968), who noted that hepatic 
drug-metabolizing enzymes in the rat exhibit maximal ac-
tivity during the dark phase. ..Thus, with an enhanced drug 
' metabolism and an increased urine flow to remove the met-, 
4 abolized drug in the dark phase, a decreased potency could 
J· 
'
. 
·.• 
. 
!\·· 
!!,'' 
. 
' 
be anticipated. H'bwever, the higher levels of GABA in the 
I 
CNS during the dark phase would tend to enhance the action 
of diphenylhydantoin. The drug has been shown to decrease 
the concentration of brain' glutamic acid while increasing 
that of GABA (Vernadakis and Woodbury, 1960). More 
recently, Woodbury and Kemp ( 1971) postulated that the "hy-
perpolarization of nerve endings of inhibitory neurons by 
DPH could also increase release of inhibitory neurotrans-
mitters". The increased nocturnal GABA content could lead 
to a greater inhibitory action and compensate for the en-
hanced degrad~tion of the drug in this phase, dampening 
any circadian fluctuation. 
When: the seizure component times of diphenylhydantoin 
( 
were compared with control, the following differences were 
noted: 1) increased extensor latency time in both species 
and during both phases, 2) increased clonic time during 
', 
·, .. 
<'i 
the light phase in the rat, 3) decreased tonic extension 
time during both phases in the mouse and during the light 
phase in the rat (Tables 9 & 10). The increased extensor 
latency time and decreased tonic extension time would be 
anticipated in the case of diphenylhydantoin as these 
changes are noted with most anti-convulsants (cf. Milli-
chap, 1965). The lack of a decreased tonic extension time 
in the rat during the dark phase suggests a decreased ef-
fectiveness of dilhenylhydantoin, although the fluctuation 
of this component is not reflected in the PD50 comparisons. 
This supposition is r,einforced by the decreased period of 
clonus seen in the rat during the dark phase. An increased 
period of clonus is characteristic of the hydantoins (cf. 
Woodbury and Kemp, 1971). This exacerbation of clonus 
has been attributed to a hydantoin-induced decrease in the 
level of pre-synaptic inhibition in various tracts involved 
with the production of clonic movements (Woodbury, 1969). 
These fine changes in component timing might in-
dicate a greater rhythmic fluctuation in the metabolism of 
diphenylhydantoin in the rat. This possibility is further 
emphasized by the significant decrease 'in tonic extension 
in the light phase as compared to that of the dark phase in 
diphenylhydantoin-treated rats. Thus, the comparatively 
prolonged tonic extension during the dark phase could be 
indicative of a lower efficacy at that time, although this 
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change is subliminal when only the PD50 is considered. A 
study of the circadian pattern in diphenylhydantoin metab-
olism and turnover could prove to be valuable in consider-
ing these aforementioned fine changes. 
c. Meprobamate 
In contrast to the two drugs previously discussed, 
the PD50 of meprobamate was significantly higher in the noc-
turnal phase in the mouse, and a similar difference of bor-
• derline significance was obtained in the rat (Tables 7 & 8). 
Meprobamate's anti-convulsant actions were first described 
~ by Berger (1954), although the drug is more commonly used 
.:'. as a sedative anti-anxiety agent (Domino, 1971). The drug 
is readily absorbed and uniformly distributed; 88-9~ of 
the total dose is metabolized to either the hydroxy deriva-
·' tive (6~) or the glucuronide metabolites (30%). These met-
:··· 
abolic ch~nges occur in the liver, and their products are 
excreted in the urine (cf. Domino, 1971). The mechanisms 
of meprobamate action probably lie in its depressant ac-
tions on several CNS areas, viz. the thal~us, limbic 
system, reticular formation, hypothalamus, and spinal cord 
(cf. Smith, 1965). The higher PD50 values obtained in the 
~ 
dark phase ~ight be due to the alt~red motor activity of 
Increased motor activity during this stage 
in the circadian cycle could have antagonistic effects on 
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the general depressant action of meprobamate. One addi-
tional factor involved in the nocturnal elevation of the 
PD50 would be an increased hepatic metabolism of the drug 
during this phase. Radzialowski and Bousquet (1968) demon-
strated that the hepatic drug metabolizing enzymes have 
maximal activity in the. dark phase in rodents. These com-
bined factors probably lead to the altered efficacy of the 
drug seen in the dark phase. 
Meprobamate•increased extensor latency time and de-
creased tonic extension time in both species and all phases, 
;, when compared with controls (Tables 9 & 10). As dis-;. 
cussed previously (cf. discussion, section V-D-2-a and 
V-D-2-b) these changes were anticipated, and confirm the 
r anti-convulsw;a.t efficacy of this agent. The duration of 
:( 
the clonic phase was also increased during both phases in 
the mouse and during the light phase in the rat. This 
increased clonus with diphenylhydantoin and acetazolamide 
has been previously discussed (cf. discussion, section 
V-D~2-b); however, an action of the type noted for di-
phenylhydantoin has not been demonstrated for meprobamate. 
The enhanced clonue noted during the light phase in the 
~ 
rat might be indicative.of the increased potency of·mepro-
· bamate during this phase of diminished activity. 
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d. Phenobarbital Sodium 
Phenobarbital in rodent species during both phases 
gave identical changes as those noted with diphenylhydan-
:.c toin, viz. an unaltered PD50 value (Tables 7 & 8), with 
finer differences in the duration of rat seizure components 
(Tables 9 & 10). Phenobarbital is 77-89% metabolized in 
the liver via para hydroxylation of the phenyl ring. This 
inactive metabolite is excreted in the urine (Woodbury and 
Kemp, 1971). In ae.dition, roughly one third of an ad-
" 
' 
ministered dose of phenobarbital is bound to plasma protein 
(cf. Millichap, 1965). The anticonvulsant actions of phen-
obarbi t'al are "multiple and rather nonselective as compared 
with the rather pure effects possessed by DPH" (Woodbury, 
1969). Some of these effects include inhibition of oxi-
dative metabolism, altered transport of sugars, uncoupling 
of oxidative phosphorylation (cf. Woodbury, 1969) and a 
decrease in the production of free acetylcholine (McLen-
nan and Elliot, 1951). In consideration of phenobarbital's 
metabolism and mechanisms of action, a maximal effect 
might be expected to occur during the light phase of the 
cycle due to decreased hepatic metabolism (Radzialowski 
and Bousquet, 1968) and decreased urinary flow (Zsoter and 
Sebok, 1955). In addition AOh levels are lower at this 
time (Friedman and Walker, 1969b; Massarelli .!! ~·• 1970) 
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and oxidative metabolism appears to be minimal as reflected 
·y.· 
" by the decreased GABA levels of this phase. The stability 
of the PD50 and phenobarbital's reeemblence to diphenyl-
hydantoin under similar conditions suggests that these 
aforementioned mechanisms are less important for pheno-
barbital's anti-convulsant action than the common action 
that it shares vith diphenylhydantoin - an inhibition of 
post-tetanic potentiation (cf. Woodbury, 1969). 
When seizu~ component times are considered, pheno-
barbital administration led to an increased extensor 
latency time in both species during both phases, and a de-
creased tonic extension and.an increased clonic time during 
both phases in the mouse, and during the light phase in 
the rat (Tables 9 & 10). Once again, these alterations 
were similar to those of diphenylhydantoin, and might be 
due to similar mechanisms. The reason for the fine dif-
ferences in the seizure component times of the rat during 
different phases is unclear, but might lie either in some 
difference in the metabolic pattern or in the degree of 
subliminal depression in these two species. 
e. Amino-oxyacetic Acid 
' . Amino-oxyacetic acid (AOAA) has been reported to 
. . 
be an effective ant1-oonvuJ.eant oapable of abolishing the 
tonic extensor phase ot electroshock seizures (Kuriyama 
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et al., 1966). Attempts to duplicate this action in the 
--
i-,·. present study were unsuccesefu1, even though the trial 
doses ranged between the ED1 and LD40. There were only two 
apparent differences between the two studies: 1) the 
seizure induction method, 2) the type of light source used. 
Kuriyama and co-workers ( 1·966) used sku11 electrodes, 
whereas corneal electrodes were used in the present study. 
· These two methods of seizure induction are apparently dif-
i. 
ferent in their ac4tion, as the minimal electroshock thres-
hold is 61 ma. in ~ne (sku11 electrodes) and 10 ma.' in the 
other (corneal electrodes). A plausible explanation of 
this difference might lie in the pathways involved in 
seizure induction. ·A shock administered via sku11 elec-
trodes might initiate seizure by either direct stimulation 
of surface tissue layers or by a direct spread of the cur-
rent across the sku11 or meningial linings to the spinal 
cord. Administrati.on of shock via corneal electrodes 
probably initiates a seizure via supra maximal stimulation 
of afferent tracts; the seizure occurs due to transmission 
of this stimu1us through the brain pathways to the spinal 
, cord. 
~ 
It is also possible that the difference in the 
quality of light source used could contribute to the dif• 
ferences noted in the data between the two laboratories. 
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Fluorescent lighting was used as a light ~ource in the in-
itial study (Roberts, personal communication), while full 
spectrum. daylight (Vitalite) was used in the current study 
(cf. Figure 1). Although this difference might seem unim-
portant, the effects of altered spectrum. of light can be 
marked in certain biological systems (cf. section II-A-2). 
Two consistent findings were noted with higher 
doses (50-70 mg./Kg.) of AOAA: an increase in extensor 
latency and tonic•extension times (Table 13). The in-
' 
creased extensor latency time is not surprising in light 
of the action of AOAA in increasing GABA content of the 
CNS (Kuriyama .ll .!J:.., 1966). The role of increased content 
of this putative inhibitory substance in seizure mechan-
isms has already been described (cf. section II-D-5). 
However, the increased duration of tonic extension is quite 
interesting as many drugs that prolong extensor latency 
time cause a decreased tonic extension time (.!!!!!supra). 
However, both tonic phases (flexion and extension) of MES 
seizure are enhanced by the drug. This prolongation of the 
tonic phase seems to be quite an ano~alous response in 
light of GABA's inhibitory actions, and a study of the 
~ 
actual role of GABA in the timing of seizure components 
would prove to be a most informative and valuable study. 
:~ 
E. A Critique .2! the ~ .Qf Twenty-four 
1!Q!!!: Rhythms ..!!! Research 
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Studies of the 24-hour fluctuations in the content 
of biochemically important substances are necessary for a 
true assessment of the dynamic relationships involved in 
homeostasis. Studies of this type allow the investigator 
to observe a dynamic rather than the static picture usually 
observed in studies done at a single timepoint. All too 
• 
often, investigators observe static phenomena at a spec-
ified timepoint and fail to denote the time of their ob-
servation in their reports. Misleading estimates of par-
ameters result when one attempts to evaluate data obtained 
by different research groups at undefined times. In con-
trast to the incomplete information gleaned from a single 
timepoint study, the knowledge of circadian patterns allows 
the investigator to establish dynamic interrelationships in 
biochemical and/or physiological systems, and permits him 
to select an optimal time for the study of a given system. 
A certain amount of caution must be exercised in 
the interpretation of 24-hour fluctuations in biochemical 
levels since the contenttof the substance is not the only 
critical factor. The actual mechanisms occurring at the 
receptor l•Tel t~r these aubatancee are also quite impor-
tant, and measurement of the total content of a eubetanoe 
.::. 
221 
yields little information concerning the intrinsic activity 
at a given time. Furthermore, the presence of simultan-
eous rhythms of different biochemical substances in mutu-
ally \antagonistic or ·synergistic systems can obscure the 
specificity of a related physiological rhythm. 
studies in chronotherapeutics are just beginning to 
elicit useful information concerning diurnal and nocturnal 
drug dosage schedules. The relative importance of an ap-
preciation of circ\.dian rhythms in drug metabolism be-
comes apparent in the latter sections of the discussion 
(~supra). Monitoring of the rhythms in drug responses 
allows for some speculation concerning the drug's relation-
ship to biochemical parameters, and studies of this type 
might eventually aid in clarifying the actual mechanism of 
action of certain drugs. It is apparent from this study 
that drugs, which affect a specific neurochemical system, 
are more likely to follow the circadian fluctuations of 
that system than drugs, which' have non-specific actions. 
This latter group appears to affect multiple neurochemical 
systems and their rhythms, if present at all, are more dif-
ficult to define due to .the possibility· of actions on many 
( 
systems that might have differential patterns with differing 
maxima and periods. In conclusion, the current atudy in-
dicates the need for further research in the area o.f chron-
opharmacology a~d chronotherapeutics. 
• 
.. · 
CJIAPTER SIX 
SUMMARY 
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1. The study involved an initial adaptation of adult rats 
and mice to controlled laboratory conditions for three 
weeks prior to analyses of regional brain content of trans-
mitter suspects or to evaluation of convulsant and anti-
convulsant activity. Full spectrum lighting was used. 
Two lighting cycles that were 1800 out of phase with each 
other were used to determine the endogenous or exogenous 
character of some of the measured parameters. The normal 
cycle lasted from ~800-2000 hours, and the reverse cycle 
from 2000-0800 hours. 
2. The.catecholamine (either DM.or NE) content of various 
areas of the rat brain was found to vary in a circadian 
fashion. The lev~ls of these amines in the corpus stria-
tum varied in an exogenous circadian pattern, while that of 
the _upper brainstem (US) and lower brain~tem (LS) exhibited 
an endogenous circadian one. The peak of the striatal 
rhythm was noted during the nocturnal phase, while that of 
the brainstem rhythm occurred at 2400 or 0600 hours, re-
gardless of the lighting cycle used. 
3. Serotonin levels of rat brain exhibited differential 
' circadian patterns depending upon the region examined. 
Striatal and upper brainstem 5-HT content varied in an ex-
ogenous circadian pattern with a diurnal peak. The rhythm 
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of 5-HT levels of the LS exhibited a circadian pattern with 
a nocturnal peak on the normal light cycle. Reversal of 
the light cycle appeared to cause a flattening of the 
rhythm, possibly because of the presence in this ti'saue of 
concomitant endogenous and exogenous rhythms. 
4. The GABA levels of the rat frontal cerebral lobe, 
cerebellum, and corpora quadrigemina fluctuated in an ex-
ogenous circadian pattern with a nocturnal maxima. The 
GABA rhythm of the TH-HT appeared to represent the inter-
action of two or more patterns, since an exogenous circadian 
pattern !!!h marked fluctuation was noted in this area. 
5. Circadian patterns were found in glycine levels in most 
regions of the CNS examined. Patterns with sharp nocturnal 
peaks were noted in the pons and thoracic cord, while 
rhythms with sustained maximal levels throughout the dark 
phase were found in the cervical and lumbar enlargements. 
No definitive pattern was noted in the medulla. The 
rhythms of the spinal cord enlargements were thought to 
be related to the inhibitory functions of glycine in in-
terneuronal inhibition. 
6. Photoperiod reversal appeared to cause some alterations 
in catecholamine metabolism, while it had little effect 
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on the levels of 5-HT or GABA. Dopamine content of the 
CS and LS is significantly elevated by the reversed light 
' cycle. Norepinephrine levels of the CS and LS also ex-
hibited a significantly increased peak level over that seen 
on the normal cycle, while the basal level of NE in the US 
was elevated by photoperiod reversal. These effects on 
regional catecholamine content are indicative of the adap-
tation stress due to photoperiod reversal. 
7. An examination of the susceptibility of vehicle-
treated mice to MES seizure in different phases of the 
programmed lighting schedule revealed only one significant 
alteration in seizure component timing. The extensor lat-
ency time was shorter in duration during the dark phase. 
No change was noted in the minimal electroshock seizure 
threshold. A comparison of the two control groups, saline-
treated versus acacia-treated, revealed a significantly 
increased tonic extension time in the acacia-treated group. 
8. Peak toxicity of the convulsant compounds allylglycine 
and strychnine in mice occurred during the light phase. 
This peak toxicity corresponded with the phase in which 
t 
minimal GABA and glycine level,s occur in rodent species. 
The data suggest that information regarding the action of 
such agents on biochemical systems can be obtained in 
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studies of 24-hour fluctuation in drug effect. 
9. The anti-convulsant action of acetazolamide, diphenyl-
hydantoin, and phenobarbital in the rat or mouse was un-
changed when evaluated in light and dark phases. Diphenyl-
hydantoin and phenobarbital gave similar changes in seizure 
component times in both rodent species: increased ex-
tensor latency during both phases in both species, and in-
creased duration of clonus with decreased tonic extension 
time in both phases in the mouse and during the light 
phase in the rat. These phase differences in the rat ·sug-
gest some finer differences in the metabolism or respon-
siveness between the two species. 
10. The PD50 of meprobamate was significantly elevated 
during the dark phase in the mouse. A similar elevation of 
borderline significance occurred in the rat. This fluc-
tuation of the PD50 appeared to be due to an alteration of 
the animal's responsiveness to the general depressant ac-
tions of meprobamate. 
11. Amino-oxyacetic acid pretreatment .in mice prolonged 
the tonic extension phas~, when administered in doses of 
greater than 50 mg~/Kg. No discernible circadian differ-
ences were noted in thie response. Although potent anti-
convulsant actions have been attributed to this agent when 
r 
; 
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seizure is induced ~ia skull electrodes, these effects are 
apparently lacking when MES is administered via corneal 
electrodes. 
CHAPTER SEVEN 
APPENDIX 
~ [;. I 
Appendix ! 
Cortical GABA levels of rate on a "normal" illumination 
cycle.* 
Table 14. GABA levels are expressed in micromoles/gram 
WTW plus or minus their respective standard deviation 
(n = 6). 
TIME GABA, mcM./gm. WTW 
0600 2.68 ± 0.26 [) 
1200 2. 33 ± 0.43 
1800 2.38 ± 0.45 
2400 2.47 ± 0.32 
*This study was conducted in the month of March, 1970. 
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Appendix ~ 
A comparison of the circadian fluctuations of dopa-
mine and homovanillic acid levels in rat CS revealed an 
inverse relationship (Figure 27 & 28). 
; 
HVA levels were determined by the method of Juorio 
and co-workers (1966). The method involved the separation 
of HVA from an acetic acid brain extract on a Dowex 1X2 
column (0.4 x 2.0-2.5 cm.). The column was washed with 
distilled water, and HVA was eluted with 0.1N HCl. A 
portion of the acid eluate was developed for fluorimetric 
quantification by addition of 5N NH40H containing FeCl3, 
20 mcg./ml. The reaction was stopped after four minutes 
by addition of 0.1% cysteine hydrochloride, and fluores-
cense was read at }20 mm. (excitation) and 4~5 mm. (emis-
sion) on an Aminco-Bowman SPF (slit sche~e 2). 
The biphasic rhythm was probably produced by the 
housing of these animals in our general research labora-
tory. Thus, a peak occurred at the mid-dark phase, with 
a supplemental peak occurring in the midafternoon, when 
environmental stimuli and feeding led to arousal in these 
normally quiescent animals. These circumstances caused 
an increase.in motor activit7 during the afternoon. 
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Figure 27. The concentration of DM and HVA in the rat cor-
pus etriatum ae a function of time. DM content ie expres-
sed in mcg./gm. WTW on the 1eft ordinate. The concentra-
tion of HVA in mcg./gm. WTW is expressed on the right or-
dinate. ~ is expressed on the abscissa in hours CST. 
The black ~ indicates the dark phase of the illumination 
~ 
cycle. yertical brackets are used to indicate the stan-
dard error of the mean (n = 6). 
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Figure 28. The concentration of DM and HVA in rat corpus 
striatum as a function of time. The levels of DM and HVA 
from the previous figure are expressed 'as a percentage of 
< 
the minimal, or trough, value. The percentage is indi-
cated on the ordinate. The abscissa is as for the pre-
vious figure. 
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Appendix Q 
The analysis of variance (ANOV) was also performed 
on the pooled ~ to investigate the significance of the 
differences noted between tissues, phases, and cy.cles. 
Interactions between tissues and phases, tissues and cycles, 
phases and cycles, and.tissues and phases and cycles were 
also examined by this method. 
The 3-way ANOV determination was performed at the 
University of Illinois College of Pharmacy, using a stan-
dardized program on.the Wang 700-A computer (a description 
of this technique can be found in "Biostatics in Pharma-
cological Testing" by c.w. Dunnett in Selected Pharmacolott-
~l Testing Methods, Volume 3, Marcel Dekker, Inc.: New 
York, 1968). 
The P-values are summarized in Table 15. It is evi-
dent from this table that s~atistically significant dif-· 
ferences were noted only between pooled levels of DM and of 
glycine. Significant differences between the normal and 
reverse cycles were noted in the case of DM and GABA levels 
of the CTX and CBLM indicating the possibility of a lunar 
or annual influence in these rhythms, 
t 
A tissue-phase interaction was noted in the case of 
D~ content. Thie is not surprising as other statistical 
COMPARISONS 
Tissue-
tissue 
5-HT GABA 
(CQ/ 
TH-HT) 
~ 
(CTX/ 
CBLM) 
( 0.01 <0.01 <0.01 <0.01 <0.01 
GLY 
-
0.05 
~!~~tph~::e- <0.01 >0.05 >0.05 0.05 >0.05 0.05 
Normal cycle- 0.05 >0.05 )0.05 )0.05 (0.01 Reverse cycle 
INTERACTIONS 
Tissue-
phase 
Tissue-
cycle 
Phase-
cycle 
Tissue-
phas e-
cycle 
(0.01 >0.05 >0.05 >0.05 >0.05 >0.05 
>0.05 >0.05 >0.05 )0.05 >0.05 
>0.05 <0.01 >0.05 >0.05 )0.05 
>0.05 0.01 >0.05 )0.05 >0.05 
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Table 15. Summary of probability values determined by 
analysis of variance. Compounds are. indicated horizontal-
( 
ly and the various items compared are described in the 
vertical column at the left. 
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procedures had indicated a reversal in only one of the 
rhythms tested. When tissue-cycle interactions were tested, 
no significant differences were found. NE levels exhibited 
significant differences when tested for both phase-cycle 
and tissue-phase-cycle interactions. 
From this finding it is apparent that reversal in the 
amine rhythm was not complete for the period of the reversed 
illumination cycle used. This fact was evident and noted 
earlier when it was shown that reversal of the brainstem 
NE did not occur. 
This analysis differs from that utilized in the thesis 
in that only pooled data was considered. The findings, how-
ever, are in g~neral agreement with those of the Results 
Section. Some of the significant differences obtained be-
tween peak and trough values by techniques normally used in 
chronobiology are lost when data is thusly pooled • 
• 
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